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Abstract
Accurate empirical modelling of the treatment beam is necessary to ensure accurate delivery of dose
to the intended target site. Dose calculations within the treatment planning system (TPS) for
Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) treatment rely upon accurate
beam data. Inaccuracies within the empirical measurements will propagate as errors throughout
calculated patient dose distributions (Tyler, 2013). The necessary empirical measurements for beam
commissioning include: percentage depth dose (PDD), output factor (OF) and beam profiles. Thus,
especially for the consideration of the afore mentioned small radiation fields, it is important to
ensure the most appropriate detector is chosen to conduct measurements of the treatment beams to
achieve the highest possible accuracy in measurement of beam parameters.

Stereotactic Body Radiation Therapy (SBRT) requires precise delineation of the target using modern
imaging modalities (MRI, CT etc.), accurate dosimetry to ensure the planned dose is delivered
correctly and effective patient immobilisation. For extracranial sites the treatment accuracy is
affected by tumour delineation which identifies the extent of the tumour volume and tumour motion
resulting from the physical, biological and physiological processes of the human body. Delivery of
radiation using highly conformal and small radiation beams presents challenges for dosimetry and
quality assurance (Heydarian, 1996), (Das, 2008). To correctly measure dose in a small field an
ideal dosimeter must exhibit properties including: small sensitive volume, near water equivalence,
minimal beam perturbation and no dose-rate, energy or directional dependence (Pappas, 2008).
Also, treatment planning for dose calculation must be conducted using algorithms which can
account for the impact of the heterogeneities found in the abdomen and thoracic cavities to ensure
calculation of the dose to tissue in regions with complex scattering conditions is accurate (Rubio,
2013).

In charged particle radiation therapy, the deposition of dose by charged particles within a small
volume at the Bragg peak is uniquely sensitive to the particles penetration range, and it is directly
dependent upon the incident beam energy and any small variations in material density and stopping
power along the beam path (Mirandola, 2018). Significant tumour under/over dosage can be the
result of incorrect estimation of in-patient beam penetration (Paganetti, 2012). The routine
measurement and verification of percentage depth dose curves of Bragg peaks for charged particle
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radiotherapy delivery systems is vital to ensure safe provision of radiotherapy treatment (Cantone,
2013). Unfortunately, devices providing a means of fast verification (for daily measurement) of
beam energy stability in-phantom with high precision, accuracy and reliability are not readily
available.

The Serial Dose Magnifying Glass (sDMG) is a multi-strip silicon detector designed by the Centre
for Medical Radiation Physics (CMRP) and is comprised of two linear arrays of 128 diodes
separated with pitch 0.2 mm. A monolithic silicon detector array, referred to and designated as DUO,
designed by the CMRP is comprised of 505 silicon diodes arranged in two bisecting orthogonal
linear arrays of 253 diodes, sharing a common central pixel, with pitch 0.2 mm.

This work examines the properties of the high spatial resolution linear silicon detector array, sDMG,
for small field dosimetry and quality assurance (QA) of SRS, SBRT and Motion Adaptive Radiation
Therapy (MART) using photons and the feasibility of the detector for fast, independent energy
verification in charged particle beam radiation therapy. The 2D monolithic silicon detector array
DUO was also investigated for dose verification in heterogeneous scattering conditions in MART
and beam profiling in proton therapy.
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Chapter 1
Introduction

1.1 Overview
Radiation therapy is a cancer treatment modality which is both safe and effective for many different
types of cancers. Treatment by radiotherapy comprises the precise application of radiation to
abnormal cancerous cells and involves the use of different forms of radiation, such as; high energy
X-rays, gamma rays, electrons, protons or carbon-ions, to damage and/or kill cancerous cells while
preserving healthy cells and thus prevent the cancer cells from growing abnormally within the
human body (What is Radiation Therapy? - Targeting Cancer, 2020).

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) require precise
delineation of the target using modern imaging modalities (MRI, CT etc.), accurate dosimetry to
ensure the planned dose is delivered correctly and effective patient immobilisation. For extracranial
sites, in SBRT, the treatment accuracy is affected by tumour delineation which identifies the extent
of the tumour volume and tumour motion resulting from the physical, biological and physiological
processes of the human body.

Delivery of radiation using highly conformal and small radiation beams, of photons or charged
particles, presents challenges for dosimetry and quality assurance (Heydarian, 1996), (Das, 2008).
To correctly measure dose in a small field, an ideal dosimeter must exhibit properties including:
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small sensitive volume, near water equivalence, minimal beam perturbation and no dose-rate,
energy or directional dependence (Pappas, 2008).

In charged particle radiation therapy the deposition of dose by charged particles within a small
volume at the Bragg peak is uniquely sensitive to the particles penetration range, and it is directly
dependent upon the incident beam energy and any small variations in material density and stopping
power along the beam path (Mirandola, 2018). Significant tumour under/over dosage can be the
result of incorrect estimation of in-patient beam penetration (Paganetti, 2012). The routine
measurement and verification of percentage depth dose (PDD) curves of Bragg peaks for charged
particle radiotherapy delivery systems is vital to ensure safe provision of radiotherapy treatment
(Cantone, 2013). Unfortunately, devices providing a means of fast verification (for daily
measurement) of beam energy stability in-phantom with high precision, accuracy and reliability are
not readily available.

This work investigates the utilisation and accuracy of silicon detector arrays, designed and
developed at the Centre for Medical and Radiation Physics (CMRP) at the University of
Wollongong (UOW), for independent dose verification of small photon radiation beams in motion
adaptive radiation therapy and fast independent energy verification in charged particle radiation
therapy.

1.2 Objective of the study
The objective of this work is to examine the properties of the high spatial resolution linear silicon
detector array, Serial Dose Magnifying Glass (sDMG), for small field dosimetry and quality
assurance (QA) of Stereotactic radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT)
and Motion Adaptive Radiation Therapy (MART) using photons and the feasibility of the detector
for fast, independent energy verification in charged particle beam radiation therapy. The 2D
monolithic silicon detector array DUO was also investigated for dose verification in heterogeneous
scattering conditions in MART and beam profiling in proton therapy.
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1.3 Thesis structure
This thesis is composed of 7 chapters investigating the use of two silicon detectors as QA devices
across photon and charged particle beam radiation therapy. This chapter, Chapter 1, provides; a
short introduction, an overview of the thesis objective and the essential structure of the work.

Chapter 2 provides a literature review and background to introduce the forms of advanced external
beam radiotherapy treatment delivery modalities available today, such as; IMRT, SBRT, SRS,
proton therapy and carbon-ion therapy. The chapter describes the necessity and importance of
quality assurance processes, discusses and highlights the complexities of small field dosimetry
relative to available quality assurance devices and summarises the specifications of the
commercially available systems.

Chapter 3 characterises the dosimetric properties of the Serial Dose Magnifying Glass (sDMG)
under photon irradiation, investigating and presenting the results of measurements of radiation
hardness, dose linearity, dose per pulse dependence, percentage depth dose measurement, beam
profiling and output factor relative to the gold standard clinical dosimeters, ionisation chambers and
radiochromic film. This chapter also proposes an investigation into the optimum resolution required
to reconstruct beam profiles in stereotactic radiation therapy (SRT) modalities based on an analysis
of high resolution radiochromic film data, conducted to generate recommendations for the pixel
separation required to accurately measure beam penumbrae and profiles.

Chapter 4 is centred on the complexities of QA and dose verification of treatments of small volume
tumours within the lungs which require small conformal radiation beams and real time motion
adaptation to improve treatment efficiency and reduce normal tissue toxicity. Motion adaption is
achieved through Multi Leaf Collimator (MLC) tracking, which has been applied clinically to lung
Stereotactic Ablative Body Radiotherapy (SABR) treatments (Booth et al., 2016). The combination
of small field dosimetry, target motion and heterogeneous scattering conditions is challenging for
accurate dose measurement in real-time and thus measurements utilising sDMG and DUO in
phantoms with various scattering conditions and motion strategies are discussed. The measurements
undertaken in Chapter 4 investigate the effects of homogenous and heterogeneous scattering
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conditions upon the delivered dose distribution in the treatment of dynamic targets using small
photon radiation fields and aims to evaluate the performance of the sDMG and DUO detectors
compared to the gold standard of high spatial resolution two-dimensional dosimetry, EBT3 film.

Chapter 5 aims to introduce the use of the sDMG and DUO detectors for lateral beam profile
measurements in a clinical proton radiation beam with energy 129.46 MeV at the Francis H. Burr
Proton Therapy Center (FHBPTC) at Massachusetts General Hospital (MGH). The measured results
from sDMG and DUO for exposure to a proton pencil beam spot, used in proton pencil beam
scanning, will be compared to a commercially available ionisation chamber array, MatriXX, used
routinely in the clinic. The experimental results of an investigation will be presented into the efficacy
and accuracy of the sDMG as a fast, independent proton energy verification system.

Chapter 6 introduces the use of the sDMG as a fast, independent energy verification system for use
in charged particle therapy with a heavy-ion carbon beam.

Chapter 7 concludes the work undertaken to investigate the properties of the high spatial resolution
silicon detector arrays, sDMG and DUO, for small field dosimetry and QA of SRS, SBRT and
MART using photons and the feasibility of the sDMG for fast, independent energy verification in
charged particle beam radiation therapy.
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Chapter 2
Literature Review

This chapter aims to introduce some of the forms of advanced external beam radiotherapy treatment
delivery modalities available today, such as; IMRT, SBRT, SRS, proton therapy and carbon-ion
therapy. The necessity and importance of quality assurance processes is highlighted and the
complexities of small field dosimetry are described. Finally, the operation and utility of essential
dose measurement devices are described and the tools and devices commercially available are
summarized.

2.1 Cancer and Radiation Therapy
Cancer refers to a disease of the cells of the human body in which abnormal cells grow in an
uncontrolled way into a mass, known as a tumour. These abnormal cells eventually damage or
invade surrounding healthy tissues and may spread to other parts of the body and cause further harm
through uncontrolled growth of additional tumours (What is cancer? | Cancer Australia, 2020). This
invasive action of abnormal cells spreading throughout the body and forming secondary tumours is
referred to as a process known as metastasizing.

The World Health Organisation (WHO) describes cancer as the second leading cause of death
worldwide, being responsible for approximately 9.6 million deaths in 2018 (Cancer, 2018). The
three leading modalities for the treatment of cancer are surgery, chemotherapy and radiation therapy
(radiotherapy) (Types of Cancer Treatment - National Cancer Institute, 2020).
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In 2018, the most common causes of cancer related death worldwide were (Cancer, 2018):



Lung – 1,760,000 deaths



Colorectal – 862,000 deaths



Stomach – 783,000 deaths



Liver – 782,000 deaths



Breast – 627,000 deaths

Radiation therapy is a cancer treatment modality which is both safe and effective for many different
types of cancers. Treatment by radiotherapy comprises the precise application of radiation to
abnormal cancerous cells and involves the use of different forms of radiation, such as; high energy
X-rays, gamma rays, electrons, protons or carbon-ions, to damage and/or kill cancerous cells while
preserving healthy cells and thus prevent the cancer cells from growing abnormally within the
human body (What is Radiation Therapy? - Targeting Cancer, 2020). The applied radiation
physically damages the DNA in the abnormal cancerous cells which biologically interrupts the
cancer cells ability to multiply, this leads to shrinking and eventually destruction of the tumour.
Unlike the cancer cells, normal healthy cells within the human body can recover from the effects of
the radiation more easily (What Is Radiotherapy? Benefits & Side Effects - TROG Cancer Research,
2020).

The potential benefits of radiotherapy to the patient, in contrast to chemotherapy and surgery,
include (What Is Radiotherapy? Benefits & Side Effects - TROG Cancer Research, 2020):



Patients find that radiotherapy treatments have minimal impact upon their daily schedules,



Radiotherapy treatments are generally conducted without requiring prolonged
hospitalisation,



Individual treatment sessions often require less than one hour to be completed, sometimes
less than thirty minutes.

Radiation therapy may be prescribed as a definitive treatment modality in some cases, but it is most
often prescribed in combination with other treatment modalities, such as; chemotherapy and surgery,
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to achieve the greatest curative benefit to the patient.

2.2 External Beam Radiotherapy
External Beam Radiotherapy (EBRT) describes the most common method of providing and
delivering radiotherapy and primarily includes the utilization of a linear accelerator, often referred
to as a linac. The linac generates high energy photon or electron beams of radiation, outside of the
patient, which are precisely directed at a target within the patient (Mayles, 2007).

2.2.1 3D Conformal Radiotherapy (3DCRT)
The essential form of modern external beam radiotherapy delivered to patients is referred to as 3D
Conformal Radiotherapy (3DCRT). The goal of conformal radiotherapy is to achieve the delivery
of a high-dose, which conforms to the targeted volume, whilst ensuring the organs-at-risk (OARs)
receive a low-dose, so as not to cause any complications (Mayles, 2007). 3DCRT involves the
utilisation of three primary technological advances (Elith, 2011):



Advanced imaging modalities, such as; computed tomography (CT), magnetic resonance
imaging (MRI) and positron emission tomography (PET), to visualise and provide a 3D
anatomical model of the target and OARs for accurate identification,



Improvements in computational technology enabling the treatment planning system (TPS)
to incorporate these images and produce dose calculations visualised on the images,



Development of the MLC allowing precise shaping of the radiation beam to the shape of
the target volume in the beams-eye view (BEV).

The combination of these advances enabled three-dimensional images to guide the treatment
planning process. This form of EBRT is widely used in the treatment of tumours in; the central
nervous system, head and neck, thorax, pancreas, prostate and rectum (Purdy, 2008). The most
significant disadvantage of 3DCRT is the limited ability to generate conformal doses to concave
targets, this results in higher organs-at-risk doses as the target wraps around critical structures.
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2.2.2 Intensity Modulated Radiotherapy
Intensity Modulated Radiotherapy (IMRT) is a form of external beam radiotherapy delivery which
utilises radiation beams with non-uniform radiation fluence (Webb, 2003). IMRT enables the
delivery of comparatively improved dose distributions relative to 3DCRT due to the capability to
sculpt and conform the dose distribution around targets which are composed of complex shapes
(Elith, 2011).

The features of IMRT which were not associated with 3DCRT include (Galvin, 2007):



Inverse treatment planning methodology, the treatment plan is generated algorithmically
based on supplied dose and target constraints



Large numbers of treatment fields and/or subfields which produce a radiation field with a
modulated intensity

Modulation of the radiation field intensity is possible using custom designed beam compensators,
however the patient specific design and production process would be impractical for modulating
large numbers of treatment fields across multiple patients. The MLC is key in modulating the beam
fluence and thus making the delivery of IMRT possible, IMRT is delivered with fixed gantry angles
with either static MLC dose segments, often referred to as step-and-shoot IMRT (or static MLC), or
with dynamic MLC dose segments, often referred to as sliding window IMRT (or dynamic MLC or
DMLC). In sliding window IMRT, the MLC leaf pairs move across the radiation field throughout
beam delivery to deliver a fluence modulated dose which is conformed to the target shape (Mayles,
2007). The capability to modulate the radiation fluence within the beam allows for significant
improvements in the sparing of surrounding critical structures due to the rapid dose falloff (Lee,
2008).

IMRT offers significant advantages in generating conformal dose to complex targets in close
proximity to critical structures (OARs), but there are some disadvantages. A significantly larger
number of monitor units (MU) are required to deliver a comparable prescription dose to 3DCRT
due to the increased utilisation of multiple subfields with small MLC apertures (Purdy, 2008).
Additionally, due to the increased number of radiation beams and beam directions used when
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delivering IMRT, there is an increase in the volume of normal healthy tissue which is exposed to a
lower radiation dose, when compared to conventional radiotherapy (Hall, 2003), resulting from the
increased exposure to head scatter and leakage radiation from the linac.

2.2.3 Stereotactic Body Radiotherapy & Stereotactic Radiosurgery
Stereotactic Radiotherapy (SRT) and Stereotactic Radiosurgery (SRS) are a class of radiotherapy
treatment characterised by the use of highly conformal photon beams to deliver high doses with
minimal geometric error within a hypofractionated regimen (Charlie Ma, 2019).

The application of this treatment methodology to tumour sites within the body, known as
Stereotactic Body Radiation Therapy (SBRT), requires accurate target delineation of the tumour
volume relative to the surrounding healthy tissue and minimisation of the safety margins resulting
from the biological and physiological motions of the tumour (Kavanagh, 2006). These goals are
realised through the implementation of accurate pre-treatment imaging protocols, image guidance
and motion management strategies. SBRT is generally utilised for the treatment of tumours with
diameters less than 5 cm (Hanna, 2015). Within the thoracic and abdominal region, possible
treatment sites may include: lung, liver and kidneys (Kavanagh, 2006),(Rubio, 2013).

Essentially, SBRT is classified as the treatment of tumours with 1-5 dose fractions which occur
outside of the brain (extracranial). SRS is generally classified as the treatment of intracranial
tumours with a single or few fractions. Dose fractions of 5 Gy or more for extracranial treatment
sites are generally considered stereotactic with fractions of 10 Gy or more for intracranial tumours
(Brown, 2014).

SBRT requires precise delineation of the target using modern imaging modalities (MRI, CT etc.),
accurate dosimetry to ensure the planned dose is delivered correctly and effective patient
immobilisation. For extracranial sites the treatment accuracy is affected by tumour delineation
which identifies the extent of the tumour volume and tumour motion resulting from the physical,
biological and physiological processes of the human body. Delivery of radiation using highly
conformal and small radiation beams presents challenges for dosimetry and quality assurance
(Heydarian, 1996), (Das, 2008). To correctly measure dose in a small field an ideal dosimeter must
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exhibit properties including: small sensitive volume, near water or tissue equivalence, minimal beam
perturbation and no dose-rate, energy or directional dependence (Pappas, 2008). Also, treatment
planning for dose calculation must be conducted using algorithms which can account for the impact
of the heterogeneities found in the abdomen and thoracic cavities to ensure calculation of the dose
to tissue in regions with complex scattering conditions is accurate (Rubio, 2013).

There are a several hypothesised radiobiological effects which describe the greater antitumour
efficacy exhibited by doses per fraction of 10 Gy and above, these include (Brown, 2014):



Damage to endothelial cells may enhance the cytotoxic effect of irradiation of tumour cells



Vascular damage which is induced by high doses of radiation lead to indirect tumour cell
death



Irradiation of a tumour at one site, with high doses, induces an antitumour immunological
rejection of any metastatic lesions present at a distant site

SBRT can be delivered using any modern linac, provided the appropriate access to image guidance
and immobilisation devices. Radiosurgery can currently be delivered via a number of contemporary
systems which include; the Gamma Knife Perfexion (Elekta AB, Stockholm, Sweden), Cyberknife
(Accuray, Sunnyvale, USA), TrueBeam STx (Varian, Palo Alto, USA) (Sheehan, 2014) and Versa
HD (Elekta AB, Stockholm, Sweden).

2.2.4 Motion Adaptive Radiation Therapy
Modern cancer therapy utilising external beam radiation therapy (EBRT) is becoming increasingly
complex having progressively introduced radiation beam shaping, intensity modulation and moving
forward to clinical implementation of radiation therapy treatments which adapt to the changing
internal anatomy attributable to patient breathing, motion and positioning.

Real-time adaptive radiation therapy (ART) is an emerging class of highly advanced external beam
radiotherapy which aims to improve the conformal delivery of radiation dose and minimise the need
for large treatment margins which are accounting for motion. These effects are achieved by reoptimising the treatment based upon the patient-specific changes in anatomy which occur during
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treatment. Within the abdomen and thorax of the patient, periodic changes in anatomy are
predominantly attributed to the motion resulting from patient breathing; such intrafraction organ
motions, can adversely impact treatment accuracy (Shirato, 2004).

Motion management strategies seek to mitigate the effects of target motion, such strategies include:
gating (Kubo, 1996), breath-hold techniques, compression and tumour tracking (Bertholet, 2019).
Tumour tracking methodologies re-position the treatment beam and/or patient robotically (Depuydt,
2011; Lang, 2014) to compensate for tumour motion. In all forms of tracking, the position of the
tumour site must be localised in real-time. Numerous technologies offer real-time localisation
capabilities, including; optical imaging of external markers or surrogates (Heinzerling, 2020),
implanted internal markers (active or passive), fluoroscopic imaging and on-board imaging (such as
kV or MV imaging) (Ng, 2012), MRI (Green, 2018), (Henke, 2018), (Keall, 2020).

Multi-Leaf Collimator (MLC) tracking (Booth, 2016), (Keall, 2014) is a motion adaptive strategy
that applies real-time tumour localisation to modify and re-position the MLC shape during
treatment. Tumour localisation can be provided using implanted radiofrequency emitters, named
beacons (Shah, 2011), within the patient. The beacons are positioned within close-proximity to the
target and deliver surrogate motion data to localize the position of the target during irradiation.

The Calypso (Varian, Palo Alto, CA) system, Figure 2.1, is the most commonly used means of
providing non-ionising continuous real-time 3D localization of implanted transponders. For clinical
use of localisation and monitoring of an internal target, three transponders are implanted in or near
to the target. Each transponder is an electromagnetic resonance circuit with a different resonance
frequency (300-500 kHz), sealed in a glass capsule for tissue compatibility and protection. A panel
positioned above the patient contains an array of excitation coils and a second array of receiver coils.
Each transponder is excited in series and the signal localised by triangulation to provide a 3D spatial
coordinate of the centroid of the transponder with a frequency of 10-25 Hz relative to the position
of the panel. The position of the transponders is then determined relative to the linac isocentre based
on the calibration of three in-room cameras detecting infrared (IR) markers on the panel (Bertholet,
2019). The panel is present in the path of the treatment beam throughout delivery with the influence
of the Calypso panel on dose difference was found to be clinically insignificant (Zou, 2013).
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(a)

(b)
Figure 2.1 (a) The Calypso panel and intrafraction motion monitoring system, the panel is
extended and positioned over the patient during treatment (Calypso | Varian, 2020). (b) The 17G
transponder beacon can be implanted in any soft tissue for localisation using Calypso (Bertholet,
2019).

2.3 Charged Particle Beam Radiotherapy
Charged particle beam radiotherapy, also referred to as ion or hadron therapy, utilises beams of
charged particles, such as protons or heavier ions, like carbon, instead of photons, to deliver dose to
the target (Mayles, 2007).

Particle beams exhibit an increase in energy deposition, and physical absorbed dose, with increasing
penetration depth, reaching a sharp maximum value of energy deposition which occurs at the end
of the particles range in the material through which it traverses. For a mono-energetic beam of
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particles this is referred to as the pristine Bragg peak (Schulz-Ertner, 2007). This behaviour of
particles is in direct contrast to the initial maximum intensity deposited by photons upon reaching
charged particle equilibrium in the medium followed by decay in intensity due to attenuation. A
percentage depth dose (PDD) comparison between photons, protons and carbon ions is shown in
Figure 2.2.

Figure 2.2 PDD profile comparison between 21 MeV photons, 148 MeV protons and 270 MeV/U
12

C ions (Schulz-Ertner, 2007). Figure reproduced with permission from ASCO Publications.

The range of the particle in the medium is directly determined by the energy of the incident particles.
Particle beams also demonstrate steep dose fall-off at the field edges, this effect combined with the
Bragg peak means that particle beams can localise dose to the target with greater precision than
photons (Trikalinos, 2009).

2.3.1 Proton Therapy
The pristine Bragg peak of a mono-energetic proton beam is too narrow and sharp to be used directly
to treat tumours of the various shapes and sizes necessary for cancer treatment. Thus, it is necessary
to broaden the peak of the beam to conform to the shape of the tumour, the spread-out Bragg peak
(SOBP). This is generally achieved using one of two methods, either; passive scattering or pencil
beam scanning, Figure 2.4.
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Figure 2.3 Diagram of the relative dose distributions from the surface of the skin for protons,
carbon ions and X-rays. The SOBP of the proton and carbon-ion beams are generated by the
summation of contributions from pristine Bragg peaks to cover the tumour target volume
(Ishikawa, 2019). Figure reproduced with permission from Wiley.

Passive scattering utilises a ridge filter to generate a spread-out Bragg peak which corresponds to
the necessary size to cover the targeted volume. Pencil beam scanning dynamically alters the path
of the particle beam using powerful scanning magnets, allowing generation of the SOBP by the
deposition of dose as individual spots within the target volume. This is often termed dose painting
and in proton therapy can be most commonly achieved by one of two methods; slice-by slice where
dose is delivered from the most distal to proximal layer of the target sequentially (Saini, 2016) or
volumetrically where repeated scans through the target volume are delivered in depth (Zenklusen,
2010). The clearest advantages of pencil beam scanning relative to passive scattering result from
the capability to optimise dose delivery, in terms of absorbed dose conformality, at both the distal
and proximal extents of a target. Additionally, availability of inverse planning methods allows for
deposition of multiple dose levels within a single field (Saini, 2016).
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Figure 2.4 Schematic illustration of the two primary methods of particle beam delivery, specific
to proton therapy. (a) Passive scattering method – a broad particle beam is generated by scatterers,
the SOBP is generated by a ridge filter, a binary range shifter alters the beam energy, and patient
specific compensation bolus and collimator is used to conform the distal edge of the SOBP to the
target in the patient. (b) Pencil beam scanning – a collimator defines the field size and scanning
magnets are utilised to scan the pencil beam in three dimensions through the target (Ishikawa,
2019). Figure reproduced with permission from Wiley.

Proton beams deposit very little physical dose within the medium beyond the depth of the Bragg
peak, shown in Figure 2.2. Thus, the physical radiation dose delivered to normal tissues at the
entrance of the radiation field and beyond the targeted area is less for protons when compared to
photons (Trikalinos, 2009).

In terms of the biological advantages of protons in comparison to photons, protons exhibit a higher
linear energy transfer (LET) than photons, however, the radiobiological properties of protons are
not that substantially different to photons (Morimoto, 2014). LET is the rate at which a particle
beam loses energy when penetrating into tissue. Photons, electrons and protons are considered to be
sparsely ionizing radiations and often referred to as low-LET radiations (Tsujii, 2012).
28

2.3.2 Carbon-ion Therapy
Important differences exist between carbon ions and protons. The foremost physical difference
between carbon ions and protons is that the peak-to-plateau ratio in the PDD profile (Figure 2.2) is
greater in carbon ion beams than it is in proton beams (Shioyama, 2015). Additionally, the beam
penumbra is smaller in carbon ion beams compared to protons beams as a result of the reduced
influence of Coulomb scattering for particles with a larger mass. Carbon ion beams also exhibit an
energy spread and range straggling that is smaller than proton beams thus carbon ion beams possess
an improved lateral dose fall-off at the field edges. Carbon ion beams demonstrate a higher physical
dose at the distal end beyond the Bragg peak compared to protons, this is caused by the primary
carbon ions undergoing nuclear interactions and fragmenting into lower atomic number particles,
referred to as a fragmentation tail (Tsujii, 2012).

In contrast to the biological comparison of protons and photons, heavy ions, such as carbon, exhibit
the similarly favourable physical properties of protons, in addition to superior biological advantage
over protons, in comparison to photons (Morimoto, 2014). Carbon-ions are densely ionising
particles and are thus considered to be a high-LET radiation type. The LET of a particle is an
important parameter to consider to evaluate biological effect as the relative biological effectiveness
(RBE) of a radiation type increases with increasing LET. The RBE is defined as the delivered dose
of radiation under investigation which is required to produce the same biological effect as a
delivered dose of reference radiation (assumed to be a Co-60 source) (Mayles, 2007). In terms of
different common radiotherapy particle types; the RBE of photons is assumed to be 1.0, for protons
an RBE of 1.1 is generally clinically used and for carbon-ions the RBE is assumed by most
institutions to be 3.0 (Lühr, 2018). These assumptions introduce uncertainties in establishing the
radiobiological dose to targets and thus more sophisticated methods of modelling RBE are in
constant active development. Carbon ions exhibit an advantageous radiobiological property
whereby the LET of carbon ions increases with increasing depth, reaching a maximum in the Bragg
peak where the targeted tumour will be located (Tsujii, 2012).

The tumour sites generally targeted for treatment using carbon ions include; non-small cell lung
cancer, malignant tumours in the head, neck and spine, ocular melanoma, prostate cancer, uterine
cancer and bone and soft tissue sarcomas (Trikalinos, 2009).
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2.4 Quality Assurance in Radiation Therapy
The processes of quality assurance (QA) in radiation therapy involve the ongoing evaluation of
functional performance characteristics of the treatment machine (Low, 2011). Assessment and
routine validation of the stability and consistency of such performance characteristics is vital for
ensuring safe patient treatment as the functional performance of a radiotherapy machine directly
influences the geometrical and dosimetric accuracy of the delivered treatment. Evaluation of
functional performance characteristics are conducted with high accuracy and precision during the
commissioning of a radiotherapy treatment delivery system. From these initial measurements
routine QA check methods utilizing the most appropriate tool or detector are established to ensure
functional performance characteristics are accurately and efficiently monitored for fluctuation or
fault. The development of new QA tools and devices which offer measurements with high spatial
resolution without requiring laborious clinical time on the machine are important for improving
treatment delivery outcomes throughout radiotherapy.

It is important and necessary to establish a distinction between routine quality assurance checks of
machine performance characteristics and patient specific quality assurance to measure the
magnitude and distribution of dose intended to be delivered to a patient.

For complex external beam radiotherapy treatment modalities (i.e. VMAT or IMRT; step and shoot
or sliding window) it is important to conduct patient specific quality assurance (QA) involving
physical measurements (i.e. in-phantom). This practice encompasses the investigation and
evaluation of the dose distribution delivered by the treatment machine compared to the predicted
dose distribution calculated by the treatment planning system (TPS) (Miften, 2018).

The most appropriate dosimeter and phantom for measurement-based patient specific verification
practices is dependent upon a number of factors:



Detector-related performance characteristics, such as; effective point of measurement,
tissue-equivalency, energy dependence, resolution, volume averaging, sensitivity, active
area, angular dependence, dose-rate dependence, output information
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Delivery technique-related characteristics, such as; beam energy, flattening filter free,
dose-rate, field sizes, dose distribution gradients, gantry rotation

Dose verification can be conducted as spatial analysis in one-dimension (a single point or line), twodimensions (a plane) or three-dimensions (a volume). The method of assessment of delivered dose
must be carefully chosen considering the strengths, weaknesses, available equipment, intended
treatment technique and time (Miften, 2018):



1D measurements - provide accurate absolute dose measurement at a single point or along
a line-profile in a phantom



2D measurement methods - must be calibrated (to yield absolute dose) and provide more
comprehensive information for plan analysis, but only in a single predetermined plane of
interest within the phantom



3D methods - can be either; true 3D measurements or calculated from 2D projections based
on reconstruction algorithms. They must also be calibrated and offer three-dimensional
assessment of the delivered dose throughout a representative volume, but are increasingly
complex and to provide accurate QA results (i.e. tolerance and action limits) must be
carefully commissioned assessing the error detection capability

2.4.1 Small Field Dosimetry
The physics of small radiation fields is an important area of investigation due to the increasing
utilization of SBRT and SRS worldwide in the treatment of cancer. Accurate and precise
measurement of absorbed dose in small radiation fields is vital to ensure radiation therapy is safely
provided to patients who will be able to directly benefit from the improvements in local control and
overall survival demonstrated by SBRT and SRS in the treatment of some cancers.

The characteristics of the ideal dosimeter for use in small field dosimetry, and consequently SBRT,
may be summarised to include the properties: near water equivalence, minimal beam perturbation
and high spatial resolution due to small sensitive volume and minimal extra cameral material, as
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well as dose-rate, energy and directional independence (Pappas, 2008). Several detectors and
dosimetry systems possess a number of these properties.

The treatment of small volume cancers often requires small area radiation beams to minimise effects
on healthy tissue. Measuring the physical effects of small radiation fields requires specialised
detectors. The challenges of small photon field dosimetry include: steep dose gradients, partial
occlusion of the beam source and lateral electron disequilibrium, as well as considerations related
to beam perturbation effects, detector size and detector packaging composition (Heydarian, 1996;
Das, 2008; Bouchard, 2015, 2015). The implications of the three main physical small field
conditions will be summarized.

2.4.1.1 Lateral Charged Particle Equilibrium
A loss of lateral charged particle equilibrium (LCPE, often referred to as lateral electron
disequilibrium) is found to occur if the maximum range of secondary electrons is larger than the
half width (or radius) of the photon beam (Aspradakis, 2010). A parameter is determined which
describes the minimum radius of a circular photon field for which at the centre of the field, the
absorbed dose to water and the collision kerma in water are equal, equation (2.1) (Palmans, 2017).

𝑟𝐿𝐶𝑃𝐸 = 8.369 × 𝑇𝑃𝑅20,10 (10) − 4.382

(2.1)

The rLCPE establishes the relationship between the minimum detector size, for which the conditions
of LCPE exist, and the photon beam field size. This parameter is dependent upon the ratio of the
measured tissue-phantom ratio (TPR) at 20cm depth in water to 10cm depth in water, this is a
common energy specifier in MV radiotherapy (Andreo, 2006). In a region in which the LCPE
condition does not exist; absorbed dose is not equal to the collision kerma in water and thus a
detector (or cavity) is unable to accurately measure absorbed dose.

2.4.1.2 Partial Source Occlusion
The focal spot of the X-ray beam is not a point but can be represented by the full-width at half
maximum (FWHM) of the bremsstrahlung photon fluence distribution that is exiting the X-ray
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target, which can be termed the direct beam source. This distribution is typically represented by a
Gaussian distribution and is the result of blurring of the finite-size electron pencil beam striking the
X-ray target caused by bremsstrahlung production and electron scattering (Aspradakis, 2010).

From the point of measurement, less of the direct beam source is visible as the collimator setting is
decreased, Figure 2.5. Thus, the indirect and extra-focal scatter becomes less important to the
measurement of dose at the point of measurement. That is, for small collimator settings, such as
those for small radiation beams, the direct beam source is obstructed (or shielded) from the view of
the point of measurement. Thus, the number of primary photons reaching the isocentre, and the point
of measurement, is reduced, this phenomenon is referred to as partial source occlusion (Aspradakis,
2010).

Figure 2.5 Schematic diagram illustrating the phenomenon of partial source occlusion (Palmans,
2018). Figure reproduced with permission from Wiley.

2.4.1.3 Volume Averaging
The size of the detector relative to the size of the radiation field is an important feature of the physics
of small field dosimetry. The signal produced within a detector (measuring absorbed dose), in
response to a radiation field, is proportional to the mean absorbed dose over its sensitive volume.
This signal is also influenced by the homogeneity of the absorbed dose over the volume of detection
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and this effect results in volume averaging. Figure 2.6 is an illustrative depiction of the
consequences, in one-dimensional (1D) space, of volume averaging upon a physical measurement
of a small radiation beam, which exhibits Gaussian curvature, by a detector which is 5 mm wide.
The dimensions of the ideal and circular detector, relative to the ideal and circular radiation beam,
are depicted in Figure 2.6 as two black dots, upon the plot. This is a theoretical depiction of the
consequences of attempting to measure the Gaussian curve (black solid line) of a small radiation
beam with a detector with volume averaging over a dimension of 5 millimetres (black dotted line)
(Wuerfel, 2013). The result measured by the detector (black dotted line) is shown to not perfectly
record the intensity of the small radiation beam, exhibiting underestimation of the radiation peak
and overestimation of the beam penumbra. Additionally, the presence of the detector within the
radiation field results in a perturbation of the charged particle fluence, this perturbation effect is
entangled with volume averaging (Palmans, 2018).

Figure 2.6 A Gaussian (solid black) curve approximates a small radiation field in one dimension,
the dotted black curve demonstrates the measurement of a detector with a volume effect (5 mm
wide), the deviation between the curves is displayed as a dot-dashed black line (Palmans, 2018).
Figure reproduced with permission from Wiley.
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2.4.2 Current QA tools
2.4.2.1 Ionisation Chamber
The ionisation chamber is the simplest form of a gas-filled detector and consists of a receptacle
filled with gas and two opposing electrodes. A voltage is applied between the electrodes and as the
gas is (theoretically) a perfect insulator, no electric current flows between the two electrodes.
Incident radiation traversing the gas will interact with and ionise the gas, the electric field present
between the electrodes causes the diffusion of the ions produced by the radiation in the gas towards
the electrodes. This produces a current which can be measured using an electrometer (Mayles,
2007).

Cavity ionisation chambers encompass two basic geometries of ionisation chamber: cylindrical (or
thimble) chambers and parallel-plate (or plane-parallel) chambers. Both of these geometries of
ionisation chamber are designed to perform as Bragg-Gray cavities in megavoltage photon qualities.

The Bragg-Gray cavity theory establishes a link between the absorbed dose in a medium and the
absorbed dose measured in a detectors sensitive volume (often referred to as a cavity). If the cavity
is small and doesn’t perturb the fluence of charged particles in the medium and if the absorbed dose
in the cavity is solely deposited by particles crossing it then the cavity is said to be obey the BraggGray conditions. Under the conditions of Bragg-Gray cavity theory the dose in the medium, D med
can be related to the absorbed dose in the cavity, D cav through the ratio of the average unrestricted
mass stopping powers of the medium and the cavity.

𝑆̅
𝐷𝑚𝑒𝑑 = Dcav ( )
𝜌 𝑚𝑒𝑑,𝑐𝑎𝑣

(2.2)

For the chamber to behave as a good approximation of a perfect Bragg-Gray cavity it should possess
the following features (Mayles, 2007):



The air cavity should be small such that the sensitive volume is well-defined.
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The central electrode and wall should be constructed from materials which are as
homogenous and water-equivalent as possible.



The chamber walls should be as thin as possible.

The Spencer-Attix cavity theory is an extension of the Bragg-Gray cavity theory which accounts for
the production of secondary electrons resulting from the hard collisions of primary electrons that
are slowing down while traversing the cavity. These secondary electrons may possess enough
kinetic energy, above a cut-off value (often denoted Δ), to either escape the sensitive volume or
produce further ionisations, thus they must be considered a part of the electron spectrum traversing
the cavity. To account for this phenomenon modification is required to the stopping power
calculated within the cavity to include this additional particle fluence (Mayles, 2007). Thus, the
absorbed dose in the medium can be related to the absorbed dose in the cavity through the mean
restricted mass collision stopping power ratio of the medium to the cavity.

In the case of small field dosimetry and small sensitive volumes it is necessary to utilise Monte
Carlo simulation to accurately model and determine the electron fluences. The accurate
determination of the particle fluence allows the use of the Spencer-Attix cavity theory for the
determination of the necessary stopping powers for calculation of dose within the medium
(Bouchard, 2015).

Deviations of the design and construction of ionisation chambers away from being perfect BraggGray and Spencer-Attix cavities necessitates the use of perturbation correction factors to ensure
accurate measurement of absolute dose to the medium. These correction factors include (Andreo,
2006):



Chamber cavity - The presence of an air-filled ionisation chamber introduces a low-density
heterogeneity into the medium.



Chamber wall - The electron fluence within the air cavity of an ionisation chamber consists
partly of electrons generated in the uniform medium surrounding the chamber which
traverse the wall, and partly of secondary electrons generated by interactions within the
chamber wall.
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Central electrode material - The cylindrical ionisation chamber has a central electrode
which is generally composed of either aluminium or graphite.



Replacement of medium by chamber - A certain volume of the medium is displaced by the
presence of the detector when a measurement with an ionisation chamber is performed.

Furthermore, the charge collected within an ionisation chamber can be different from the charge
produced by the complete interactions of radiation within the chamber gas. This difference arises
from the practicalities of electrical design and the physics of ion transport. The phenomena which
affect the charge collected include; air density correction at time of measurements, ion
recombination, polarity effects and stem (and leakage) effects. The mechanism of influence for each
phenomena must be understood and the appropriate means of correction or mitigation (or
minimisation of effect) applied.

2.4.2.2 Diamond Detector
Diamond detectors operate as a form of solid-state ionisation chamber (Laub, 2014). Ionising
radiation incident upon the diamond crystal produces electron-hole pairs which move freely through
the crystal lattice altering the electrical conductivity of the diamond. With the application of an
external bias voltage the current generated by ionising radiation is proportional to the incident
radiations dose-rate.

As diamond is composed almost entirely of carbon (except for some necessary impurities), diamond
detectors exhibit near tissue equivalent properties as the ratio of the mass attenuation coefficients of
water to carbon are nearly constant for all photon energies (X-ray Mass Attenuation Coefficients |
NIST, 2020). Diamond detectors are well suited for dosimetry in stereotactic radiosurgery and high
dose gradient regions due to their high resistance to radiation damage (Planskoy, 1980), negligible
directional dependence (Veselsky, 2018), high sensitivity (Vatnitsky, 1993), stability in prolonged
response (Hoban, 1994), small physical size (high spatial resolution) and near energy independence.
Synthetic single crystal diamond detectors with sensitive volumes of about 0.0038 mm3 have been
fabricated for relative dosimetry in small photon and electron beams. The investigated small volume
synthetic diamond dosimeter demonstrated good linearity, dose rate independence, energy
independence and minimal angular and temperature dependences (Ciancaglioni, 2012).
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To achieve accurate and reproducible dose measurements with diamond detectors it is necessary to
stabilize their dose response with pre-irradiation prior to use (Veselsky, 2018). The irradiation prior
to use reduces the impact of the polarization effect where the electric field generated by the external
bias is reduced by electrons captured in ionized traps. Diamond detector exhibit very small
temperature dependence (Veselsky, 2018) which is easily corrected and dose-rate dependence which
must be appropriately corrected to yield accurate results (Hoban, 1994).

2.4.2.3 Thermoluminescent Detectors (TLD)
The thermoluminescent dosimeter (TLD) is an ionising radiation detector which operates using the
principle of thermoluminescence (TL) (Kron, 1994, 1995). TLDs are composed of specific types of
crystal which upon exposure to ionising radiation absorb and store the delivered energy within their
crystal lattice structure, when heated the crystals re-emit that energy as light (Mayles, 2007). TL
materials are generally produced by doping phosphors with activators as with lithium fluoride doped
with magnesium and titanium (LiF:Mg-Ti) and lithium borate doped with copper (Li2B4O7:Cu)
(Sadeghi, 2015). Detection and measurement of the light output (generally using a photomultiplier
tube, PMT) upon heating can be used to identify the magnitude of dose previously delivered to the
crystal (Kry, 2020).

The processes of TL within a crystal can be explained using band theory. When the crystal is
irradiated, holes and free electrons are produced within the lattice. The free electrons may travel
within the conduction band for a short time until they are either (Mayles, 2007):



Trapped at defects within the crystal lattice, recombining with holes either radiatively (e.g.
fluorescence) or non-radiatively within the valence band or,



Captured at activated luminescence centres, and thus deactivating the centre by emission
of light.

When the crystal is heated after irradiation the electrons which were trapped within the defects in
the lattice are provided with sufficient thermal energy to escape into the conduction band. Once in
the conduction band the free electrons will again travel freely until they are either:
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Trapped at defects,



Recombine with holes within the valence band (either radiatively or non-radiatively) or,



Captured and recombine at the luminescence centres which are activated by holes
(thermoluminescence).

The final of the three processes mentioned above is responsible for the capability to accurately
measure the magnitude of dose to which the crystal was exposed by measurement of the
luminescence. The light output from the crystal is measured during the readout heating cycle using
a photomultiplier tube (PMT), converting the luminescence or light output into a current. Different
temperatures are required to readout the intensity of light emitted from different trapping centres
which possess different depths within the crystals bandgap structure. The temperature of the TLD
is increased while monitoring the light output forming a glow curve graph of signal vs temperature.
The thermoluminescence signal over a region of interest or the maximum intensity of a
thermoluminescence peak defines the measured signal from the crystal (Kry, 2020). Following the
heating and readout cycles the crystal will either return to its natural state or may require additional
heating, known as annealing, to restore it to its natural state.

The appropriate and accurate clinical utilisation of TLD’s in radiotherapy requires consideration of
the detectors clinical advantages and disadvantages. TLD’s exhibit near tissue equivalence as a
result of the chosen crystal composition. Appropriate clinically acceptable TLD materials must be
chosen to appropriately minimise the dosimetric performance related to energy dependence for the
radiation quality being measured. The limitations in use of TLD’s in a radiotherapy clinic are related
directly to the functional physical size, temperature dependence, thermal and optical fading, dose
dependence (supralinearity) and accuracy and the significant read-out and handling requirements.

Optically stimulated luminescent dosimeters (OSLD) function similarly to TLD’s except are readout using optical stimulation rather than heat. The properties of these dosimeters are similar to
TLD’s with similar disadvantages related to handling and read-out and physical size.
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Figure 2.7 An example of a thermoluminescent glow curve for LiF:Mg,Ti (TLD-100) material,
which is readout following different pre-irradiation annealing processes. The peaks 1-5 identify
the trapping centres (Kry, 2020). Figure reproduced with permission from Wiley.

2.4.2.4 Radiochromic (EBT3) Film
Radiochromic (often referred to as Gafchromic) film is a transparent and colourless film medium
which responds to ionising radiation and ultraviolet light by turning deep blue, exhibiting two
nominal absorption bands at 636 nm and 582 nm (León-Marroquín, 2016). The colour change
induced by the ionising radiation traversing the film material is proportional to radiation dose and
formed by a process of solid-state polymerisation within the sensitive layer. The radiation-induced
molecular process produces conjugated double bonds between the ends of neighbouring polymer
chains, combining to form longer structures which absorb light. This polymerisation process is
responsible for the characteristic darkening of the film and occurs over time without the need for
additional thermal, optical or chemical processing (Mayles, 2007).

The polymer chains produced within the sensitive layer upon exposure to ionising radiation absorb
light. The transmission of light through the film and thus the image present within the film can be
read out by a standard flat-bed transmission scanner (or other densitometer). The attenuation of light
traversing the film medium is described by the Beer-Lambert law relating the properties of the film
to the absorption of light. The blue image generated within film is stable up to temperatures of 60°C,
above these temperatures the image changes from blue to red.
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Radiochromic (radiotherapy) films are manufactured and sold in a number of standard
configurations designed for different purposes i.e. EBT3, EBT-XD, RTQA2, MD-V3, HD-V2. In
general these film configurations are intended for different dose ranges and are composed of
different active and base layer thicknesses (Radiotherapy Films - GAFchromicTM, 2020). EBT3 film
is the standard radiochromic film for patient dosimetry and IMRT verification and is designed for
the dose range 0.2-10 Gy. The structure of EBT3 film is symmetrical, consisting of a single active
layer (~28 um of active component, marker dye and stabilisers) between two clear polyester base
substrate laminates (~125 um) (Niroomand-Rad, 1998). The active component of radiochromic
EBT3 film is lithium-10, 12-pentacosadiyonate (LiPCDA) in crystalline form (Lewis, 2016). The
surface of the polyester substrates is treated to contain microscopic silica spheres which prevent the
formation of Newton’s Rings interference patterns when scanning using a flatbed scanner
(Marroquin, 2016). Other configurations (e.g. asymmetrical layer geometries) of radiochromic film
are available, optimised for different intended purposes.

The photon mass energy absorption coefficient (μ en/ρ) and electron mass collision stopping power
for radiochromic film are very similar to those for skeletal muscle and water. This can be attributed
to the near tissue equivalent composition of radiochromic films (9.0% hydrogen, 60.6% carbon,
11.2% nitrogen, 19.2% oxygen) (Avevor, 2017). Thus, radiochromic films (EBT3) may be
considered near tissue equivalent in response, exhibiting minimal energy dependence over the
therapeutic (MV & kV) photon energy ranges (Ataei, 2019).

Figure 2.8 Schematic drawing identifying the thickness and structure of EBT3 Gafchromic film
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(Devic, 2016). Figure reproduced with permission from Elsevier.

After irradiation the degree to which the radiochromic film darkens in response to the delivered dose
to the sensitive layer can be quantified by measuring how much light is attenuated as it passes
through the film. The darkening is measured in terms of net optical density (OD) which is defined
as the log10 of the ratio of the intensity of light transmitted through the film prior to irradiation (I 0)
to the intensity of light transmitted through the film after exposure to radiation (I) (Butson, 2003).
This quantity is proportional to dose (within certain limiting conditions):

𝑁𝑒𝑡 𝑂𝑝𝑡𝑖𝑐𝑎𝑙 𝐷𝑒𝑛𝑠𝑖𝑡𝑦, 𝑂𝐷 = 𝑙𝑜𝑔10

𝐼0
𝐼

(2.3)

For the purposes of radiotherapy dosimetry, film is generally scanned in 48-bit RGB (Red Green
Blue) colour mode at a nominal spatial resolution with the results saved in .TIFF file format. The
intensity across the film is digitised over a grid determined by the selected spatial resolution and
quantified in terms of a 16-bit pixel value describing the magnitude of red, green and blue colour at
each pixel location.

To derive dose from the intensity quantified as a 16-bit pixel value (in one of the three colour
channels), a calibration curve is necessary to relate the net optical density to dose. Ideally the
relationship between these two quantities should be linear, however in reality it is not and is only
linear over a short range, and may differ based on film batch number. Thus, the characteristic or
dose calibration curve should be established for each film batch by exposing a set number of film
pieces to known dose quantities, measuring the resultant film darkening after a standardised period
of time. Fitting the data of the calibration curve (dose as a function of net optical density) with a
polynomial (or other interpolant method) enables determination of dose values from measured net
optical densities. Further film pieces may now be irradiated with complex dose deliveries, the
delivered dose distribution along the plane of the films’ sensitive layer will be recorded and may be
read out and converted to dose values for interrogation of the delivery quality.
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In practice, for dosimetry in radiotherapy applications the red colour channel is most often used as
it provides the best sensitivity up to doses of 8-10 Gy. The green channel is used to measure higher
dose values (Papaconstadopoulos, 2014) while the blue channel offers homogeneity correction
(Chen, 2016).

Radiochromic film represents an effective solution for dosimetry in SBRT as it is high spatial
resolution, near water equivalent in response (Huet, 2014) and does not require chemical processing
to develop (Low, 2011). Film dosimetry offers a planar two dimensional measurement of dose
distributions and has been used extensively within intensity modulated radiation therapy (IMRT)
quality assurance. However, dosimetry with radiochromic film possesses significant limitations,
particularly in adaptive radiotherapy, as it is not a real-time dose measurement tool and demands a
strict calibration and handling protocol to achieve an acceptable accuracy (Tyler, 2013).

2.4.2.5 Semiconductor (silicon) detectors
Diodes are generally composed of crystals of semiconductor (i.e. silicon, germanium etc.) where
the energy of electrons within the crystal (or amorphous solid) are described by electronic band
structure theory. Band structure theory describes the ranges of energy an electron may possess
(known as bands, a continuum of acceptable energy levels) and may not possess (known as band
gaps, ranges of forbidden energies) as a part of the crystal lattice structure of the solid, a result of
obeying the Pauli Exclusion Principle (Mayles, 2007).

The controlled introduction of impurities (known as doping) alters the electronic characteristics (i.e.
electrical conductivity) of the crystal. Impurities refer to the additional ions of alternate elements to
the main constituents of the crystal which when introduced may act as either an electron donor or
electron acceptor within the crystal. Doping with electron donor elements causes an excess of
electrons (negative charge carriers) and produces an n-type semiconductor whereas doping with
electron acceptor elements creates a deficit of electrons (or excess of electron holes, positive charge
carriers) and produces a p-type semiconductor (Rosenfeld, 2020).

The most common form of diode for radiation dosimetry is the p-n diode which is composed of the
junction of a p-type (positive majority charge carrier, excess of electron holes) semiconductor with
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an n-type (negative majority charge carrier, excess of electrons) semiconductor. At the junction of
the two semiconductors the confluence between the excess electrons and excess holes produces a
region devoid of charge carriers (known as the depletion region). The terminals of the p-n diode are
attached to the n-type region (the cathode) and the p-type region (the anode). When a sufficiently
high voltage (of the correct polarity) is applied to the cathode the width of the depletion region is
narrowed until forward conduction of the majority charge carriers is allowed. The nature of the p-n
junction prevents the movement of electrons in the opposite direction.

Figure 2.9 Schematic diagram of a silicon p-n junction as a radiation detector. The incident
radiation generates excess electron (●) and hole pairs (○) which diffuse, over one diffusion length
Lp, to the p-n junction and are subsequently swept across by the built-in potential and collected
by the electrometer (Shi, 2003). Figure reproduced with permission from Wiley.

Ionising radiation traversing the semiconductor junction (which forms the sensitive detection
volume of the diode) generates electron-hole pairs by collision processes (either directly or
indirectly) along its track through the crystal lattice, Figure 2.9. For dosimetry, the quantity of
practical interest is the average energy lost by the primary ionising particle which is necessary to
produce an electron-hole pair within the crystal, known as the ionization energy. This quantity is
independent of incident radiation type and energy and provided the particle is fully stopped within
the sensitive volume of the detector, allows interpretation of the number of electron-hole pairs
generated as an indicator of the energy absorbed within the diode as a result of irradiation. The
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production of the majority and minority charge carriers in the form of electron-hole pairs and their
consequent movement within the semiconductor junction forms an electrical current within the
diode which is collected and measured. The magnitude of the collected current within the junction
under irradiation may be related to the delivered radiation dose under known conditions.

For reliable dosimetry using semiconductor detectors the correction factors and dependencies which
need to be considered include:



Diode Calibration –
o

For single point diodes it is necessary to calibrate the response of the diode to a
known radiation dose to convert charge collected to dose (Gy).

o

For arrays consisting of multiple diodes it is also necessary to expose the diodes
to a uniform stimulus to identify the independent intrinsic gains and sensitivities
(resulting from manufacturing tolerances in diode doping and pre-amplifier gain)
in each channel and correct for the discrepancies.



Temperature Dependence – diode response is expected to increase with ambient
temperature (Welsh, 2001). This effect may be attributed to the increasing thermal energy
of the charge carrying electrons.



Directional Dependence – the geometrical construction and packaging of diodes is
commonly asymmetrical, i.e. the shape, composition and relation of components
(terminals, etc.) to one another is different for different orientations. This asymmetry can
affect the response of the detector to irradiation as the beam traverses the diode at different
angles of incidence (Jursinic, 2009). Correcting for directional dependence is vital for
reliable dosimetry with semiconductor detectors in rotational treatment modalities.
Semiconductor diodes exist which exhibit minimal directional dependence as a result of
improved fabrication technology and packaging design (Petasecca, 2015).



Dose Dependence – semiconductors suffer ongoing radiation damage affects with
increasing accumulated dose as atoms within the crystalline lattice are displaced forming
recombination centres which capture charge carriers. This effect reduces sensitivity as it
limits charge carrier collection. The effects of dose dependence in diodes are reduced by
pre-irradiation (American Association of Physicists in Medicine Radiation Therapy Task
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Group 62, 2005).


Energy Dependence – diodes are composed of high effective atomic number materials (i.e.
silicon doped with phosphorous or boron) and thus are not directly tissue equivalent for all
photon energies (especially low energies) (Mayles, 2007).

Silicon diodes are commonly used in small field dosimetry (Tyler, 2013) and the quality assurance
of complex radiotherapy modalities as both point detectors and arrays. Diodes may be designed and
fabricated with a small sensitive area and size, and arrays of diodes can possess submillimeter spatial
resolution, especially in the case of a monolithic diode array topology (Wong, 2010). Silicon diodes
are not tissue equivalent but dependencies upon energy, dose-rate, temperature and angle of
radiation incidence can be corrected.

The metal oxide field effect transistor (MOSFET) dosimeter is technologically similar to a
semiconductor diode but is composed of semiconductor silicon substrate, a layer of insulating oxide
and a metal gate. The MOSFET as a dosimeter shares similar advantages and disadvantages with a
diode such as; small sensitive volume, temperature dependence, directional dependence and energy
dependence. Due to the increased complexity of the MOSFET junction they are not as readily
available in the form of pixelated arrays.

2.4.2.6 (Pixelated) Array Detectors
Pixelated detectors or array detectors are a composite dosimeter in which numerous individual
detectors are combined together in a structured geometric pattern to form an array for simultaneous
measurement across a plane or volume in a radiation field. These detector arrays are generally
composed of a series of semiconductor dosimeters or ionisation chambers forming the individual
pixels. The following table summarises the available commercial pixelated array detector systems
for radiation dose measurements and patient specific QA in EBRT, Table 2.1.

Table 2.1 Currently available commercial detector array systems, summarizing properties of both
2D and 3D dose acquisition systems (OCTAVIUS 4D - PTW Freiburg GmbH, 2020; ArcCHECK®
- Sun Nuclear, 2020; Products, 2020; MapCHECK® 3 - Sun Nuclear, 2020; OCTAVIUS Detector
1600 SRS - PTW Freiburg GmbH, 2020; SRS MapCHECK® - Sun Nuclear, 2020).
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Detector:

SRS MapCHECK®

OCTAVIUS Detector
1600 SRS

MapCHECK® 3

Company:

Sun Nuclear

PTW

Sun Nuclear

Detector
Type:

SunPoint® 2 diode
detectors

Plane-parallel, liquidfilled ionization
chambers

SunPoint® 2 diode
detectors

Number of
Detectors:

1013

1521

1527

Detector
Spacing:

2.47 mm
(centre-to centre),
Checkerboard pattern:
X & Y – 3.5 mm

2.5 mm in centre area
(6.5 x 6.5 cm2),
5.0 mm in outer area (15
x 15 cm2)

7.07 mm
(centre-to-centre),
checkerboard pattern;
X & Y – 10 mm

Detector
Size:

0.48 x 0.48 mm
(0.007 mm3)

2.3 x 2.3 x 0.5 mm3
0.003 cm3
(3 mm3)

0.48 x 0.48 = 0.23 mm2
(0.007 mm3)

Array Size:
(mm2)

77 x 77

150 x 150

320 x 260

Dose
Distribution
Analysis
(i.e. 2D or
3D)

2D

3D
(using Octavius 4D
phantom)

2D

Weight

1.9 kg

5.9 kg

5.6 kg

Detector:

OCTAVIUS® 1500

Company:

PTW

IBA

Sun Nuclear

Detector
Type:

Plane-parallel vented
ionization chambers

Air-vented parallel
ionization chambers

SunPoint® diode
detectors

Number of
Detectors:

1405

1020
(~ 32 x 32 grid)

1527

Detector
Spacing:

7.1 mm
(centre-to-centre),
checkerboard pattern;
X & Y – 10 mm

7.62 mm
(centre-to-centre),
matrix/grid pattern

7.07 mm
(centre-to-centre),
Checkerboard pattern:
X & Y – 10 mm

Detector
Size:

4.4 x 4.4 x 3 mm3
(60 mm3)

Array Size:
(mm2)

270 x 270

MatriXX
Evolution

MatriXX
FFF

4.5 (Φ) x 5
(h) mm3
(80 mm3)

4.5 (Φ) x 2
(h) mm3
(32 mm3)

244 x 244
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MapCHECK® 2

0.64 mm2
(0.019 mm3)
320 x 260

Dose
Distribution
Analysis
(i.e. 2D or
3D)

3D
(using Octavius 4D
phantom)

2D

2D

Weight

6.0 kg

10 kg

7.1 kg

Detector:

Delta4+

ArcCHECK®

OCTAVIUS® 1000 SRS

Company:

Scandidos

Sun Nuclear

PTW

Detector
Type:

p-Si diodes

SunPoint® diode
detectors

Plane-parallel, liquidfilled ionization
chambers

Number of
Detectors:

1069
(distributed on coronal
and sagittal planes)

1386

977

Detector
Spacing:

5 mm
(central 6x6 cm2 area),
10 mm
(outer area)

10 mm
Helical Grid (HeliGrid)

2.5 mm
(centre-to-centre) in
centre (5.5 x 5.5 cm2),
5 mm
(centre-to-centre) in
outer area (11 x 11 cm2)

Detector
Size:

2 (Φ) x 0.05 (h) mm3
(0.04 mm3)

0.64 mm2
(0.019 mm3)

2.3 x 2.3 x 0.5 mm3
0.003 cm3
(3 mm3)

Array Size:
(mm2)

Max. field size: 200 x
200 mm2 (200 x 380
mm2 with merging)

210 x 210
(Array diameter x length)

110 x 110

Dose
Distribution
Analysis
(i.e. 2D or
3D)

3D

3D

3D
(using Octavius 4D
phantom)

Weight

27 kg

15.4 kg

5.4 kg

2.4.3 Gamma Analysis
The measurement of an absorbed dose distribution by a detector system in two dimensions or three
dimensions necessitates a method for quantifiable evaluation of the measured distribution compared
to an expected (or reference) dose distribution. Quantifying the agreement between a measured and
expected dose distribution is uniquely important for commissioning of a TPS, commissioning a new
treatment technique and patient specific QA, the complexity of these tasks is compounded by the
presence of small area radiation beams and steep dose gradients. One methodology for evaluation
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of two and three dimensional distributions is through the use of gamma analysis.

Gamma analysis (Low, 1998) combines a distance to agreement criterion with a dose-difference
criterion. It compares the dose difference at various points of interest in a measured and comparison
dose distribution and evaluates the distance between points with the same magnitude of dose. The
distance to agreement component is particularly important for measurements within high dose
gradient regions. This method of gamma analysis can be summarised by defining two acceptance
parameters; ΔDM and ΔdM as the dose-difference criterion and distance-to-agreement criterion
respectively.

The one-dimensional representation of the application of the dose and distance difference criterion
for evaluation, gamma analysis, between two dose measurements, with one spatial dimension, is
shown in Figure 2.10, the (measured) point of interest to be evaluated is at the origin, Dm(xm), xm.

Figure 2.10 One-dimensional representation of dose-difference and distance to agreement
evaluation between dose values which possess one spatial dimensions (Low, 1998). Figure
reproduced with permission from Wiley.

The abscissa represents the spatial location of the points; measurement (xm) and comparison (xc),
and the difference in spatial location is evaluated between them, i.e xc-xm. The ordinate represents
the magnitude of dose of the points; measurement (Dm(xm)) and comparison (Dc(xc)), and the
difference in dose magnitude is evaluated between the points, δ.
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The two-dimensional representation of gamma analysis, utilizes an ellipsoidal surface to evaluate
the dose-difference and distance to agreement simultaneously between points, shown in Figure 2.11.
In this two-dimensional example the spatial notation is extended to be a vector of the twodimensional location of each of the dose points. The evaluation of the gamma value between points
can be further extended to a three-dimensional analysis.

Figure 2.11 Two dimensional representation of gamma analysis using the ellipsoid dose
difference and distance to agreement evaluation method (Low, 1998). Figure reproduced with
permission from Wiley.

The surface of the ellipsoid, shown in Figure 2.11, describes the limits of acceptance and is defined
by the following equation:

𝑟 2 (𝑟⃗𝑚 , 𝑟⃗) 𝛿 2 (𝑟⃗𝑚 , 𝑟⃗)
1=√
+
2
2
𝛥𝑑𝑚
𝛥𝐷𝑚

(2.4)

𝑟(𝑟⃗𝑚 , 𝑟⃗) = |𝑟⃗𝑚 − 𝑟⃗|

(2.5)

𝛿(𝑟⃗𝑚 , 𝑟⃗) = 𝐷(𝑟⃗) − 𝐷𝑚 (𝑟⃗𝑚 )

(2.6)

Where:
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If any portion of the compared point Dc(rc) in Figure 2.11 intersects with the defined ellipsoids
surface, the calculation is said to have passed at 𝑟⃗𝑚 . A generalized acceptance criteria calculation
can be defined using the right hand side of equation (2.3), Γ.

𝛤(𝑟⃗𝑚 , 𝑟⃗) = √

𝑟 2 (𝑟⃗𝑚 , 𝑟⃗) 𝛿 2 (𝑟⃗𝑚 , 𝑟⃗)
+
2
2
𝛥𝑑𝑚
𝛥𝐷𝑚

(2.7)

Points lying inside (and including) the surface of the ellipse, with axes having the criteria values,
have a gamma value equal or smaller than one and therefore pass. That is, if γ ≤ 1, pass or if γ > 1,
fail. This evaluation method allows for a quantitative evaluation of the agreement between twodimensional and three-dimensional dose distributions.

2.4.4 Charged Particle Range Verification
Verification of the constancy of radiation beam performance characteristics is a vital component of
a routine QA program for the delivery of radiotherapy (Arjomandy, 2019). However, extensive or
time consuming QA measurements and processes limit the time a machine is available for patient
treatment.

The deposition of dose by charged particles within a small volume at the Bragg peak is uniquely
sensitive to the particles penetration range, and it is directly dependent upon the incident beam
energy and any small variations in material density and stopping power along the beam path
(Mirandola, 2018). Significant tumour under/over dosage can be the result of incorrect estimation
of in-patient beam penetration (Paganetti, 2012). The routine measurement and verification of PDD
curves of Bragg peaks for charged particle radiotherapy delivery systems is vital to ensure safe
provision of radiotherapy treatment (Cantone, 2013). Unfortunately, devices providing a means of
fast verification (for daily measurement) of beam energy stability in-phantom with high precision,
accuracy and reliability are not readily available.
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In charged particle radiotherapy, measurements of the PDD distribution are routinely performed,
commonly measured using an ionization chamber and a computerized scanning water tank
dosimetry system. The measurement of the PDD distribution along the central axis of the charged
particle radiation beam is time-consuming with a scanning water tank due to the prolonged and
complex setup. Other dosimetry systems are available for verification of charged particle
range/energy in-phantom.

Multi-layer ionization chamber (MLIC) systems are devices which are composed of a stack of
numerous parallel plate ionization chambers sharing a single central axis of measurement (Yajima,
2009). These systems can be aligned to the central axis of the incident charged particle radiation
beam for fast measurement of charged particle depth dose distributions. The Zebra (IBA dosimetry,
Schwarzenbruck, Germany) is an MLIC consisting of 180 independent 2.5 cm diameter circular
vented plane parallel ionization chambers with a 2 mm native resolution (Dhanesar, 2013), Figure
2.12. The Zebra system is a bulky device with a mass of 10 kg and measuring 43.9 cm x 19.5 cm x
17.5 cm (Zebra - Scan monolayer & SOBP measurements | IBA Dosimetry, 2020).

Figure 2.12 The Zebra multi-layer ionization chamber device (Zebra - Scan monolayer & SOBP
measurements | IBA Dosimetry, 2020).

Radiochromic films in solid slab phantoms provide another means of charged particle range
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verification in-phantom. Film dosimetry provides significant advantages in high spatial resolution,
however also significant disadvantages in the time-consuming film processing requirements, and
for charged particles specifically, significant energy dependence in the region of the Bragg peak
(Castriconi, 2017).

Prompt Gamma Emission (PGE) and Positron Emission Tomography (PET) are potential imaging
modalities which offer potential for accurate proton range verification.

Positron Emission Tomography for range verification utilises coincident gammas which result from
the annihilation of emitted positrons with electrons, as a small fraction of protons traversing the
medium will produce positron emitting isotopes (Rutherford, 2020). A PET camera can be used to
observe the recombination of emitted positrons with an electron in the surrounding material. This
method can be performed either ‘off-line’, after treatment or ‘on-line’, during treatment (Knopf,
2013). The beam range is able to be verified by PET imaging, in clinical head-and-neck patients to
well-co-registered bony structures, to an accuracy of 1-2 mm (Parodi, 2007).

Prompt Gamma Emission is an indirect method which measures the emission of single photons
(prompt gammas) which follow the inelastic collisions (and excitations) between the nuclei of the
target and the incident protons. A direct correlation exists between the point of emission of the
prompt gamma photons in the material and the range of the incident protons upon the material
(Zarifi, 2017). This method is useful for online in-vivo verification as the time between
excitation/de-excitation of the target nuclei and detection of the prompt gamma photon is of the
order of nanoseconds (Knopf, 2013). This method has reported position verification accuracy of 1
to 2 mm at the Bragg peak of 100 MeV proton beam in a phantom (Min, 2006).

2.5 Devices designed by Centre for Medical Radiation Physics
2.5.1 Serial Dose Magnifying Glass (sDMG)
The Serial Dose Magnifying Glass (sDMG) is a multi-strip silicon detector designed by the Centre
for Medical Radiation Physics (CMRP) and is comprised of two linear arrays arranged in sequence
with each individual array consisting of 128 diodes, with physical thickness 0.04 mm, separated
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with pitch 0.2 mm and each diode presenting a sensitive strip area of 0.02 x 2 mm2. The sDMG
consists of n+ silicon strips implanted upon a thin p-type silicon substrate and is operated in passive
mode (without an external bias voltage applied). This linear array is based upon the technology of
the Dose Magnifying Glass (DMG), which has been investigated for use in radiotherapy QA (Wong,
2011), IMRT QA (Wong, 2010) and helical tomotherapy QA (Wong, 2011). The density of silicon
is 2.33 g/cm3 thus the water equivalent thickness of each individual diode along the axis of the linear
array is approximately 0.466 mm and perpendicular to the axis of the linear array is 0.0186 μm.

The sDMG is composed of two linear arrays with a physical gap separating the linear arrays of 0.6
mm. The arrays are wire bonded end-to-end, to a flexible printed circuit board (PCB) which is
0.5mm thick, providing the connections to the readout electronics and data acquisition (DAQ)
system. The single axis of detection of the sDMG measures a length of 50.8 mm. The detector and
PCB are enclosed within a rigid holder composed of two slabs of recessed Solid Water (GAMMEX,
WI, USA) material, 5 mm thickness each, to provide protection, rigidity and appropriate scattering
conditions around the detector. The upper Solid Water slab which encompasses the detector is
machined with a 2mm recess into the Solid Water larger than the dimensions of the detector, in
which the detector sits, this leaves a 1.6mm air gap above the detector and a 1mm air gap
surrounding the detector.

(a)

(b)

Figure 2.13 The Serial Dose Magnifying Glass (sDMG). (a) Schematic diagram of silicon strip
detector, DMG (Debrot, 2018). (b) sDMG mounted and wired bonded to a thin printed circuit
board (PCB). Figure 2.13(a) reproduced with permission from Wiley.
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Figure 2.14 sDMG enclosed within Solid Water phantom and connected to data acquisition
system.

2.5.2 Monolithic silicon detector array (DUO)
DUO is a monolithic silicon detector array designed by the CMRP and comprised of 505 silicon
diodes arranged in two bisecting orthogonal linear arrays of 253 diodes, sharing a common central
pixel. This form of the DUO detector array investigated was fabricated on a bulk p-type silicon
substrate with thickness of 470 µm and with a total area of 52 x 52 mm2. The individual diodes
present a sensitive volume of 0.04 x 0.8 mm2 with diode pitch of 0.2 mm. The array is wire bonded
to a 50 µm thick printed circuit board which provides the connections to the data acquisition (DAQ)
system for readout.

Figure 2.15 The DUO detector mounted and wire bonded to the thin PCB.
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The central pixel of the DUO array is 0.18 x 0.18 mm2, the four pixels which directly surround the
central pixel are 0.16 x 0.2 mm2, and the subsequent pixels which compose the orthogonal arms of
the array are 0.04 x 0.8 mm2. The separation between each detector pixel in the DUO array is 0.2
mm. The monolithic silicon array and the PCB are enclosed between two recessed slabs of PMMA,
each 5 mm thick, to provide protection, rigidity and scattering to the detector.

DUO is operated without an external bias applied to the p-n junctions. The performance of DUO for
small field dosimetry has previously been reported including a detector characterization for doseper-pulse dependence, dose-rate response, radiation damage, output factor, PDD and beam profiling
(Al Shukaili, 2017).

2.5.3 Data Acquisition System
The data acquisition (DAQ) system utilised to readout the sDMG detector and DUO was designed
and developed by CMRP and is based upon a custom-design multi-channel electrometer with Field
Programmable Gate Array (FPGA) interface.

2.5.3.1 AFE
The electrometer, AFE0064 (Texas Instruments, Dallas, USA), is a current integrator and possesses
64 parallel input channels and two differential outputs. The current is measured individually from
each detector channel and integrated over a capacitor for a user defined time-interval, the resulting
output charge is normalised to the nominated dynamic scale, from 0.13 to 9.6 pC.

The DAQ system utilised in conjunction with the sDMG is comprised of four AFE0064 chips
serving 256 individual channels and readout by two analogue to digital converters (ADC), with a
resolution of 16 bit. The system utilised in conjunction with the DUO detector is comprised of eight
AFE0064 chips serving 512 individual channels for readout by four ADC’s with a resolution of 16
bit.

Synchronisation of the electronics is managed by the FPGA; enabling measurement, acquisition and
transfer of data from the electrometers to the host computer via a USB2.0 communication protocol.
Acquisition of data from the AFE0064 chips is triggered and synchronised by the FPGA to the
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electron gun trigger pulses of the linac by a coaxial connection between the FPGA and the linacs
sync pulse (Varian). An internal trigger generator can also be used to acquire signal from the
detector, up to a frequency of 10 kHz, in case of irradiation by a continuous radiation source. For
further information about the performance and design details of the AFE DAQ please refer to Fuduli
et al. (Fuduli, 2014).

For the experiments described in Chapter 3, Chapter 4 and Chapter 5, the detectors used, were
readout using the AFE DAQ technology.

Figure 2.16 The sDMG detector connected to the AFE DAQ system with FPGA.

2.5.3.2 TERA
The TERA06 is a readout electrometer consisting of 64 channels per chip. The TERA06 chip is
based on a charge to frequency converter and digital 16-bit counter, referred to as an application
specific integration circuit (ASIC). The TERA06 DAQ system reads out the 256 detector channels
of the sDMG with zero dead time and provides a large dynamic range and high temporal resolution
(Fuduli, 2014). The sDMG is readout by four TERA06 chips synchronized and managed by the
FPGA, connected to a personal computer by USB 2.0 interface.

2.5.4 Graphical User Interface
The graphical user interfaces (GUIs) which are used for; connection to the DAQ, acquisition of data
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from the detector, visualisation and analysis, are designed by CMRP. The sDMG and DUO detectors
utilise GUIs with different visualisations configurations, Figure 2.17 for sDMG and Figure 2.18 for
DUO respectively, but the underlying architecture, programming and communication of the
software with the DAQ is identical. The GUI is compiled in the C++ programming language and
designed and developed using the Qt cross-platform software development toolkit. The USB
connection between the dynamic language libraries and the DAQ is managed by the GUI, which
initializes the USB connection and sends the necessary firmware to the FPGA. From the GUI the
user is able to alter the data acquisition settings, which include (but are not limited to); integration
time, acquisition time, acquisition frequency, gain, buffer size and external or internal generated
trigger. Data acquired from the detector is displayed to the user in real time with both instantaneous
response and integral response displayed in a logical representation of the geometry of the detector.
Once acquisition is complete the user can save the file in an encoded file format, which can be
decoded and visualised at any time for post-acquisition analysis.

Figure 2.17 The AFE-Histogram graphical user interface (GUI) for acquisition, visualisation and
analysis of sDMG measurements.
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Figure 2.18 The AFE-DUO graphical user interface (GUI) for acquisition, visualisation and
analysis of DUO measurements.
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Chapter 3
Device characterisation of Serial Dose
Magnifying Glass (sDMG)

3.1 Introduction
To independently assure the quality of planned treatments that use small radiation fields requires a
unique instrument which combines high spatial and high temporal resolution. The sDMG is a multistrip 1D silicon detector array to realize the requirements for an independent dosimetry tool for
patient specific quality assurance and pre-treatment verification in real-time adaptive radiotherapy
using small radiation fields matching, within the technological limitations of the number of channels
able to be readout simultaneously for this project, the resolution required for an optimal dose profile
reconstruction. This chapter first evaluates an optimum spatial resolution which would be necessary
to reconstruct quantifiable detail in measured beam profiles and then presents the results obtained
from the sDMG detector, with AFE readout, which will be compared to the gold standard detectors
adopted clinically: the ionisation chamber and radiochromic film, under identical experimental
conditions within each investigation.

3.2 Materials and Methods
3.2.1 Evaluation of the spatial resolution required by a pixelated detector
The optimum resolution required to reconstruct beam profiles in SRT modalities has never been
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assessed using discrete-time Fourier analysis of measured high resolution EBT3 film beam profiles.
This work presents an analysis of high resolution radiochromic film data conducted to generate
recommendations for the pixel separation required to accurately measure the beam penumbra and
profile.

Gafchromic EBT3 film (Ashland Advanced Materials, NJ, USA) represents the best option for high
spatial resolution measurement of radiotherapy small field beams. In applications where real-time
dosimetry is crucial, they must be substituted with a pixelated detector which should have
comparable performance. A method has been established to evaluate the minimum spatial resolution
required by a strip detector to measure the dose profile of jaw-defined square fields with the same
accuracy of an EBT3 film readout at high resolution. The method has been applied to various beam
sizes delivered by a 6MV Varian Clinac iX (Varian Medical Systems, Palo Alto, USA) medical
linear accelerator (linac) at depths of 5 cm and 10 cm in a Solid Water (Standard Imaging, Madison,
USA) block phantom. The EBT3 film pieces were scanned six times each using a MicroTek scanner
(MicroTek, Hsinchu, Taiwan) before and 72 hours after irradiation in 48 bit RGB colour mode with
a scanning resolution of 300 dpi (corresponding to 84.7 µm pixel size) and saved in .TIFF format.
The images were analysed using ImageJ 1.47v where a second-order polynomial generated from an
associated calibration curve was used upon the red colour channel to convert from pixel value to
dose via a net optical density protocol. Line profiles were extracted along the central axis of the
EBT3 film pieces for comparison. The dose profiles were normalised to the central axis (CAX)
response of the 10 x 10 cm2 field for the corresponding depth. Figure 3.1 illustrates the results of
the line profiles extracted from the high resolution film scans for the various field sizes and depths
in Solid Water.
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(a)

(b)
Figure 3.1. Dose profiles for various field sizes measured in a Solid Water block phantom using
EBT3 film. (a) At depth 5 cm in Solid Water field sizes 0.5x0.5 cm2 to 10x10 cm2. (b) At depth
10 cm in Solid Water field sizes 0.5x0.5 cm2 to 10x10 cm2.

In this initial study, the penumbral width (PW) was defined as the distance between either the 3%
and 97% (PW3-97%) response values or the 20% and 80% response values (PW 20-80%) and was
measured on the left hand side (LHS) of the normalised dose profiles for all field sizes investigated.
The full-width at half-maximum (FWHM) was also determined.
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Within the scope of modern radiotherapy treatment modalities steep dose penumbrae are necessary
to achieve highly conformal treatments. Accurate reconstruction of the penumbral features is
necessary as treatment margins are reduced and the steep dose gradients generated by sharp field
penumbrae approach critical organ boundaries.

Further investigation into the resolution required by a detector to reconstruct the penumbra in small
field applications was conducted using discrete-time Fourier analysis to identify the frequency
composition of the penumbral structures for different field sizes. For a discrete signal xn with a
finite-duration, sampled at N points with frequency k, the Fourier series representation of the
sequence is:

N−1

xn =

1
2π
2π
∑ Xk ∙ [cos ( kn) + i sin ( kn)]
N
N
N

(3.1)

k=0

The discrete Fourier Transform (DFT) (Oppenheim, 1999) is:

N−1

(3.2)

X k = ∑ xn ∙ e−i(2π/N)kn
n=0

And the normalised amplitude |Xk|/N, is defined as:

√Re(Xk )2 + Im(Xk )2
N

(3.3)

The bandwidths (BW90%) of the Fourier spectra generated in this work are defined as the width of
the frequency band that contains 90% of the total area under the amplitude spectrum. The NyquistShannon sampling theorem was applied to the identified frequency bandwidths for each field size’s
penumbral spectrum to calculate a recommended sampling resolution to accurately reconstruct the
penumbra.
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Nyquist Resolution =

1
2 ∙ BW90%

(3.4)

3.2.2 Radiation Hardness Characterisation
The response of the sDMG detector was measured under irradiation by a photon beam from a 6 MV
linac (Varian Medical Systems, Palo Alto, USA). The detector was positioned at 1.5 cm depth (d max
for 6 MV photons) in a phantom composed of Solid Water. The detector was then irradiated up to
40 kGy using a Co-60 gamma emission source in steps of 20 kGy without a bias applied to the
detector during irradiation to mirror the standard operation procedure of the detector during clinical
use. The response of the detector was then measured and recorded under 6 MV photon irradiation
at 0, 20 and 40 kGy absorbed doses to evaluate the effect of radiation damage upon the detector
response.

3.2.3 Dose Linearity
The linearity of the detector’s response was examined and verified. The detector was positioned
within a Solid Water phantom at a depth of 1.5 cm and irradiated using a 6 MV photon beam from
a linac with a field size of 10 x 10 cm2 and source to surface distance (SSD) of 100 cm. The delivery
ranged from 50 MU to 500 MU at 600 MUmin-1, corresponding to a dose range of 50 cGy to 500
cGy at these conditions in 50 cGy dose increments.

3.2.4 Dose per Pulse Dependence
An investigation into the dose per pulse dependence (DPP) of the sDMG detector was carried out
within the range of 2.1x10-5 Gy pulse-1 to 2.78x10-4 Gy pulse-1. This was undertaken utilising a 6
MV linac beam with dose-rate 600 MU min-1 and field size 10 x 10 cm2. The detector was positioned
at a depth of 1.5 cm (dmax for 6 MV photons) with 10 cm of backscattering material in a water
equivalent phantom, the source to surface distance (SSD) was varied sequentially from 100 cm to
366 cm and the detector response tested by irradiating the detector with a 10 x 10 cm2 field size (at
100 cm SSD). The detectors depth in the phantom remained constant for all measurements to
minimise variation in the detectors response, which may be attributed to changes in the energy
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spectrum of the incident radiation beam. A reference data set was collected through the repetition
of the experiment utilising a CC13 (IBA Dosimetry, Schwarzenbruck, Germany) ionisation chamber
in place of the sDMG detector. The response of the sDMG was normalised to the response of the
ionisation chamber for each measurement point to quantify the detectors dependence upon dose per
pulse values compared to the ionisation chamber.

3.2.5 Percentage Depth Dose Measurements
The detector is secured and encapsulated within a protective holder composed of two 5 mm pieces
of Solid Water. The sDMG detector and holder was positioned between 30 x 30 cm2 sections of
Solid Water material to form a volume surrounding the detector possessing water-equivalent
scattering conditions. A series of 30 x 30 cm2 Solid Water slabs are placed beneath the detector,
totalling 10 cm for backscattering and the amount of Solid Water above the detector is varied from
0.5 cm to 25 cm. The system is irradiated by a 6 MV linac photon beam with field size 10 x 10 cm2
at a constant source to surface distance (SSD) of 100 cm, delivering 100 MU for each depth. The
response of the sDMG detector is compared to the response of a Markus ionisation chamber (PTWFreiburg, Freiburg, Germany) irradiated in Solid Water utilising the same procedure.

3.2.6 Beam Profile Measurements
The clinical megavoltage photon beam possesses an axial profile composed of inter-umbral,
penumbral and out of field regions. Linacs which utilise flattening filters exhibit inter-umbral
regions of dose uniformity, whereas the penumbral region of a beam profile describes the rapid
dose-falloff at the radiation field edges. For small field dosimetry and stereotactic treatments, the
penumbral width measured between the 20% and 80% points of the maximum dose intensity is an
important metric. The beam profiles of small fields of 0.5 x 0.5 cm2, 1 x 1 cm2, 1.5 x 1.5 cm2, 2 x 2
cm2, 3 x 3 cm2, 4 x 4 cm2 and 5 x 5 cm2 defined by the collimation jaws, with the MLC retracted,
were measured. The sDMG was positioned at a depth of 10 cm in a Solid Water phantom with 10
cm of backscattering material. The system was irradiated at 90 cm SSD using a 6 MV linac for 200
MU at 600 MU min-1 for each of the field sizes investigated. The detector was aligned to the central
axis of 0.5 x 0.5 cm2 field such that the axis of detection of the sDMG bisected the square field.

The measurements were repeated using Gafchromic EBT3 film. The film was cut into 4 x 4 cm2
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pieces for field sizes 3 x 3 cm2 and below and 6 x 6 cm2 pieces for the larger field sizes. The film
was aligned and irradiated with each of the square fields investigated by the sDMG detector. Prior
to exposure to the radiation fields, each film piece was scanned using a MicroTek scanner, in 48-bit
RGB colour mode. The film pieces were positioned in the centre of the scanner field of view and
scanned at 72 dpi (corresponding to a 0.353 mm pixel size). Six scans were conducted for each
individual film piece, the results saved in .TIFF format, with the first three scans for each film piece
discarded. This procedure was repeated 72 hours after radiation exposure with care taken to maintain
the orientation of the film pieces before, during and after irradiation. A further set of films from the
same batch were prepared and irradiated following the outlined protocol to produce a dose
calibration curve. Analysis was conducted using ImageJ 1.47v where the red channel was used for
the pixel value to net optical density to dose conversion based upon a second-order polynomial
derived from the associated film calibration curve. Line profiles were extracted along the same axis
of measurement as the sDMG from the dose converted images for comparison and quantitative
analysis. The full-width at half-maximum (FWHM) and penumbral widths of the profiles were
measured for both the EBT3 film and sDMG detector and subsequently compared.

3.2.7 Output Factor Measurements
The output factor is defined, within this study, as the ratio of the dose per monitor unit measured at
the centre of the radiation field size under investigation relative to dose per monitor unit measured
at the centre of a specific reference radiation field. The reference field size considered was 10 x 10
cm2 with all measurements conducted at 10 cm depth and 90 cm SSD (isocentre) with 6 MV photon
beams.

The square radiation fields under investigation were aligned with the detector to ensure that the
centre of the radiation field coincided with the centre of the sDMG detector, the response within
these channels was utilised to calculate the output factor values. Radiation fields ranging in size
from 0.5 x 0.5 cm2 up to 10 x 10 cm2 were investigated. The measurements were repeated using
EBT3 film for direct comparison between sDMG and EBT3 film under identical conditions. The
film was scanned with resolution 72 dpi, the acquisition and analysis of the EBT3 film followed the
procedure outlined above (3.2.1).
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3.3 Results
3.3.1 Evaluation of the spatial resolution required by a pixelated detector
The results of the measurements of FWHM and PW are presented in Table 3.1. It is evident that
across the field sizes and depths investigated the PW 20-80% is shown to range between 2-3 mm. The
PW3-97% value ranges from 4-18 mm across the field sizes investigated as this metric incorporates
both shoulders of the field penumbra. The distance over which the dose falls-off to zero is of the
order of a few millimetres (PW 20-80%) thus it is clear the penumbra of a jaw-defined square field
contains steep dose gradients, Figure 3.1(a) and (b).

Table 3.1 Penumbral width (PW) and Full-Width at Half-Maximum (FWHM) measurements for
EBT3 film dose profiles.

Square
Field Size
(mm)

Depth 5 cm

Depth 10 cm

PW3-97%
(mm)

PW20-80%
(mm)

FWHM
(mm)

PW3-97%
(mm)

PW20-80%
(mm)

FWHM
(mm)

100

15.79

3.12

103.84

18.65

3.20

105.47

50

12.19

3.28

51.50

12.51

3.22

52.41

30

10.57

2.97

30.01

10.97

3.04

31.35

20

9.69

2.92

20.34

9.96

2.94

20.13

10

6.64

2.55

9.88

7.30

2.57

10.57

5

4.16

1.98

4.88

4.87

2.05

5.07

Figure 3.2 illustrates the amplitude spectra generated from the calculation of the discrete Fourier
transform of the 3–97% penumbral region response for the LHS of each field size investigated.
Figure 3.2(a) presents the spectrums for the penumbrae of profiles acquired at 5 cm deep in a Solid
Water phantom, Figure 3.2(b) shows the spectrums for profiles acquired at a depth of 10 cm in Solid
Water.
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(a)

(b)
Figure 3.2 One-sided Fourier amplitude spectra for the penumbral regions (3-97%) of various
field sizes. (a) Fourier spectrums of profiles acquired at depth 5 cm in a Solid Water phantom. (b)
Fourier spectrums of profiles acquired at depth 10 cm in a Solid Water phantom.

The bandwidths and Nyquist resolutions calculated for each field size and depth in Solid Water
investigated are presented in Table 3.2. The analysis has identified a suggested resolution for the
sampling of radiation field profiles to be of the order of 100-200 µm to effectively resolve the
complex features of these profiles.
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Table 3.2 90% bandwidth measurements and corresponding Nyquist resolutions for various field
sizes.
Depth 5 cm
Square Field Size
(mm)

Depth 10 cm

Bandwidth90
(cm-1)

Nyquist
Resolution (µm)

Bandwidth90
(cm-1)

Nyquist
Resolution (µm)

100

35.91

139.23

34.61

144.45

50

36.91

135.48

36.44

137.23

30

37.98

131.65

37.67

132.75

20

38.96

128.34

37.89

131.95

10

39.93

125.21

39.27

127.33

5

40.72

122.78

39.57

126.35

3.3.2 Radiation Hardness Characterisation
Figure 3.3 shows the response of five pixels of the sDMG detector normalised to the response
attributed to the pre-irradiation condition of the detector. The normalised response is presented for
five independent channels across the array as a function of accumulated dose delivered to the
detector. These five pixels were chosen as exhibiting the maximum and minimum deviations in
individual response from the mean normalised response of the array for each accumulated dose. The
response is measured with the detector operated in passive mode and demonstrates the increase and
stabilisation of the charge collection efficiency to within +/-5% for the whole detector array after 40
kGy of delivered dose. The error bars indicate an uncertainty corresponding to two standard
deviations in the response of each pixel over three repetitions of the response measurements.
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Figure 3.3 Experimental result for the measurement of the response of five pixels normalised to
the pre-irradiation condition of the sDMG detector as a function of accumulated dose. Each pixel
in the legend is denoted as a ‘Ch’, this is an abbreviation for channel, which relates to the
chronological number of the individual pixel in the linear array.

3.3.3 Dose Linearity
Figure 3.4 illustrates the measured dose linearity for the sDMG detector within the dose range of 50
cGy to 500 cGy. The measurements were taken in increments of 50 cGy over the range investigated
and the resulting accumulated charge measured within the central channel of the sDMG fitted with
a linear function. The conversion factor determined from the linear fitting function is 105 pC/cGy.
The error bars indicate an uncertainty corresponding to two standard deviations in the fluctuation of
results recorded by the central pixels of the sDMG.
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Figure 3.4 The accumulated charge measured within the central channel of the sDMG detector
as a function of applied photon radiation dose.

3.3.4 Dose per Pulse Dependence
Figure 3.5 presents the dose per pulse dependence of the sDMG detector. The response of the sDMG
is normalised to the response of a CC13 ionisation chamber (IBA dosimetry, Schwarzenbruck,
Germany), at a depth of 1.5 cm (dmax) in a 10 x 10 cm2 6 MV photon beam. The value of 2.78 x 104

Gy/pulse corresponds to the dose per pulse experienced by the CC13 ionisation chamber under

these conditions at 100cm SSD.

The results presented in Figure 3.5 illustrate that the sDMG possesses a maximum dose per pulse
dependence of approximately -40 % across the range investigated. This significant dependence in
the response of the sDMG detector, relative to the CC13 ionisation chamber, must be accounted for
utilising correction factors. The methodology undertaken within this portion of the study assumes
the response of the CC13 ionisation chamber is independent of the dose rate.
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Figure 3.5 The dose per pulse response for the sDMG detector normalized to the estimated dose
per pulse delivered at 1.5cm depth in water and 100cm SSD of 2.78x10 -4 Gy/pulse.

3.3.5 Percentage Depth Dose Measurements
Figure 3.6 illustrates the PDD response of the sDMG detector measured under irradiation by a 6
MV photon beam with field size of 10 x 10 cm2 at 100cm SSD, compared to response of a Markus
Ionisation chamber under the same conditions. The PDD was investigated within the range of 5 mm
to 250 mm depth in Solid Water for both detectors. Figure 3.6(a) shows the sDMG detectors initial
PDD behaviour, the exhibited agreement is within +/-8% for depths less than 5 cm in Solid Water,
at greater depths the percentage difference between the sDMG and Markus chamber increases to a
maximum of 20%.

This discrepancy at depths greater than 5 cm in Solid Water is the result of the intrinsic dose per
pulse dependence of the sDMG detector. Following the characterisation of the dose per pulse
dependence of the detector, this behaviour is able to be corrected. Correction factors are generated
for the range of dose per pulse values experienced by the detector within the experiment by fitting
a polynomial to the relationship shown in Figure 3.5. The dose per pulse experienced by the detector
at each depth is calculated and the necessary correction factor is determined from the polynomial
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equation. The dose per pulse correction factors are in turn applied to the sDMG results at each depth.
The result of the application of the calculated correction factors is shown in Figure 3.6(b). The
observed maximum difference is reduced from −20% (Figure 3.6(a)) to maintaining an overall
agreement of ±1.27% for depths greater than 1.5cm in Solid Water.

(a)

(b)
Figure 3.6 PDD response measured with the sDMG detector and Markus ionisation chamber for
a 6MV photon beam with 10 x 10 cm2 field size at 100cm SSD and percentage difference. (a)
Uncorrected PDD response of sDMG detector. (b) PDD response of sDMG detector corrected for
intrinsic dose per pulse dependence of sDMG detector.
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3.3.6 Beam Profile Measurements
Figure 3.7 presents the results measured from the sDMG detector for 6 MV photon beam field sizes
ranging from 0.5 x 0.5 cm2 to 5 x 5 cm2 at 10cm in Solid Water and 90 cm SSD. The sDMG profiles
are compared to those measured under identical conditions using Gafchromic EBT3 film. The
sDMG profiles are normalised to the response of the central axis (CAX) pixel within the detector
and are aligned to the left hand side spatial coordinate of the 50% response of the CAX pixel value.
Profiles measured using the EBT3 film are normalised to the average pixel value within a 1 mm
window surrounding the CAX of the film profile. A quantitative analysis of the agreement between
the datasets was undertaken using MATLAB (R2013a MathWorks) and the Curve Fitting Toolbox.
The individual datasets were fitted with a ‘Piecewise Cubic Hermite Interpolating Polynomial’, the
data was interpolated to calculate the spatial coordinates of the 20%, 80% and 50% responses
relative to the CAX within each profile. The left-hand side (LHS) penumbral width (20%-80%) and
full width at half maximum, FWHM (50%-50%), were determined and compared between the
detectors. The average uncertainty calculated across all measurements for the EBT3 film is ±1.9%
(Aldosari, 2014) and for the sDMG detector is ±1 %. The results are summarised, including
percentage difference between datasets, in Table 3.3.

(a)

(b)
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(c)

(d)

(e)

(f)

Figure 3.7 sDMG and EBT3 film measured beam profiles for 6MV photon beam at 10cm deep
and 90cm SSD for small radiation fields. (a) Field size 0.5 x 0.5 cm2. (b) Field size 1 x 1 cm2.
(c) Field size 1.5 x 1.5 cm2. (d) Field size 2 x 2 cm2. (e) Field size 4 x 4 cm2. (f) Field size 5 x
5 cm2.

The sDMG detector demonstrates an agreement with EBT3 film measurements within 0.90% for
the determination of the FWHM of the radiation field sizes for all measured beams. The penumbral
width exhibits an agreement within at most 60 µm that confirms that the spatial resolution of sDMG
of 0.2 mm enables accurate reconstruction of the penumbral region in 6 MV photon fields for sizes
below 5 x 5 cm2.

Table 3.3 sDMG and EBT3 film measurement FWHM and penumbral width (20%-80%)
comparison for different small field sizes.

sDMG
Square
Field size
(mm)

FWHM
(mm)
±0.01mm

Penumbra,
LHS (mm)
±0.01mm

EBT3
FWHM
(mm)
±0.1mm
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Penumbra,
LHS (mm)
±0.1mm

Difference (sDMGEBT3)
ΔFWHM
(µm)

ΔPenumbra
(µm)

5

5.04

2.11

5.0

2.1

40

10

10

10.03

2.62

10.0

2.6

30

20

15

15.14

2.71

15.1

2.7

40

10

20

19.92

2.88

20.0

2.9

-80

-20

30

29.84

3.46

29.9

3.4

-60

60

40

40.00

3.85

39.8

3.8

160

50

50

50.12

3.75

49.7

3.7

450

50

3.3.7 Output Factor Measurements
Figure 3.8 illustrates the results of the experimental measurement of output factor utilising the
sDMG detector and EBT3 film. The response of the pixels closest to the CAX of each field for
sDMG and the pixel region surrounding the CAX for the EBT3 film for each field size is normalised
to the response under irradiation by a 10 x 10 cm2 field size. The results are investigated as a function
of radiation field size, delivered at a depth of 10 cm at isocentre for a 6 MV photon beam. Figure
3.8(a) presents the uncorrected output factor results acquired with the sDMG. Based on the
calculated output factor result of the EBT3 film for each field size investigated a dose per pulse
correction factor is calculated and applied, as in 3.3.5, to the sDMG results for each field size, Figure
3.8(b). The sDMG is shown to under-respond relative to the EBT3 film for field sizes smaller than
1.5 x 1.5 cm2 up to a maximum of 3.1% for the field size of 0.5 x 0.5 cm2. For radiation field sizes
greater than 1.5 x 1.5 cm2 the sDMG detector is observed to over-respond relative to EBT3 film
with the agreement remaining within 2%.
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(a)

(b)
Figure 3.8. Response of sDMG detector and EBT3 film to varying field size of a 6 MV photon
beam normalised to response of detector to 10 x 10cm2 field size. Percentage difference between
sDMG and EBT3 film presented as a function of radiation field size. (a) Uncorrected OF response
of sDMG detector. (b) OF response of sDMG detector corrected for intrinsic dose per pulse
dependence.

3.4 Discussion
The results of Table 3.2 identify a series of recommended sampling resolutions to accurately
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reconstruct 90% of the features present in the radiation field penumbra for different field sizes and
depths in Solid Water. The penumbral width of a radiation field decreases for smaller field sizes and
shallower depths in phantom material, as shown in Table 3.1. It is evident from Table 3.2 that as the
field size decreases the Nyquist resolution decreases, identifying a need for higher resolution
sampling to resolve the sharper features of smaller field sizes. Also, as depth in phantom material
decreases the penumbral width is shown to decrease, thus, penumbral features become sharper closer
to the material surface.

The Serial Dose Magnifying Glass (sDMG), Figure 2.13, is a multi-strip silicon detector comprised
of two linear arrays of 128 diodes with pitch 200 µm. The response of the detector operated in
passive mode was measured under irradiation by a Co-60 gamma emission source. The radiation
damage study illustrates the detectors response increase and stabilisation of the charge collection
efficiency across the detector to within +/-5% for the array after 40 kGy of delivered dose. sDMG
shows a variation of the response versus accumulated dose opposite to the expected trend from a
silicon diode array. This behaviour has been extensively investigated and an explanation provided
by means of Technology CAD simulations in Aldosari et al. (Aldosari, 2013) where a pad detector
fabricated by the same p-type substrate manufacturing technology has been characterised.
Additionally, it has been demonstrated previously that the charge collection efficiency of this
detector technology remains stable up to 120 kGy of lifetime accumulated dose (Aldosari, 2013),
assuming a conservative delivery of 200 Gy per week for quality assurance of stereotactic
treatments, this would result in a minimum lifetime of approximately 7.7 years.

Normalised beam profile measurements were conducted for field sizes between 0.5 x 0.5 cm 2 and 4
x 4 cm2 and compared between the sDMG and EBT3 film. The sDMG detector exhibited agreement
to within 0.90 % for the determination of the FWHM of the radiation field sizes when compared
with EBT3 film measurements. The disagreement in penumbral width measurements between
sDMG and EBT3 film was found to be at most 60 µm difference for static 6 MV photon beam
delivery. This disagreement between the detectors is restricted to the submillimeter scale and is at
most 0.45 mm in the case of FWHM comparison. From Figure 3.1 and Table 3.1 it is evident that
the penumbral gradient is similar for all field sizes when the beam profile is presented as an absolute
dose distribution. As the penumbra is mostly determined by the scattering power of photons i.e.
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their energy spectra and therefore should not be dependent on the field size. Based on this it is clear
that the sDMG is applicable for penumbra measurements for field sizes both smaller and larger than
5 x 5 cm2, up to 10 x 10 cm2. These results confirm the requirement estimated by the discrete Fourier
transform method for the minimum spatial resolution (Table 3.2) required for a pixelated detector
to reconstruct dose measured by the EBT3 film.

Extensive characterisation of the DUO detector for 6 MV photons was conducted by Al Shukaili et
al. (Al Shukaili, 2017). This characterisation followed the methodology outlined in this work and
included investigation into dependence and response of DUO for dose rate (dose per pulse), PDD,
beam profiles and output factors. The dose per pulse corrected PDD was demonstrated to agree
within 1.5% of a Markus ionisation chamber for depths up to 25 cm in Solid Water. FWHM
agreement was found to be within 1% and within 0.5 mm for penumbral width (20%-80%)
measurements. These results compare favourably to the sDMG with similar beam profile accuracy
and magnitude of dose per pulse corrected PDD agreement.

3.5 Conclusion
The Discrete Fourier Transform was used to generate Fourier spectrums for the 3-97% penumbral
regions of response normalised, high spatial resolution radiochromic EBT3 film beam profiles of
radiation fields with field sizes ranging from 0.5 x 0.5 cm2 up to 10x 10 cm2. The bandwidth of the
Fourier amplitude spectrum was defined to be the frequency band containing 90% of the total area
under the curve. The Nyquist-Shannon sampling theorem was applied to the bandwidth
measurements to calculate a recommended sampling spatial resolution for the field sizes
investigated of the order of 130 - 200 µm.

The sDMG exhibits a maximum dose per pulse dependence of approximately 40% across the range
of 2.1 x 10-5 Gy pulse-1 to 2.78 x 10-4 Gy pulse-1 investigated. The response of the detector was
normalised to the response of the CC13 ionisation chamber irradiated under identical conditions.
The results were used to generate a series of correction factors to account for the dose per pulse
dependence within the sDMG detector. Based on the obtained results a recommendation is made to
fabricate new generations of DMG on low resistivity bulk Si and later on epitaxial p-Si to improve
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DPP dependence while providing the same spatial resolution.

PDD measurements for the sDMG were compared to a Markus ionisation chamber over the range
0.5 cm to 25 cm depth in Solid Water. Initially the exhibited agreement between the Markus IC and
sDMG is within +/-8% for depths less than 5 cm in Solid Water, at greater depths the percentage
difference between the sDMG and Markus chamber increases to a maximum of 20%. The
discrepancy between the response of sDMG and the Markus IC is attributed to the intrinsic dose per
pulse dependence of the sDMG. Utilising the calculated correction factors the observed maximum
difference is reduced from ±20% to ±4% with the sDMG response maintaining agreement within
±1.27% for depths greater than 1.5cm in Solid Water.

The output factor for the sDMG was measured and compared to EBT3 film for field sizes ranging
from 0.5 x 0.5 cm2 up to 10 x 10 cm2. For field sizes less than 1.5 x 1.5 cm2 the sDMG is observed
to under-respond up to a maximum of 3.3% for the field size of 0.5 x 0.5cm2 relative to EBT3 film.
For field sizes greater than 1.5 x 1.5 cm2 the sDMG detector is observed to over-respond relative to
EBT3 film with the agreement remaining within ±2%. The disagreement between the EBT3 film
and sDMG without dose rate dependence correction is within 8%, with dose rate dependence
correction agreement is within 3.1%.

Dose linearity, dose per pulse dependence, PDD, beam profile and output factor measurements were
conducted for the sDMG detector on a 6 MV linac. The results of these measurements demonstrate
the applicability of the sDMG detector for use as an accurate tool for commissioning and QA of
small area radiation fields.
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Chapter 4
Quality Assurance of stereotactic
radiotherapy combined with electromagnetic
MLC tracking using silicon detectors

4.1 Introduction
The treatment of small volume tumours within the lungs requires small conformal radiation beams
and real time motion adaptation to improve treatment efficiency and reduce normal tissue toxicity.
MLC tracking has been applied clinically to lung SABR treatments, providing reduced target
volumes whilst delivering the planned target dose in the presence of respiratory motion (Booth,
2016). The combination of small field dosimetry, target motion and heterogeneous scattering
conditions is challenging for accurate dose measurement in real-time and necessitates a specialised
tool for quality assurance (QA) and treatment verification.

This chapter investigates the effects of homogenous and heterogeneous scattering conditions upon
the delivered dose distribution in the treatment of dynamic targets using small radiation fields and
aims to evaluate the performance of the sDMG and DUO detectors with AFE readouts compared to
the gold standard of high spatial resolution two-dimensional dosimetry, EBT3 film.
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4.2 Materials and Methods
4.2.1 DUO and sDMG
DUO and sDMG are both pre-irradiated to stabilize the response of the detectors, DUO is preirradiated to 120 kGy (Al Shukaili, 2017) and sDMG is pre-irradiated to 40 kGy for uniform
stabilisation of CCE across the array, as per results of 3.3.2. A uniformity equalization is applied
prior to irradiation to correct the response of each pixel for intrinsic sensitivities and gain variations
attributed to the individual preamplifier channels. The correction factor is generated under
stimulation from a 20 x 20 cm2 6MV photon beam from a linac equipped with a flattening filter at
10 cm depth in Solid Water and 100cm SSD. In comparison to a 20 x 20 cm2 radiation field the
DUO is 5.2 x 5.2 cm2 and the sDMG is 0.2 x 5.08 cm2 with each detector aligned to the central axis
of the radiation beam. The profile of the beam across the detectors at this depth is considered flat,
with a clinically stated flatness (IEC 60976) measure in this region of 100.3, thus the stimulation of
each pixel is assumed to be uniform. An array of correction factors is generated based upon the
individual response of the pixels and the combined average response (Aldosari, 2014).

4.2.1.1 Dosimetric Validation
The results of profiling on a 6 MV linac photon beam in Solid Water using DUO has been
investigated and reported previously (Al Shukaili, 2017). To ensure the dosimetric accuracy of the
DUO detector is valid for a low-density medium, the detector was encapsulated within the
homogenous timber phantom (Figure 4.1 (b)) and irradiated with the planned 3DCRT treatment.
The irradiation was repeated with EBT3 Film within the homogeneous timber phantom and the
results of the axial beam profiles from the two detectors compared.

4.2.2 Phantom Scattering Conditions
The DUO detector was encapsulated in three different phantoms to simulate various scattering
conditions. Figure 4.1 illustrates the materials of the various phantoms in cross-section, with silicon
representing the detector. The first scattering condition, Figure 4.1(a), consists of homogenous Solid
Water (GAMMEX, WI, USA) surrounding the detector, the second scattering condition is
composed of homogenous timber as an analogue for lung material with a density of approximately
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0.4 g/cm3, Figure 4.1(b). Figure 4.1(c) represents the phantom designed to mimic the heterogeneous
conditions of a tumour within the lung, consisting of a Solid Water spherical target with diameter
of 1 cm within timber.

Figure 4.1 Cross-sections illustrating the material composition of the three scattering conditions
investigated and dimension of air gap. (a) Homogenous Solid Water phantom. (b) Homogenous
timber phantom. (c) Heterogeneous timber phantom with Solid Water target.

4.2.3 Film Dosimetry
Gafchromic EBT3 film (Ashland Inc., Wayne, NJ, USA) was used as the benchmark for the profile
measurements due to its high spatial resolution, dosimetric accuracy (Sorriaux, 2013) and energy
independence in the MV photon energy range (Borca, 2013). EBT3 film is a self-developing
dosimetry film offering symmetrical layer configuration. A single active radiochromic layer of
30µm nominal thickness is laminated between two transparent polyester layers of 125µm nominal
thickness (Huet, 2014).

The EBT3 film was scanned before and 72 hours after irradiation, maintaining identical orientation
in transmission mode using a MicroTek scanner without image corrections. Six scans were taken of
each film piece in 48-bit RGB colour mode with a resolution of 72 dpi. The images were saved in
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the .TIFF file format and were analysed and converted to optical density (OD) using ImageJ 1.47v.
A second-order polynomial was generated from an associated calibration curve acquired from the
same film batch. Using a net optical density protocol, the red colour channel information was
converted from pixel value to OD to dose (Butson, 2006). Line profiles along the central axis of the
EBT3 film pieces were examined for comparison to profiles acquired with DUO.

4.2.4 Dynamic treatment plan delivery
4.2.4.1sDMG linear detector array
The sDMG detector was placed upon a HexaMotion 6D Motion platform manufactured by
Scandidos (Sweden). The HexaMotion platform is capable of replication of motion along 6 axis of
freedom and is designed as accessory for the Delta 4 dosimetry phantom. The prototype of
HexaMotion adopted in this work has been adapted for use with other detectors and dosimetry
systems via the addition of a rigid timber platform between the pedestals. The detectors are
positioned upon the timber platform above 6 cm of Solid Water backscattering, at a depth of 1.5cm
in Solid Water (water equivalent depth) and 100 cm source to axis distance (SAD) (isocentre). The
Calypso motion tracking array is placed above the system, consisting of a panel composed of a series
of coils able to detect the electromagnetic signal from a set of three inductors (transponder beacons)
positioned above the detector upon HexaMotion. The position of the Calypso EM tracking panel is
registered by three infrared cameras to the room coordinate reference system (Shah, 2011) and the
tracking information recorded by Calypso drives the algorithms which modify the position of the
MLC leaves to compensate for motion of the target (Keall, 2014). Within this investigation the
motion of the detector is limited to the ‘x’ and ‘y’ directions only. Figure 4.2(a) illustrates the
direction of the spatial vectors relative to the physical experimental setup, Figure 4.2(b) shows the
quantitative magnitudes of the spatial displacement expected along both spatial axis as a function
of time. The temporal pattern shown in Figure 4.2(b) is indicative of real patient lung motion, the
coordinates are supplied to the HexaMotion via a formatted text file as absolute ‘x’ and ‘y’ spatial
displacements from the origin within the coordinate system of HexaMotion, every 20ms.
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Figure 4.2 (a) The sDMG detector positioned upon the HexaMotion platform above 6cm of Solid
Water for backscatter and beneath 1.5cm of Solid Water. The Calypso motion tracking array is
suspended above the detector, beneath the linac head, with the transponders suspended upon a
foam insert above the detector to enable tracking. (b) The temporal pattern supplied to the
HexaMotion phantom to mimic the motion of a lung in x and y direction during irradiation of the
detector, x direction is into the image.

Square MLC fields of sizes 1x1cm2 and 3x3cm2 are delivered from gantry angle of 0 degrees, to
both the sDMG detector and Gafchromic EBT3 film independently within the experimental setup.
The sDMG is first aligned along the ‘y’ direction of motion (Figure 4.2(a)), acquiring a complete
data set and then rotated 90 degrees to be aligned along the ‘x’ direction to repeat acquisition of the
dataset. The jaws within the linac head are retracted a further 1 cm in each direction from the MLC
leaf end positions to minimise leaf-leakage out of field, without restricting the complete range of
motion necessary for the MLC leaves. From Figure 4.2(b) the maximum displacement is +8mm in
the ‘y’ direction and +2 mm in the ‘x’ direction for this temporal pattern.

The silicon detector, sDMG and the EBT3 film are irradiated with 1000 MU at 600 MUmin -1 with
a 6MV photon beam for three cases; static platform (HexaMotion), dynamic platform without
motion tracking and dynamic platform with motion tracking (MLC tracking enabled). Under the
static platform conditions, the detector is positioned upon the platform, which remains stationary
throughout the treatment time. The first dynamic case consists of the HexaMotion platform
providing the temporal lung motion during the treatment time without motion tracking engaged.
Lastly, the HexaMotion provides the dynamic lung motion during the treatment delivery while the
Calypso system tracks the motion of the RF transponder beacons, relaying this information to the
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MLC to compensate for this motion by re-positioning the beam aperture.

4.2.4.2DUO monolithic detector array
The detector was irradiated using a 6MV Varian 21EX linac (Varian Medical Systems, Palo Alto,
USA) photon beam to assess the performance of the detector and investigate the impact of motion
and scattering conditions upon the delivered dose distribution. DUO placed in each of the phantoms
(Figure 4.1) was placed upon the HexaMotion 6D motion platform. The HexaMotion platform is
capable of replicating motion with 5 degrees of freedom.

The detector and HexaMotion platform were positioned at 100 cm source to axis distance (SAD)
with the gantry at 0 degrees throughout delivery. A series of spatial coordinates in the form of
absolute displacements from origin in the ‘X’ (Left-Right) and ‘Y’ (Superior-Inferior, ‘Sup-Inf’)
directions are supplied to the platform. The platform drives to the coordinates in series, altering the
position of the detector throughout treatment. The motion pattern supplied is a real patient’s lung
motion (Figure 4.2(a)) restricted to two-dimensional motion in the ‘X’ and ‘Y’ axis only, Figure 4.2
(b).

A planning CT was acquired with the detector encapsulated in the heterogeneous phantom (Figure
4.1(c)), positioned upon HexaMotion. From this image dataset, the Solid Water target was
delineated as Gross Tumour Volume (GTV) and a +5 mm margin was applied to the GTV to form
the Planning Target Volume (PTV). A 3-D Conformal Radiotherapy (3DCRT) plan and an Intensity
Modulated Radiotherapy (IMRT) were generated with the Eclipse treatment planning system to
deliver a mean dose of 500 cGy to the PTV for the 3DCRT plan and 540 cGy to the PTV for the
IMRT plan. The 3DCRT plan consisted of a single beam conforming to the PTV using the MLC.
The IMRT plan consisted of a single beam with MLC leaves beginning in a closed position and
sweeping across the field while conforming to the shape of the PTV. The plans were exported to the
linac and delivered to the detector for all experimental configurations (i.e. motion and scattering
conditions).

4.2.4.3Scattering conditions
For dynamic treatment plan delivery to DUO in each scattering condition, the Calypso panel (Varian
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Medical Systems, Palo Alto, USA) was positioned above the moving platform. The location of the
panel within the room coordinate system is determined by three fixed infrared cameras (Shah, 2011).
The position of transponder beacons placed on the platform is recorded. The spatial localization
information provided by Calypso is used to modify the position of the MLC aperture (Keall, 2014).
The linac collimator is rotated such that the driven direction of the leaves is aligned with the SupInf direction (‘Y’ direction, Figure 4.2(b)). A predictive algorithm is applied during MLC tracking
to extrapolate the trends in the targets motion and predict the necessary position of the MLC aperture
to mitigate motion effects and account for the expected time delay between motion detection and
MLC re-positioning (Ruan, 2010).

The generated 3DCRT and IMRT plans are delivered for a series of motion cases: (i) ‘no motion’
(NM) which represents the ideal case where the platform remains stationary at its home position
throughout delivery, (ii) ‘motion’ (M) where the platform is provided with the motion and moves
during delivery with the MLC remaining static and not adapting, (iii) ‘motion+tracking’ (MT), the
platform moves and the MLC tracking system is engaged to track and compensate for identified
motion by adapting the MLC during delivery. The three motion management schemes were repeated
for each of the three phantom scattering conditions.

4.3 Results
4.3.1 DUO Dosimetric Validation
The axial profiles for each motion case are aligned at 50% on the left-hand side penumbra. The 50%
response coordinate is determined relative to the response of the pixel positioned along the central
axis (CAX) of the beam. The charge to dose conversion factor for the DUO is (56.34±0.04)
pC/cGy/pixel. The conversion factor is used to transform the response of the detector from charge
in pC to dose in cGy. Figure 4.3 demonstrates the direct comparison of the dose profiles measured
by DUO to the dose profiles measured using EBT3 Gafchromic film.
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Figure 4.3 Comparison of EBT3 film and DUO beam profiles for 6 MV linac in homogenous
timber phantom. (a) Superior-Inferior direction. (b) Left-Right direction.

Table 4.1 summarises the measurements of Full-Width at Half Maximum (FWHM) and left-hand
side (LHS) penumbral width (PW) between the 20% and 80% response values for the EBT3 film
and DUO.

Table 4.1 Comparison of Full-width at Half Maximum (FWHM) and Penumbral Width (PW)
measurements for EBT3 Film and DUO in Superior-Inferior (Sup-Inf) and Left-Right directions.
DUO
Profile
Direction

EBT3 Film

Difference (DUO-EBT3)

FWHM
(mm)
±0.02 mm

PW, LHS
(mm)
±0.02 mm

FWHM
(mm) ±0.1
mm

PW, LHS
(mm) ±0.1
mm

ΔFWHM
(mm)

ΔPW (mm)

Sup-Inf

2.48

0.44

2.46

0.51

0.012

-0.065

LeftRight

3.04

0.80

3.05

0.77

-0.015

0.030

4.3.2 Dynamic treatment plan delivery with varying scattering conditions
4.3.2.1sDMG linear detector array
The diagrams in Figure 4.4 present a sample of the measurements of beam profiles along the ‘y’ and
‘x’ direction for the irradiation of the sDMG and EBT3 film by square MLC-defined fields under
static and dynamic platform conditions. The one-dimensional beam profiles reconstructed from the
sDMG detector are compared with profiles extracted under identical conditions from the
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Gafchromic EBT3 film measurements. The beam profiles presented include those of 1 x 1 cm2 in
the ‘y’ and ‘x’ directions and 3 x 3 cm2 in the ‘y’ direction. For the irradiation of the sDMG by the
3 x 3 cm2 field size, the beam is centred on the physical gap between the sequential linear arrays.
The radiation beam profile is reconstructed based on the accurately known distance separating the
ends of the two linear arrays. The response of each channel within the sDMG detector is normalised
to the response of the central axis (CAX) pixel within the profile. The EBT3 film response is
normalised to the response of the pixels occupying a 1 mm window surrounding the CAX of the
beam profile. The beam profiles acquired from both detectors are aligned such that origin lies at the
coordinate corresponding to 50% response of the CAX beam profile pixel for sDMG and CAX beam
axis pixels for the EBT3 film.

(a)

(b)

(c)

(d)

(e)

(f)
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(g)

(h)

(i)

No Motion

Motion

Motion and Tracking

Figure 4.4 6 MV Photon beam profiles measured with sDMG detector and EBT3 film at 1.5 cm deep
and 100 cm SAD (isocentre) for characterisation of high resolution dynamic quality assurance
capabilities with different field sizes. (a) No motion, 1 x 1 cm2, along y-direction. (b) Motion, 1 x 1cm2,
along y-direction. (c) Motion and Tracking, 1 x 1 cm2, along y-direction. (d) No motion, 1 x 1 cm2, along
x-direction. (e) Motion, 1 x 1 cm2, along x-direction. (f) Motion and Tracking, 1 x 1cm2, along xdirection. (g) No motion, 3 x 3 cm2, along y-direction. (h) Motion, 3 x 3 cm2, along y-direction. (i)
Motion and Tracking, 3 x 3 cm2, along y-direction.

An investigation was conducted to evaluate the quantitative agreement between the EBT3 film and
sDMG datasets using MATLAB (R2013a MathWorks) as in 3.2.6. The right-hand side (RHS) PW
(20%-80%) and FWHM (50%-50%) were calculated and compared between the detectors. The
average uncertainty across all measurements with the sDMG detector is ±1.5 %, induced by the RF
generated by Calypso, which effects the SNR of the DAQ system. The results are summarised,
including the associated percentage difference between the datasets, in Table 4.2.

Table 4.2 sDMG and EBT3 film measurement FWHM and penumbral width (20%-80%)
comparison for cases without motion, with motion and with motion and tracking enabled.

sDMG
Field
size
(mm)

10

30

Case

Percentage
Difference (sDMGEBT3)

EBT3

FWHM
(mm)
±0.01mm

Penumbra,
RHS
(mm)
±0.01mm

FWHM
(mm)
±0.1mm

Penumbra,
RHS
(mm)
±0.1 mm

ΔFWHM
(%)

ΔPenumbra
(%)

No Motion

11.39

2.94

11.4

2.6

-0.09

11.56

Motion

11.99

4.94

11.9

4.6

0.75

6.88

Motion&Tracking

11.20

3.98

11.1

3.4

0.90

14.57

No Motion

31.00

3.67

30.6

3.1

1.3

15.53

Motion

30.53

5.43

31.0

5.4

-1.54

0.55

Motion&Tracking

30.75

4.77

31.0

4.3

-0.81

9.85
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The motion supplied to the HexaMotion platform, experienced by the detectors, demonstrates a clear
baseline shift along the ‘y’ axis of motion, Figure 3.1(b). This baseline shift is approximately +4
mm in magnitude from the platform origin and effectively distorts the dose profile along the ‘y’ axis
in the positive ‘y’ direction.

Table 4.2 summarises the quantitative analysis of the independent detectors datasets and highlights
the agreement between the devices. The agreement observed between the measurements of FWHM
of the static and dynamic radiation field sizes was within 1.73 %. The most significant disagreement
between the detectors was observed in the penumbral width measurements with a maximum spatial
difference of 0.82 mm for the 3x3cm2 static radiation field. Both datasets from the independent
detectors confirm the effectiveness of MLC tracking to reduce the impact of dose smearing
attributed to the supplied lung motion.

Figure 4.4 (d), (e) and (f) present the results of measurements taken along the ‘x’ direction of motion,
evident in Figure 4.2(a). The ‘x’ motion supplied to the motion platform possesses an absolute
spatial displacement in the ‘x’ direction of maximum 2 mm. This limits the effective distortion
occurring to the reconstructed profile along this direction of motion. The beam profiles are still
distorted by the ‘y’ component which is evident in Figure 4.4(e) and partially compensated in Figure
4.4(f). The distal penumbral regions of the profiles illustrate the effect of MLC inter-leaf leakage,
radiation escapes along the edges of the MLC leaves until the retracted jaws shield the out of field
regions.

4.3.2.2 DUO monolithic detector array
Axial profiles of a 6MV linac photon beam for the three separate motion cases with three different
scattering conditions and two different treatment modalities were acquired, Figure 4.5 and Figure
4.6. The three motion cases are compared for each of the scattering conditions investigated. The
average uncertainty calculated for the DUO is ±1.5%, induced by fluctuations in the response
baseline by the radiofrequency field generated by Calypso. The measured profiles of the dose
distributions in the Left-Right and Sup-Inf directions are compared using a point-to-point validation
to assess the similarity of the profiles to the ‘no motion’ case. Figure 4.5 illustrates the results and
direct comparison of the three motion cases for each scattering condition with a 3DCRT delivery.
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(a)

(b)
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(c)

(d)

93

(e)

(f)
Figure 4.5 3DCRT 6MV linac beam profiles for the three different scattering conditions and three
different motion cases (No Motion, Motion and Motion+Tracking) using DUO and the
corresponding point-to-point profile comparison. (a) Sup-Inf direction with homogenous Solid
Water phantom. (b) Left-Right direction with homogenous Solid Water phantom. (c) Sup-Inf
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direction with homogenous timber phantom. (d) Left-Right direction with homogenous timber
phantom. (e) Sup-Inf direction with heterogeneous timber and Solid Water target phantom. (f)
Left-Right direction with heterogeneous timber and Solid Water target phantom.

Figure 4.5(a) illustrates the beam profile comparison in the Sup-Inf direction for the homogenous
Solid Water phantom. The impact of the applied motion during treatment is evident because the
central axis of the beam is displaced 0.5 cm and the penumbrae are smeared out with a difference
between the ‘no motion’ and ‘motion’ profiles in the penumbral region at most 340 cGy
(approximately 80%). The deformation or skewing of the profile is attributed to the slow periodicity
of the applied motion pattern. The impact of motion produces a systematic under and overdosing
outside the intended target volume. Implementation of MLC tracking returns the features of the
delivered dose distribution to the ‘no motion’ case, with only small discrepancies in the penumbral
regions at most 85 cGy (approximately 15%). The activation of the predictive algorithm with MLC
tracking results in additional improvements within the penumbral region with the discrepancy
reduced to at most 80 cGy difference. Figure 4.5(b) presents the results of the axial profiles in Solid
Water for the Left-Right direction which is perpendicular to the direction of MLC leaf travel and
shows the interleaf leakage out of field. The impact of the applied motion in this direction is minimal
because the motion has a dynamic magnitude of approximately ± 0.5 mm (X axis in Figure 4.2(a))
and results in minor differences between the profiles.

Figure 4.5(c) and (d) show the axial beam profiles for the homogenous timber phantom. These
profiles exhibit similar features to the Solid Water case. Relative to the homogenous Solid Water
phantom the beam profiles within the lower density homogenous timber phantom show a less flat
in-field dose deposition with broader penumbrae, as expected due to the larger lateral scattering
range of the electrons [22]. Despite the broadening effect of the low-density material, the application
of motion has a significant impact upon the total dose delivered in the Left-Right direction as shown
in Figure 4.5 (d). The motion in the Sup-Inf direction displaces the beam from the central axis of
the detector and the Left-Right profile measures across the beam penumbra where the field has
narrowed leading to under-dosing of at most 150 cGy (Figure 4.5(d)), in direct contrast to Figure
4.5(b) where the effect from motion is almost absent. Introduction of MLC tracking is shown to
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mitigate the effects of the applied motion upon the beam profiles and recovers the characteristics of
the ‘no motion’ profile with minor discrepancies.

The results of axial beam profiles in the heterogeneous timber phantom with hidden Solid Water
target are shown in Figure 4.5(e) and (f). Dose enhancement surrounding the higher density Solid
Water hidden target is evident in the profiles. The effects of the applied motion and implementation
of MLC tracking are similar to the observed effects in the homogeneous timber phantom where the
magnitude of motion and the lateral range of the scattering electrons in the low-density medium
interplay to cause greater discrepancy in the Left-Right direction.

To further investigate the impact of scattering conditions upon MLC tracking a 1D pass/fail gamma
analysis (Low, 1998) was conducted on the 3DCRT results. Determination of the global
normalisation gamma index in absolute dose was achieved with a 2%/2mm (Low, 2003) criterion
and 0% dose threshold for each motion case beam profile compared with the ‘no motion’ case for
DUO, Table 4.3. A 0% dose threshold was selected to include all measurement points within the
comparison.

Table 4.3 Percentage agreement from global gamma analysis for 2%/2mm criterion for SuperiorInferior and Left-Right directions between ‘no motion’ (NM) and ‘motion’ (M) or
‘motion+tracking’ (MT) for 3DCRT plan delivery with DUO.
Superior-Inferior Direction
Motion
Cases

Left-Right Direction

Solid
Water

Homogenous
Timber

Inhomogene
-ous Timber

Solid
Water

Homogenous
Timber

Inhomogene
-ous Timber

NM-M

27.2

19.3

17.7

76.4

4.7

16.1

NM- MT

99.6

100.0

100.0

91.7

86.2

79.5

Table 4.3 shows the global gamma analysis and the effectiveness of MLC tracking to mitigate the
impact of motion. In the Solid Water scattering condition the percentage agreement between ‘no
motion’ and ‘motion’ is 27.2% for the Superior-Inferior direction, with the implementation of MLC
tracking the agreement between the axial profiles becomes 99.6%. For the homogeneous timber
phantom, the motion is shown to have a greater effect as the initial agreement is 19.3%. Motion has
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greater impact in the inhomogeneous timber phantom with the agreement reduced to 17.7%. With
tracking the agreement between the beam profiles is found to be 100% for homogeneous and
inhomogeneous scattering conditions in the Sup-Inf direction. For the Left-Right motion MLC
tracking is shown to improve results for all scattering conditions and thus minimise the effects of
motion upon the delivered dose distribution. It is shown to be less effective in the Left—Right
direction in the inhomogeneous phantom than in the Solid Water phantom, this result may be
attributed to the significant effect of the Sup-Inf motion to displace the central axis of the radiation
beam from central axis of the detector.

The central pixel of the DUO detector was aligned to the linac treatment isocentre by the external
room lasers, this point coincides with the centre of the hidden target and thus the PTV. A region of
interest (ROI) was selected on each of the axial profiles to encompass the exact spatial location of
the PTV (20 mm) and the mean absorbed dose calculated in this ROI and compared across the
motion and scattering conditions investigated. The results of this analysis for the 3DCRT delivery
are shown in Table 4.4 and Table 4.5.

Table 4.4 Mean absorbed dose in PTV for Superior-Inferior axial profiles of 3DCRT delivery.
Solid Water

Homogenous Timber

Inhomogeneous Timber

Motion
Cases

Mean
Dose in
PTV (cGy)

Standard
Deviation

Mean
Dose in
PTV (cGy)

Standard
Deviation

Mean
Dose in
PTV (cGy)

Standard
Deviation

NM

507.2

2.6%

458.6

4.5%

452.8

6.2%

M

430.0

30.0%

390.8

29.0%

392.8

28.7%

MT

504.7

4.3%

452.5

6.3%

448.6

7.5%

Table 4.5 Mean absorbed dose in PTV for Left-Right axial profiles of 3DCRT delivery.
Solid Water

Homogenous Timber

Inhomogeneous Timber

Motion
Cases

Mean
Dose in
PTV (cGy)

Standard
Deviation

Mean
Dose in
PTV (cGy)

Standard
Deviation

Mean
Dose in
PTV (cGy)

Standard
Deviation

NM

510.4

1.4%

468.6

2.3%

463.8

3.9%
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M

509.7

1.1%

428.7

6.3%

436.0

7.6%

MT

509.8

1.4%

467.0

2.5%

462.4

4.5%

The mean absorbed dose in the no motion case with Solid Water scattering achieves the prescription
with 507.2 cGy delivered to the PTV. The introduction of the motion significantly affects the dose
delivered to the PTV in the sup-inf direction, reducing the mean absorbed dose to 430 cGy. The
introduction of the MLC tracking improves the delivery of dose to the PTV, achieving the
prescription with 504.7 cGy mean dose. The introduction of the timber in the homogenous and
inhomogeneous timber scattering conditions significantly affects the mean absorbed dose to the
PTV as the dose in the PTV region decreases due to the significant change in density of the phantom
material. In each case of scattering condition the MLC tracking system works effectively to
compensate for the physical motion of the phantom and detector and achieve a dose delivered to the
target similar to the case without motion.

Figure 4.6 illustrates the results and direct comparison of the three motion cases for each scattering
condition with an IMRT delivery.
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(a)

(b)
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(c)

(d)

100

(e)

(f)
Figure 4.6 IMRT 6MV linac beam profiles for the three different scattering conditions and
three different motion cases (No Motion, Motion and Motion+Tracking) using DUO and the
corresponding point-to-point profile comparison. (a) Sup-Inf direction with homogenous
Solid Water phantom. (b) Left-Right direction with homogenous Solid Water phantom. (c)
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Sup-Inf direction with homogenous timber phantom. (d) Left-Right direction with
homogenous timber phantom. (e) Sup-Inf direction with heterogeneous timber and Solid
Water target phantom. (f) Left-Right direction with heterogeneous timber and Solid Water
target phantom.

Table 4.6 and Table 4.7 present the mean dose results for the ROI analysis over the PTV for the
IMRT delivery. The mean absorbed dose in the Solid Water scattering conditions without motion
achieves the planned dose prescription to the PTV, 540 cGy. Introduction of the clinical patient
motion significantly reduces the dose delivered to the PTV, the application of MLC tracking
mitigates this influence and restores the dose to the PTV. As in the 3DCRT case, the motion is most
influential in the superior-inferior direction. The reduced scattering conditions with the
measurements in timber and inhomogeneous timber results in a reduction of the measured absorbed
dose in the PTV and lessens the overall influential effect of the motion upon the delivered dose. The
measured results, with sliding window IMRT delivery, agree with the 3DCRT results,
demonstrating the efficacy of the MLC tracking system to mitigate the influences of the applied
motion trace upon the delivered dose based upon a representative measurement in the PTV.

Table 4.6 Mean absorbed dose in PTV for Superior-Inferior axial profiles of IMRT delivery.
Solid Water

Homogenous Timber

Inhomogeneous Timber

Motion
Cases

Mean
Dose in
PTV (cGy)

Standard
Deviation

Mean
Dose in
PTV (cGy)

Standard
Deviation

Mean
Dose in
PTV (cGy)

Standard
Deviation

NM

539.9

2.3%

491.6

1.6%

487.2

3.0%

M

484.7

18.3%

445.7

17.7%

456.5

14.9%

MT

535.4

1.4%

497.3

3.3%

485.2

3.6%

Table 4.7 Mean absorbed dose in PTV for Left-Right axial profiles of IMRT delivery.
Solid Water
Motion
Cases

Mean
Dose in
PTV (cGy)

Standard
Deviation

Homogenous Timber
Mean
Dose in
PTV (cGy)
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Standard
Deviation

Inhomogeneous Timber
Mean
Dose in
PTV (cGy)

Standard
Deviation

NM

533.1

3.1%

491.2

2.8%

485.2

4.1%

M

529.0

5.7%

479.7

6.4%

475.2

6.1%

MT

532.1

4.5%

494.2

4.5%

486.9

4.3%

4.4 Discussion
Adaptive radiotherapy (ART) aims to improve the outcome of radiation treatment through reoptimisation of patient treatments based on patient-specific changes in anatomy and biology during
delivery. MLC tracking is one real-time motion adaptive strategy that applies real-time tumour
localisation and tracking to modify and re-position the MLC shape during patient treatment. Patient
specific quality assurance of MLC tracking treatments is complex due to the daily variations in a
patients’ tumour motion track, creating new adaptations each day. The use of the sDMG and DUO
detectors for high spatial resolution beam profiling in motion adaptive radiotherapy lung treatments
with MLC tracking has been investigated through the use of the detectors upon a HexaMotion
motion platform to recreate patient-specific lung motion during irradiation.

Shown in Figure 4.3 are the axial profiles for the Superior-Inferior and Left-Right directions
measured with DUO within the static homogenous timber phantom under exposure by a 6 MV linac
compared with EBT3 film. The shape and features of the profiles are consistent between the
detectors. From Table 4.1, DUO can reconstruct the FWHM of the delivered beam in a low-density
medium with equivalent accuracy to EBT3 film, with at most an absolute difference of 0.015 mm
between the two detectors. For the LHS PW the greatest difference between DUO and EBT3 film
was 0.065 mm, demonstrating the agreement between the detectors.

In all scattering condition cases, and both 3DCRT and IMRT delivery techniques, the introduction
of MLC tracking compensates for the effects of motion upon the dose distribution delivered,
reducing the discrepancy for a motion scenario. MLC Tracking is shown to effectively mitigate the
penumbral smearing and recover the characteristics of the beam profiles and doses delivered without
motion.
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4.5 Conclusion
Small MLC defined square fields were delivered to both the sDMG and EBT3 film for three motion
cases to investigate the detectors dosimetric performance in adaptive deliveries. The cases
investigated include: static platform (no motion), dynamic platform without motion tracking
(motion) and dynamic platform with motion tracking (motion+tracking). The quantitative
agreement between the sDMG and EBT3 film was established through measurement and
comparison of the FWHM and penumbra widths for each beam profile. The agreement between the
sDMG and EBT3 film for measurements of the FWHM of the static and dynamic radiation field
deliveries was within 1.31%. The most significant disagreement between the detectors was observed
in the measurements of the profiles penumbral width, with a maximum spatial difference of 0.58
mm between the individual detectors measurements for the 1 x 1 cm2 dynamic radiation field with
tracking.

It is observed that motion distorts the planned dose profile in the homogenous Solid Water,
homogenous timber and heterogeneous timber phantoms. MLC tracking reduces the dose smearing
significantly as demonstrated by the ‘no-motion’ and ‘motion+tracking’ results. The global gamma
analysis of the axial beam profiles highlights the effectiveness of the MLC tracking system to
compensate for the effects of motion upon delivered dose yielding excellent agreement between
‘motion+tracking’ beam profiles and ‘no-motion’ beam profiles in the 3DCRT delivery. The DUO
and sDMG detectors have proven to be effective tools for pre-treatment verification of real-time
adaptive stereotactic deliveries with high spatial resolution for dose profiling.
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Chapter 5
Quality Assurance in Proton spot scanning
radiation therapy

5.1 Introduction
This chapter aims to introduce the use of the sDMG and DUO detectors for lateral beam profile
measurements in a clinical proton radiation beam, with energy 129.46 MeV, at the Francis H. Burr
Proton Therapy Center (FHBPTC) at Massachusetts General Hospital (MGH). The measured results
from sDMG and DUO for exposure to a proton pencil beam spot, used in proton pencil beam
scanning, will be compared to measurements using a commercially available ion chamber array,
MatriXX, used routinely in the clinic. The experimental results of an investigation will be presented
into the efficacy and accuracy of the sDMG as a fast, independent proton energy verification system.

A published manuscript, of which I am the second author, uses the same experimental data presented
here to compare with Monte Carlo simulations.

Merchant, A. H., Newall, M., Guatelli, S., Petasecca, M., Lerch, M., Perevertaylo, V., Milluzzo, G.,
Petringa, G., Romano, F., Cirrone, G. A. P., Cuttone, G., Jackson, M. and Rosenfeld, A. B. (2017)
‘Feasibility study of a novel multi-strip silicon detector for use in proton therapy range verification
quality

assurance’,

Radiation

Measurements,

10.1016/j.radmeas.2017.03.017.
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106,

pp.

378–384.

doi:

The first page of this manuscript is included in Appendix B.

5.2 Materials and Methods
The following experimental results were acquired at the Francis H. Burr Proton Therapy Center
(FHBPTC) at Massachusetts General Hospital (MGH). The facility consists of a 235 MeV cyclotron
(IBA dosimetry, Schwarzenbruck, Germany) providing a proton beam that is degraded and
transported to one room with two fixed horizontal beams and two gantry equipped rooms (Tran,
2017), (DeLaney, 2007). The proton therapy system is capable of delivering a pencil beam spot with
a range of 7 to 32 g/cm2 and a full-width at half maximum (FWHM) of 20 to 35 mm. For a Gaussian
distribution the FWHM is related to the standard deviation, σ, by:

𝐹𝑊𝐻𝑀 = 2√2 ∙ ln 2 𝜎

(5.1)

The experimental measurements were acquired in a clinical therapy room with a rotating gantry for
acquisition of data by the detector arrays with their measurement axes orientated either
perpendicular for lateral profiles or parallel for edge-on acquisitions, to the proton pencil beam
incidence. A pristine Bragg peak (PBP) proton pencil beam spot was used for irradiation of the
detector systems with a spot size (σ) of 11 mm and energy 129.46 MeV at the treatment isocentre,
which corresponds to a FWHM of 25.9 mm in air at isocentre and a range of 12.64 g/cm2 to the
distal 90% of the pristine Bragg peak in the PDD (R90).

5.2.1 Equalisation of detector
The equalisation of the individual sensitivities and gain of each channel in the arrays of the sDMG
and DUO detectors was carried out using a 6 MV linac, as described in 4.2.1. In summary, the
detectors were exposed to the uniform intensity of a 20 x 20 cm2 field size 6 MV photon beam at 10
cm depth in Solid Water with 10 cm of Solid Water backscattering material. The equalisation
correction factor for each channel (CFi) is calculated from the ratio of the individual response of
each detector channel (Ri) to the average response of all channels in the array (𝑅̅ ).
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𝐶𝐹𝑖 =

𝑅𝑖
𝑅̅

(5.2)

The calculated correction factor per channel is uniquely applied to the measured response from each
detector channel in the array.

𝑅𝑖,𝑒𝑞𝑢𝑎𝑙𝑖𝑠𝑒𝑑 =

𝑅𝑖
𝐶𝐹𝑖

(5.3)

5.2.2 Lateral profiles
For the measurement and acquisition of lateral profiles of the PBP proton pencil beam spot, the
detectors arrays; sDMG, DUO and the MatriXX ionization chamber array (IBA dosimetry,
Schwarzenbruck, Germany) were placed upon the patient treatment couch and aligned at the
treatment isocentre using the in-room lasers. The central axis of the detectors were aligned to the
central axis of the proton pencil beam spot, such that the axis of measurement of the detector systems
bisected the beam spot. Various depths of Solid Water were placed on top of the detectors for each
measurement of the proton beam spot lateral profile, with 10 cm of polystyrene material beneath for
backscattering. The following water equivalent depths were investigated; 13.8, 54.5, 105.1 and
125.9 mm with each depth repeated and measured using the sDMG, DUO and MatriXX. In this
experiment the sDMG and DUO detectors are both enclosed within rigid PMMA holders which are
recessed around the detectors at a water equivalent depth of 3.9 mm. The lateral profiles only of the
proton pencil beam spot were analysed and quantitatively compared between the three detector
systems by measuring the FWHM and penumbral widths (80%-20%) of the acquired measurements.
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Figure 5.1 Schematic diagram (not to scale) of the experimental setup of DUO detector in proton
pencil beam delivery for lateral profile measurements. Detector is positioned beneath increasing
depths of Solid Water material and aligned with the central axis of the pencil beam and the
treatment isocentre, setup is repeated for sDMG and MatriXX.

5.2.3 Edge-on acquisition
The edge-on acquisition of the proton pencil beam at MGH was conducted with the sDMG detector
aligned using the in-room lasers to the treatment isocentre, with measurement axis of the detector
parallel to the beam incidence. The gantry of the proton therapy delivery system was rotated to 270°
to simplify setup of the system, Figure 5.2. Various depths of a polystyrene phantom material are
placed in front of the linear array detector, manually degrading the energy of beam exiting the snout,
until the pristine Bragg peak occurs within the sDMG and thus within the silicon sensitive volumes.
Additional polystyrene phantom material is placed above and below the detector to improve
scattering conditions. The depth of the sDMG detector in polystyrene is varied with depths
investigated of 60, 70, 80 and 90 mm of polystyrene in front of the sDMG detector.
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(a)

(b)
Figure 5.2 Schematic diagram (not to scale) of the experimental setup of edge-on acquisition of
proton pencil beam spot delivery for pristine Bragg peak energy reconstruction with sDMG. (a)
Schematic of experimental setup, various depths of polystyrene are placed in front of the detector.
(b) Delivery of proton pencil beam spot to sDMG detector, the treatment isocentre is identified
by the green lasers, aligned to the front of the sDMG.

5.2.4 Energy Reconstruction
Energy reconstruction of the incident proton pencil beam spot is achieved through accurate
measurement of the location of the pristine Bragg peak in silicon within the sDMG linear detector
array. The proton pencil beam to which the sDMG is exposed is mono-energetic, with energy of
129.46 MeV at the treatment isocentre, which corresponds to a range of 12.64 g/cm 2 to the distal
90% of the pristine Bragg peak in the PDD (R90). Polystyrene phantom material of varying
109

thicknesses are placed in front of the sDMG detector to degrade the energy of the beam and vary
the position at which the pristine Bragg peak occurs within the silicon detector array. The physical
measurement of the spatial coordinate of the initial Bragg peak, with depth in silicon, provides an
effective means of determining the incident energy of the proton beam upon the detector based on
the known geometry and materials of the phantom surrounding the detector.

The sDMG detector is encapsulated in a complex environment of varying materials which provide
protection, provision of scattering material and a reduction of air surrounding the sensitive volumes
of the detector array. The materials surrounding the silicon detector include; Solid Water and the
printed circuit board (PCB) carrier. Due to the volume of Solid Water surrounding the detector,
upon which the proton beam is incident, a broader scattered Bragg peak from the interaction of
protons in the Solid Water material surrounding the detector is expected beyond the location of the
initial Bragg peak in silicon. This is a result of the difference in the effective mass density of Solid
Water Zeff = 1.032 g/cm3 (Solid Water® HE (GammexTM Technology) - Sun Nuclear, 2020) and the
mass density of silicon, ZSi = 2.33 g/cm3.

The energy of the incident proton beam is determined from the measurement of the Bragg peak in
silicon utilising the assumptions and predictions of Continuous Slowing Down Approximation
(CSDA). The CSDA range approximation assumes that the rate of energy loss of a charged particle
along it’s track while traversing a medium is equal to the total stopping power within that medium,
thus fluctuations in the rate of energy loss are neglected.

Determination of the initial energy of the proton beam upon the phantom surface from the
measurement of the initial Bragg peak position in silicon requires determination of the predicted
energy of the proton beam, which produces the peak in silicon, using the CSDA ranges of protons
in silicon calculated by National Institute of Standards and Technology (NIST). The energy of the
proton beam is thus determined, using the CSDA ranges of protons (Berger, 2017) in the preceding
known thickness of phantom materials, for the various depths, the energy of the proton beam at the
phantom surface can be reconstructed. The CSDA ranges for proton beams with energies from 1 to
235 MeV in silicon, polystyrene and water from NIST are shown in Figure 5.3. Fifth order
polynomials are fitted to the data for each material across the proton energy range and using the
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known geometry of the phantom the energy is reconstructed.

(a)

(b)
Figure 5.3 NIST calculated CSDA range for protons with energy from 1 to 235 MeV for silicon,
polystyrene and water (Berger, 2017). (a) Visualised with Proton Energy as the ordinate and
Projected Range the abscissa. (b) Visualised with Projected Range as the ordinate and Proton
Energy the abscissa.
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5.3 Results
5.3.1 Lateral Profiles
Figure 5.4 presents the results measured from the sDMG detector for 129.46 MeV proton pencil
beam spot at various depths in Solid Water. The lateral profile of the beam spot measured by the
sDMG is compared directly to the clinically measured profiles using the MatriXX ionisation
chamber array under identical setup conditions. The response of the detectors are normalised to the
maximum response at central axis, corresponding to the centre of the beam spot. The lateral profiles
are aligned to the centre of the beam spot.

(a)

(b)

(c)

(d)

Figure 5.4 Lateral profiles of the proton pencil beam spot for varying depths in Solid Water
compared between the sDMG and MatriXX. (a) 1.38 cm water equivalent depth. (b) 5.45 cm
water equivalent depth. (c) 10.51 cm water equivalent depth. (d) 12.59 cm water equivalent depth.
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Agreement between the quantitative measurements of the beam spots’ FWHM and penumbral width
for sDMG and MatriXX are presented in Table 5.1. These results were determined by fitting a sixth
order polynomial to the response values on each side of CAX of the detectors in each array, to
calculate the spatial coordinates of the 20%, 80% and 50% responses relative to the CAX, within
each profile. For the sDMG detector the RHS penumbral width and FWHM are calculated and
compared to the values determined by the MatriXX. The LHS penumbral width is not calculated
due to the size of the pencil beam spot being greater than the length of the sDMG detector.

Table 5.1 sDMG and MatriXX measurements of FWHM and penumbral width for left hand side
(LHS) only (20%-80%) for PBP pencil beam spot at different depths.

sDMG
Water
Equivalent
Depth (mm)

MatriXX

Difference (sDMGMatriXX)

FWHM
(mm)

Penumbra,
RHS (mm)

FWHM
(mm)

Penumbra,
RHS (mm)

ΔFWHM
(mm)

ΔRHS
Penumbra
(mm)

13.8

24.99

13.15

27.0

13.3

-2.01

-0.15

54.5

25.02

13.41

27.3

13.4

-2.28

0.01

105.1

26.34

14.06

27.8

13.6

-1.46

0.46

125.9

28.03

14.91

28.3

13.5

-0.27

1.41

Figure 5.5 presents the results acquired from the DUO detector for the 129.46 MeV proton pencil
beam spot, at the various depths in Solid Water investigated. The lateral profiles of the beam spot
measured by DUO are compared directly to the clinically measured profiles using the MatriXX
ionisation chamber array, which was exposed under identical experimental setup conditions. The
response of the detectors are normalised to the maximum response at central axis, corresponding to
the centre of the beam spot. The lateral profiles are aligned to the centre of the beam spot.
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(a)

(b)

(c)

(d)

Figure 5.5 Lateral profiles of the proton pencil beam spot for varying depths in Solid Water
compared between DUO and MatriXX. (a) 1.38 cm water equivalent depth. (b) 5.45 cm water
equivalent depth. (c) 10.51 cm water equivalent depth. (d) 12.59 cm water equivalent depth.

Quantitative agreement between the measurements of the beam spot FWHM and penumbral width
determined by DUO and MatriXX are presented in Table 5.2. These results were determined by
fitting a sixth order polynomial to response values each side of CAX of the detectors, in each array,
to calculate the spatial coordinates of the 20%, 80% and 50% responses relative to the CAX within
each profile. The LHS and RHS penumbral widths and FWHM are calculated for DUO and
compared to the values determined by the MatriXX.

Table 5.2 DUO and MatriXX measurement FWHM and penumbral width (20%-80%)
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comparison for PBP pencil beam spot for different depths.

Water
Equival
ent
Depth
(cm)

DUO

FWHM
(mm)

Difference (DUOMatriXX)

MatriXX

Penumbra
(mm)
LHS

RHS

FWHM
(mm)

Penumbra (mm)
LHS

RHS

ΔFWHM
(mm)

ΔPenumbra
(mm)
LHS

RHS

13.8

26.24

12.34

12.55

27.0

13.7

13.3

-0.76

-1.36

-0.75

54.5

27.48

12.82

13.04

27.3

13.9

13.4

0.18

-1.08

-0.36

105.1

28.39

13.26

13.47

27.8

14.2

13.6

0.59

-0.94

-0.13

125.9

28.82

13.57

14.01

28.3

14.6

13.5

0.52

-1.03

0.51

The results summarised in Table 5.2 demonstrate agreement between DUO and MatriXX in
measurement of the FWHM to within 1 mm over the range of water equivalent depths investigated.

5.3.2 Edge-on acquisition
The sDMG is exposed to a mono-energetic proton beam, with energy of 129.46 MeV at the
treatment isocentre, which corresponds to a range of 12.64 g/cm 2 to the distal 90% of the pristine
Bragg peak in the PDD (R90). Polystyrene phantom material is placed in front of the detector in a
series of thicknesses including; 60, 70, 80 and 90 mm. A coordinate system considering only depth
in silicon is used for analysis of the measured results and determination of the spatial coordinate of
the initial Bragg peak in silicon.
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Figure 5.6 Schematic diagram (not to scale) of the experimental setup of the sDMG in edge-on
acquisition with “Depth in Silicon” coordinate system described.

Figure 5.7 shows the measured results of the edge-on acquisition of the proton pencil beam spot for
varying thickness of polystyrene phantom material in front of the detector. The response of the
detector is normalised to the peak position of the Bragg peak for each individual depth investigated
as accurate determination of the spatial coordinate in depth in silicon is the necessary measurement
result.

(a)
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(b)

(c)

(d)
Figure 5.7 Results of the edge-on acquisition with sDMG in a proton pencil beam spot with
varying thickness of polystyrene phantom material in front of the detector, with measured initial
Bragg peak position highlighted in each callout box. (a) 60 mm polystyrene. (b) 70 mm
polystyrene. (c) 80 mm polystyrene. (d) 90 mm polystyrene.
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Table 5.3 summarises the results of the measured Bragg peak positions in silicon and the
subsequently reconstructed proton beam energy at the phantom surface based on the CSDA range
approximation for the varying thickness of polystyrene phantom material investigated. Based on the
results of the experiment, the energy determined for the proton pencil beam incident upon the sDMG
detector was calculated to be 129.2 ± 0.49 MeV (this uncertainty is quoted with a coverage factor
of k = 2). The measurement agrees with the delivered energy of 129.46 MeV at isocentre, within
the statistical uncertainty quoted of the measurement of the energy of the incident proton pencil
beam using the sDMG.

Table 5.3 Results of the measured Bragg peak in silicon using the sDMG in edge on acquisition
Polystyrene phantom material
preceding sDMG
(mm)
(± 0.5 mm)

Measured Bragg peak
position in silicon
(mm)
(± 0.2 mm)

Predicted proton energy at
phantom surface, E
(MeV)
(± 0.2 MeV)

60

24.4

129.5

70

18.8

129.4

80

13.0

129.1

90

7.0

128.9

5.4 Discussion
With the advent of proton pencil beam scanning systems, accurate beam data commissioning and
beam modelling measurements are vital for the treatment delivery commissioning process.
Establishing effective, independent and accurate means of conducting routine QA including
identifying tools for routine quality assurance checks is necessary for efficient and safe delivery of
advanced radiotherapy.

The sDMG and DUO detector systems were investigated for their capabilities to provide rapid,
accurate and high spatial resolution measurements of a proton pencil beam spot and compared to
the measured results of the MatriXX ionisation chamber array. The centre-to-centre distance
between the ionization chambers of the MatriXX ionization chamber array is 7.62 mm (MatriXX Universal Detector Array | IBA Dosimetry, 2020), compared to the silicon pixel spacing of 0.2 mm
for both the sDMG and DUO detector arrays. In the results presented in Table 5.1 the significantly
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higher spatial resolution of the sDMG detector compared to the MatriXX should result in a more
accurate evaluation of FWHM, however the polynomial interpolation of the RHS spatial coordinate
of the 50% response, in the space between the two silicon chips which compose the linear detector
array of the sDMG, introduces uncertainty in the quantitative evaluation when compared to the
MatriXX. This effect is also influential in the determination of the penumbral width using the
sDMG. As such the agreement between the sDMG and the MatriXX for penumbral width
measurements to within ± 0.5 mm is acceptable for the water equivalent depths 1.38, 5.45 and 10.51
cm. The measurement of the penumbral width at 12.59 cm water equivalent depth for the MatriXX
of 13.5 mm should be greater in magnitude than the measurement at 10.51 cm water equivalent
depth, this outlier generates an increased difference in measurement between the two systems. For
FWHM, the results of Table 5.1 identify a systematic determination of the FWHM quantity to be
less than measured by the MatriXX, this result is produced in part by the smaller volume of each
pixel of the sDMG compared to the volume of the MatriXX ionisation chambers over which the
signal is averaged.

It is evident that the physical dimensions and arrangement of DUO provides distinct advantages in
enabling complete simultaneous two-dimensional acquisition of the proton pencil beam spot, such
that the penumbral width of both LHS and RHS of the lateral profiles are measured simultaneously
and quantified for comparison to the MatriXX, Figure 5.5. Table 5.2 demonstrates that the measured
spot penumbrae are calculated to be sharper with the DUO evaluation than either the MatriXX or
sDMG determinations. However, the sDMG evaluation may be influenced by the increased
uncertainty due to the discontinuity in the profile measurement between the two linear arrays.

A Monte Carlo feasibility study was conducted for the sDMG detector and was related to its use in
proton therapy range verification. The results of this study, which involved Monte Carlo simulation
of the practical experimental measurements conducted in this chapter, demonstrated an excellent
overall agreement between the experimental measurements and the simulation of the Bragg peak
position in silicon, as measured in the sDMG detector (Merchant, 2017). The practical measured
results for proton range verification using the sDMG, which are presented in Figure 5.7, demonstrate
a series of detector pixels which return a measurement of zero. These pixels were found to be nonfunctional due to mechanical stresses.
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5.5 Conclusion
Pencil beam spot profiles are an important characterization parameter of proton radiotherapy
delivery in pencil beam scanning delivery systems. Quantitative measurement of spot profile
characteristics with high spatial resolution detectors provides valuable information to the clinical
department. Using the sDMG and DUO detectors the FWHM and penumbral width (80%-20%)
were quantitatively measured for a proton pencil beam spot at water equivalent depths of 13.8, 54.5,
105.1 and 125.9 mm, with each depth repeated for measurement using the sDMG (Table 5.1), DUO
(Table 5.2) and MatriXX detector systems for comparison. The sDMG and DUO calculated sharper
FWHM and penumbral widths than the MatriXX ionization chamber array.

The sDMG detector was irradiated by the proton pencil beam spot in an edge-on acquisition mode
to investigate a means of fast and independent method of proton beam energy verification. The
reconstructed entrance energy at the phantom surface was calculated to be 129.5 ± 0.2 MeV, 129.4
± 0.2 MeV, 129.1 ± 0.2 MeV and 128.9 ± 0.2 MeV for the thickness of 60, 70, 80 and 90 mm of
polystyrene phantom material respectively, Table 5.3. This results in a mean energy determination
of 129.2 ± 0.49 MeV, which compares accurately with the delivered proton beam energy of 129.46
MeV at the treatment isocentre.

The feasibility of using the high spatial resolution pixelated silicon detector arrays, sDMG and
DUO, for quantitative measurements in proton pencil beam spot scanning systems has been
demonstrated. DUO provides significant advantages in terms of simultaneous and spatially
continuous acquisitions of high resolution dose profiles for accurate penumbral and FWHM
measurements. Both sDMG and DUO demonstrate limitations in terms of capability to measure
proton pencil beam spots beyond 40 mm in size.
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Chapter 6
Energy Verification in heavy-ion radiation
therapy

6.1 Introduction
The previous chapter described the results of independent energy verification measurements using
the sDMG linear detector array in a proton pencil beam with energy 129.46 MeV. This chapter
aims to introduce the use of the sDMG and TERA data acquisition system as a fast, independent
energy verification system for use in charged particle therapy with a heavy ion carbon beam.

A published manuscript, of which I am the second author, uses the same experimental data to
compare with Monte Carlo simulations.

Debrot, E., Newall, M., Guatelli, S., Petasecca, M., Matsufuji, N. and Rosenfeld, A. B. (2018) ‘A
silicon strip detector array for energy verification and quality assurance in heavy ion therapy’,
Medical Physics, 45(2), pp. 953–962. doi: 10.1002/mp.12736.

The first page of this manuscript is included in Appendix B.
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6.2 Materials and Methods
The experimental results presented here were conducted at the Heavy Ion Medical Accelerator in
Chiba (HIMAC) with the National Institute of Radiological Sciences (NIRS), Japan.

The sDMG detector was irradiated in a research bunker with a fixed horizontal beamline using a
mono-energetic 12C ion beam with energy 290 MeV/U. The 12C ion beam exits the vacuum beam
port, within the bunker, and traverses an aluminium scattering filter and approximately 10 m of air
before it is defined by a brass collimator with 10 x 10 cm2 square field opening.

The measurement axis of the sDMG was orientated parallel to the direction of the 12C ion beam for
edge-on acquisitions of the pristine Bragg peak (PBP). The sDMG was carefully aligned to the
central axis of the defined field by measurement and an independent external laser assembly. Known
thicknesses of PMMA phantom material were placed directly in front of the sDMG detector to
degrade the energy of the incident 12C ion beam.

Various thicknesses were investigated to examine the deposition of the pristine Bragg peak within
the sDMG detector. Figure 6.1(a) is a schematic representation (not to scale) of the exposure of the
sDMG in the PMMA phantom to the incident mono-energetic 12C ion beam orientated for edge-on
acquisition. Figure 6.1(b) depicts the real experimental setup of the sDMG detector in edge-on
acquisition mode to the 12C ion beam at HIMAC.

The response of the sDMG detector was equalised for the individual sensitivities and gain of each
channel in the array using a 6 MV linac. This exposure consisted of irradiation of the detector the
uniform intensity of a 20 x 20 cm2 field size 6 MV photon beam at 10 cm depth in Solid Water with
10 cm of Solid Water backscattering material. The equalisation correction factors were calculated
following the procedure described in 5.2.1.
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(a)

(b)
Figure 6.1 Setup of edge-on acquisition of sDMG detector in

12

C ion beam. (a) Schematic

representation (not to scale) of the exposure of the linear detector array to the mono-energetic
carbon ion beam for varying depths in PMMA phantom material. (b) Setup of experimental
measurements at the carbon ion beam facility.

6.2.1 Energy Reconstruction
Energy reconstruction of the incident 12C ion beam is achieved through accurate measurement of
the location of the pristine Bragg peak in silicon within the sDMG linear detector array.

The 12C ion beam is incident upon the surface of the PMMA phantom with energy 290 MeV/U (E 0
in Figure 6.1(a)). The energy of the mono-energetic 12C ion beam degrades as it traverses the PMMA
phantom, with the 12C ion’s reaching maximum range in the sDMG detector, producing a pristine
Bragg peak in the detector. The depth of the pristine Bragg peak in silicon, measured within the
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sDMG detector, is used to reconstruct the residual energy of the

12

C ion beam upon incidence on

the silicon of the sDMG detector (E1 in Figure 6.1(a)).

The energy of the incident 12C ion beam is determined from the measurement of the Bragg peak in
silicon utilising the calculations of the projected range in matter of

12

C ions of the SRIM-2013

software package (Ziegler, 2013), (Ziegler, 2010). SRIM (The Stopping and Range of Ions in
Matter) is Monte Carlo simulation software package which calculates the range and stopping power
of ions traversing different materials using a quantum mechanical treatment of ion-atom collisions.
The software requires input of the type of ion, energy and target material and is able to calculate
(but not limited to) the ion-penetration depth and energy deposition in target material. Using SRIM2013 the projected range of

12

C ions was calculated between 100 MeV/U and 400 MeV/U for

PMMA and silicon. The results were then plotted and fit with third order polynomials for the
calculation and interpolation of; the residual energy (E1) of 12C ions at the entrance to silicon from
Bragg peak measurement in silicon (Figure 6.2(a)), the projected range of
without silicon present (Figure 6.2(b)), and the energy of

12

C ions in PMMA

12

C ions (E0) at the PMMA phantom

surface from measurement of Bragg peak in PMMA without silicon present (Figure 6.2(c)).

(a)

124

(b)

(c)
Figure 6.2 The calculated projected ranges from SRIM-2013 (Ziegler, 2013). (a) Determination
of residual energy of 12C ions at the entrance to silicon from Bragg peak measurement in depth
of silicon. (b) Determination of the projected range of 12C ions in PMMA without silicon present.
(c) Determination of the energy of 12C ions at the PMMA phantom surface from measurement of
Bragg peak in PMMA without silicon present.

125

The energy of the 12C ion beam is reconstructed from the measurement of the pristine Bragg peak
location in the silicon sDMG detector array using the calculation method described above for
various depth of PMMA phantom material.

The sDMG detector is encapsulated in a complex environment of varying materials which provides
protection, provision of scattering material and a reduction of air surrounding the sensitive volumes
of the detector array. The materials surrounding the silicon detector include; Solid Water and the
printed circuit board (PCB) carrier. Due to the energy and nature of the 12C ions in the beam incident
upon the PMMA phantom, unlike in the proton beam irradiation, a secondary phantom scatter peak
is not expected.

6.3 Results
The sDMG is exposed to a mono-energetic 12C ion beam, with energy of 290 MeV/U exiting the
vacuum port. PMMA phantom material is placed in front of the detector in a series of thicknesses
including; 54, 64, 89 and 102 mm. A coordinate system considering only depth in silicon is used for
first visualisation of the measured results with equalisation factor applied, Figure 6.3(a).

The overall shape of the pristine Bragg peak measured by the sDMG detector clearly demonstrates
the peak of maximum dose deposition, which is defined and can be accurately localised in the linear
array. Figure 6.3(b) illustrates the measured results aligned in depth in PMMA, which is used for
localisation of the pristine Bragg peak. The pristine Bragg peak measured by the sDMG detector in
silicon in the 12C ion beam is more defined than compared to the measurements in the proton pencil
beam due to reduced Coulomb scattering in the 12C ion beam.
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(a)

(b)
Figure 6.3 Combined measurements results of sDMG detector exposed to 12C ion beam in edgeon acquisition mode with varying depths of PMMA phantom material preceding detector. (a)
Results presented with abscissa describing the depth of the pristine Bragg peak delivered in depth
in Silicon of linear sDMG array. (b) Results presented with abscissa describing the depth of PBP
delivered in depth in PMMA phantom.

The measurement of the location of the pristine Bragg peak within the silicon detector (at a known
depth in the PMMA phantom) is completed after each acquisition. The energy of the beam (E1) at
entrance to the silicon detector is calculated from the experimental measurement of the location of
the pristine Bragg peak within the detector. The measured location of the pristine Bragg peak in
PMMA (projected range without silicon + build-up PMMA) is determined from this calculated
energy (E1). The energy (E0) at the entrance to the PMMA phantom is calculated from the measured
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location of the pristine Bragg peak in PMMA (without silicon) following the energy reconstruction
method described, 6.2.1.

(a)

(b)
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(c)

(d)
Figure 6.4 Individual measurements results of sDMG detector exposed to 12C ion beam in edgeon acquisition mode with varying depths of PMMA phantom material preceding detector. (a) 54
mm PMMA. (b) 64 mm PMMA. (c) 89 mm PMMA. (d) 102 mm PMMA.

The results of the measurement of the pristine Bragg peak position for a 12C ion beam incident upon
a PMMA phantom of various thicknesses and the subsequent calculation of the energy of the
ion beam at the PMMA phantom surface is presented in Table 6.1.
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Table 6.1 Results of the measurement of the pristine Bragg peak location in the sDMG detector
for various depths of PMMA phantom material and the calculation of the incident 12C ion beam
energy at the PMMA phantom surface (E0).

PMMA
Build-up
Material
(mm)
(± 0.5 mm)

Measured peak
location in
silicon
(mm)
(± 0.2 mm)

Calculated
residual energy,
E1 (MeV/U)
(± 0.7 MeV/U)

Projected range in
PMMA without
silicon from
phantom surface
(mm)
(± 0.7 mm)

Calculated Energy,
E0
(MeV/U)
(± 0.5 MeV/U)

54

48.8

119.5

132.4

278.8

64

42.2

143.7

131.2

277.8

89

27.2

186.3

130.3

278.8

102

19.5

203.4

131.1

280.4

Based on the results of the experiment, the energy determined for the 12C ion beam incident upon
the sDMG detector was calculated to be 278.9 ± 2.1 MeV (this uncertainty is quoted with a coverage
factor of k = 2).

6.4 Discussion
A Monte Carlo simulation of the experimental setup was conducted by Debrot et al. (Debrot, 2018)
with the simulated average energy of the

12

C ion beam at the surface of the PMMA phantom

determined to be 280 ± 0.2 MeV/U. The measurement of 278.9 ± 2.1 MeV using the sDMG over
various thickness of PMMA agrees with the simulated energy of 280 ± 0.2 MeV/U at the PMMA
phantom surface, within the statistical uncertainty quoted for the measurement of the energy of the
incident 12C ion beam using the sDMG. Disagreement between the measured and expected values
for the

12

C ion beam incident at the surface of the PMMA phantom is attributed to potential

uncertainties present in the thicknesses of absorber materials placed in front of the sDMG detector
as well as uncertainties related to the degradation of the energy of the beam prior to incidence upon
the phantom.

The sDMG detector was irradiated in a research bunker with a fixed horizontal beamline using a
mono-energetic 12C ion beam with energy 290 MeV/U. The deposition of the pristine Bragg peak is
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evident in the sDMG detector for each depth of PMMA investigated, shown in Figure 6.4.
Visualised in depth in silicon, Figure 6.3(a), it is also evident that individual smaller peaks occur in
regions of the detector previously irradiated by the 12C pristine Bragg peak. These smaller peaks,
occurring at depths of 21 and 27 mm, are attributed to radiation damage defects generated by the
previous measurement at depth in PMMA, measured with the same sDMG detector.

Additionally, the smaller peaks are evident because the equalisation correction factors applied to the
results acquired by the sDMG detector are generated by uniform MV photon irradiation, thus are
not accounting for the non-linear localised variations in individual sensitivity of the detectors
channels caused by the defects generated by the high LET

12

C radiation at the distal end of the

pristine Bragg peak.

Prolonged exposure of the silicon detector sDMG to the 12C ion beam in edge-on acquisition mode
was found to yield visible radiation damage defects in the form of non-linear localised variations in
individual sensitivity of the detectors channels. The presence of these effects does not influence the
accuracy of the energy reconstruction method described as the defects are highly localised within
the detector.

Deposition of energy beyond the distal edge of the pristine Bragg peak, measured by the sDMG, is
attributed to the lateral scattering of 12C ions into the detector which have a comparatively extended
range in the surrounding scattering materials of the PCB relative to the silicon detector.

6.5 Conclusion
A method of calculating the energy of the incident 12C ion beam from the measurement of the Bragg
peak in silicon was developed utilising the calculated projected range in matter of 12C ions from the
SRIM-2013 software package. The residual energy (E 1) of

12

C ions at the entrance to silicon is

determined from the measurement of the pristine Bragg peak location in silicon, the projected range
of 12C ions in PMMA without silicon present is then calculated and the energy of 12C ions (E0) at
the PMMA phantom surface is determined based on the known thicknesses of PMMA from
calculation of the pristine Bragg peak location in PMMA without silicon present. Based on the
results of the experiment, the energy determined for the
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12

C ion beam incident upon the sDMG

detector was calculated to be 278.9 ± 2.1 MeV (this uncertainty is quoted with a coverage factor of
k = 2). The results of this experimental work demonstrate the feasibility of the sDMG detector for
use in energy verification of a mono-energetic 12C ion beam.
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Chapter 7
Conclusions

7.1 Summary
The Serial Dose Magnifying Glass (sDMG), is a multi-strip silicon detector comprised of two linear
arrays of 128 diodes with pitch 0.2 mm. The radiation damage study illustrates the sDMG detectors’
increase in response and stabilisation of the charge collection efficiency across all pixels within the
array to within +/-5% after 40 kGy of accumulated uniform dose. The linearity of the detector’s
accumulated charge response to delivered dose from a 6 MV linac photon beam was examined
within the range 50 cGy to 500 cGy. The R2 of the linear fitting function was determined to be
0.99999 and the conversion factor found to be 105 pC/cGy/pixel. The sDMG exhibits a maximum
dose per pulse dependence of approximately 40% across the range of 2.1 x 10-5 Gy pulse-1 to 2.78 x
10-4 Gy pulse-1 investigated. The response of the sDMG detector was normalised to the response of
the CC13 ionisation chamber irradiated under identical conditions. These results were used to
generate a series of correction factors to account for the dose per pulse dependence within the sDMG
detector. PDD measurements for the sDMG were compared to a Markus ionisation chamber over
the range 0.5 cm to 25 cm depth in Solid Water. Initially the exhibited agreement between the
Markus IC and sDMG is within +/-8% for depths less than 5 cm in Solid Water, at greater depths
the percentage difference between the sDMG and Markus chamber increases to a maximum of 20%.
The discrepancy between the response of sDMG and the Markus IC is attributed to the intrinsic dose
per pulse dependence of the sDMG. Utilising the calculated correction factors the observed
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maximum difference is reduced from ±20% to ±4% with the sDMG response maintaining agreement
within ±1.27% for depths greater than 1.5cm in Solid Water. A series of output factors for the sDMG
were measured and compared to EBT3 film for field sizes ranging from 0.5 x 0.5 cm2 up to 10 x 10
cm2. For field sizes less than 1.5 x 1.5 cm2 the sDMG is observed to under-respond up to a maximum
of 3.3%, for the field size of 0.5 x 0.5 cm2, relative to EBT3 film. For field sizes greater than 1.5 x
1.5 cm2 the sDMG detector is observed to over-respond relative to EBT3 film with the agreement
remaining within ± 2%. The disagreement between the EBT3 film and sDMG without dose rate
dependence correction is within 8%, with dose rate dependence correction agreement is within
3.1%. Normalised beam profile measurements were conducted for field sizes between 0.5 x 0.5 cm2
and 4 x 4 cm2 and compared between the sDMG and EBT3 film. The sDMG detector exhibited
agreement to within 0.90 % for the determination of the FWHM of the radiation field sizes when
compared with EBT3 film measurements. The disagreement in penumbral width measurements
between sDMG and EBT3 film was found to be at most 60 μm difference for static 6 MV photon
beam delivery. This disagreement between the detectors is restricted to the submillimeter scale and
is at most 0.45 mm in the case of FWHM comparison.

From these measurements of dose linearity, dose per pulse dependence, PDD, beam profiling and
output factor the sDMG was demonstrated to perform accurately and effectively as a QA tool for
small radiation beam deliveries.

The use of the sDMG and DUO detectors for high spatial resolution beam profiling in motion
adaptive radiotherapy lung treatments with MLC tracking has been investigated. The quantitative
agreement between the sDMG and EBT3 film was established through measurement and
comparison of the FWHM and penumbra widths for each beam profile. The agreement between the
sDMG and EBT3 film for measurements of the FWHM of the static and dynamic radiation field
deliveries was within 1.31%. DUO is shown to reconstruct the FWHM of the delivered beam in a
low-density medium with equivalent accuracy to EBT3 film, with at most an absolute difference of
0.015 mm between the two detectors. For the LHS PW the greatest difference between DUO and
EBT3 film was 0.065 mm, demonstrating the agreement between the detectors. In all scattering
condition cases, and both 3DCRT and IMRT delivery techniques, the introduction of MLC tracking
compensates for the effects of motion upon the dose distribution delivered, reducing the discrepancy
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for a motion scenario. MLC Tracking is shown to effectively mitigate the penumbral smearing and
recover the characteristics of the beam profiles and doses delivered without motion.

The DUO and sDMG detectors have proven to be effective tools for pre-treatment verification of
real-time adaptive stereotactic deliveries with high spatial resolution for dose profiling.

With the advent of proton pencil beam scanning systems, accurate beam data commissioning and
beam modelling measurements are vital for the treatment delivery commissioning process. The
sDMG and DUO detector systems were investigated for capabilities to provide rapid, accurate and
high spatial resolution measurements of a proton pencil beam spot and their results are compared to
the measured results of the MatriXX ionisation chamber array. Using the sDMG and DUO detectors
the FWHM and penumbral width (80%-20%) were quantitatively measured for a proton pencil beam
spot at water equivalent depths of 13.8, 54.5, 105.1 and 125.9 mm, with each depth repeated for
measurement using the sDMG, DUO and MatriXX detector systems for comparison. The sDMG
and DUO calculated sharper FWHM and penumbral widths, respectively than the MatriXX
ionization chamber array.

The sDMG detector was irradiated by the proton pencil beam spot in an edge-on acquisition mode
to investigate a means of fast and independent proton beam energy verification. The reconstructed
entrance energy at the phantom surface was calculated to be 129.5 ± 0.2 MeV, 129.4 ± 0.2 MeV,
129.1 ± 0.2 MeV and 128.9 ± 0.2 MeV for the thickness of 60, 70, 80 and 90 mm of polystyrene
phantom material respectively. This results in a mean energy determination of 129.2 ± 0.49 MeV,
which compares accurately with the delivered proton beam energy of 129.46 MeV at the treatment
isocentre. The sDMG detector was also irradiated using a mono-energetic 12C ion beam with energy
290 MeV/U in edge-on acquisition mode. Based on the results of this experiment, the energy
determined for the 12C ion beam incident upon the sDMG detector was calculated to be 278.9 ± 2.1
MeV (this uncertainty is quoted with a coverage factor of k = 2). The measurement of 278.9 ± 2.1
MeV using the sDMG over various thickness of PMMA agrees with the expected energy of 280 ±
0.2 MeV/U at the PMMA phantom surface, within the statistical uncertainty quoted for the
measurement of the energy of the incident 12C ion beam using the sDMG.
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The sDMG detector is shown to provide a fast, accurate and independent means of range and energy
verification in both proton pencil beams and carbon-ion beams.

Despite the limitations relating to dose per pulse dependence and physical size for both DUO and
sDMG, the detectors have demonstrated uniquely valuable performance in providing high spatial
resolution measurements of small radiation fields in homogenous and heterogeneous scattering
conditions for accurate validation of static and dynamic delivery techniques. Furthermore, an
efficient and practical methodology is presented utilising the sDMG for independent energy
verification in proton and carbon-ion radiation beams.

7.2 Impact & Future Directions
The detailed investigation conducted in this work into the first version of the high spatial resolution
silicon detectors sDMG and DUO, developed at CMRP, and fabricated on bulk silicon substrates,
allowed for a clear demonstration of their advantages and initial shortcomings. These initial
shortcomings and limitations included; discontinuities in measurement axis (sDMG), limiting
overall physical dimensions and dose per pulse dependence. However these limitations were
determined in combination with highly valuable accuracy and performance characteristics with high
spatial resolution. These detectors merit further investigation in both small field photon dosimetry
as well as independent energy verification for proton and heavy-ion therapies.

The importance of this work is that it pioneered firstly the use of the high spatial resolution pixelated
Si dosimeters for QA in EBRT MART and has directly led to the production of the second (low
resistivity bulk) and third generation (epitaxial) silicon 1D and 2D family of CMRP dosimeters
(DMG 256 , DUO, Octa and M512).

Biasi et al. (Biasi, 2018) investigated a 2D monolithic silicon array, fabricated on a high resistivity
p-type epitaxial layer, with 512 detectors across four linear arrays arranged with a shared central
detector and the linear arrays at 45° relative to each other. Output factors, dose profiles, dose per
pulse dependence and PDDs were investigated across flattening filter free and flattened photon
beams of energy 6MV and 10MV.
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Stansook et al. (Stansook, 2019) described and investigated the changes in performance
characteristics of the family of 2D monolithic silicon detector arrays, consisting of M512, DUO and
Octa, which were initially fabricated on bulk p-type substrates and are now subsequently fabricated
on epitaxial p-type substrates. The output factors, off-axis ratios and PDDs in square 6MV and
10MV flattened photon radiation fields were presented.

Causer et al. (Causer, 2019) conducted a preliminary investigation into a monolithic silicon strip
detector (sDMG-256) which consists of 256 detectors in a single continuous linear array, with 0.2
mm pitch on a bulk p-type silicon substrate, for use in a static magnetic field of 1.2 T under exposure
to small photon beams with energy 6MV and 10MV.

Causer et al. (Causer, 2020) reported on an investigation using DUO for Bragg peak detection in a
therapeutic quality proton beam with a 0.95 T transverse magnetic field.

Alnaghy et al. (Alnaghy, 2020) utilised a 512 channel monolithic silicon detector array (M512)
arranged in a 22 x 22 grid, fabricated on an epitaxial p-type silicon substrate, to investigate the
feasibility of dose measurement in a 1.0 T inline MRI-linac during MR imaging.

The initial findings and characterisations conducted in this work, for these detectors in MART and
charged particle radiation therapy, has resulted in advanced performance of CMRP detectors which
is outlined in the many peer review papers of my colleagues at CMRP at the University of
Wollongong.
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Appendices

Appendix A

A. MATLAB scripts

The following scripts were generated in MATLAB for data analysis of decoded detector acquisition
files.

A.1. FindGamma.m
function [ Gamma ] = FindGamma( Measurement, Comparison )
% 20/05/2016
%Find Gamma value between two matrices
% Measurement - LOW Resolution Detector i.e. MagicPlate
% Comparison - HIGH Resolution Film
% The GAMMA answer will possess same dimensions as the measurement
matrix.
%This function/methodology does not work in the other direction, in
terms
%of matrix dimensions...
% Author: Matthew Newall
% Date: 6/10/12
%%
pitchMeasurment = 2.54/75; %define in cm.
pitchComparison = 0.1; %define in cm.
displacement = 0;
DistanceToAgreement = 0.2;
DoseDifference = 0.02;
(decimal)

%Distance to Agreement criterion (cm)
%Percentage dose difference criterion %

maxMeasurment = max(max(Measurement));
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sizeMeasurement = size(Measurement);
sizeComparison = size(Comparison);
TempGamma = zeros(sizeComparison(1),sizeComparison(2));
Gamma = zeros(sizeMeasurement(1),sizeMeasurement(2));
%%
%if sizeMeasurement == sizeComparison
for My = 1:sizeMeasurement(1)
for Mx = 1:sizeMeasurement(2)
for Cy = 1:sizeComparison(1)
for Cx = 1:sizeComparison(2)
dr = ((((Mx*pitchMeasurment)(Cx*pitchComparison))^2)+(((My*pitchMeasurment)(Cy*pitchComparison))^2))/(DistanceToAgreement^2);
dD = ((Measurement(My,Mx) Comparison(Cy,Cx))^2)/((DoseDifference.*maxMeasurment)^2);
TempGamma(Cy,Cx) = dr + dD;
end
end
Gamma(My,Mx) = min(min(TempGamma));
end
end
Gamma = sqrt(Gamma);
%else
%
fprintf=('Matrix sizes do not agree.\n') ;
%end
%%
T = size(Gamma,1)*size(Gamma,2);
u = reshape(Gamma, T, 1);
a=0;
for i=1:T
if u(i,:)>1
a = a+1;
end
end
A = (1-(a/T))*100;
fprintf('\n\tThe number of channels failing is %d out of %d', a, T);
fprintf('\n\tThe agreement across the array is %0.2f\n', A);
end

A.2. FindX.m
function [X] = findX(InputArray, Yvalue, isSDMG, showPlots)
% findX - this function determines the x-axis location of a single yaxis
% normalised value along a gaussian distribution (i.e. beam profile)
via
% interpolation; using the 'piecewise cubic hermite interpolation
% polynomial ('pchipinterp').
%
%
A is a two column array; the first column consists of the x-axis
%
coordinates (in cm), the second column contains the y-axis
coordinates.
%
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%
Yvalue is the y-axis value (whose location is of interest) as a
%
percentage of the maximum value in the profile, expressed as a
decimal
%
e.g. 0.5 to find the "exact" location of the Half Maximums.
%
%
Returns an array, X, containing the x-axis locations of the y-axis
%
values for the Left Hand Side (LHS) and Right Hand Side (RHS) of
the
%
distribution (about the central maximum).
%
%
Nb: The columns MUST be of equal lengths and contain ONLY real
numbers.
%% DETERMINE ACTIONS BASED UPON NUMBER OF INPUTS.
if nargin == 2
isSDMG = 0;
showPlots = false;
elseif nargin == 3
showPlots = false;
end
%% HIDDEN PARAMETERS.
% InputArray(:,1) = XinputVector;
% InputArray(:,2) = YinputVector;
useMaximumOfProfile = 0; % 0 -> No, 1-> Yes.
%% sDMG ONLY - Interpolate across gap between DMG's to find 'true'
maximum.
if isSDMG == 1
%% COMPLETE THE ARRAY.
ArrayToFit = InputArray;
% Identify outliers (dead channels) to remove based upon 'n' and
'sigma' values.
n = 8;
sigma = 1.5;
[~,I] = hampel(ArrayToFit(:,2),n,sigma);
ArrayToFit(I,:) = [];
% Plot outlier identification.
if showPlots == true
figure;
subplot(1,2,1);
title('Determine Outliers in Data');
scatter(InputArray(:,1),...
InputArray(:,2),...
40,...
'MarkerFaceColor',[0 0 .8]);
box on
xlabel('Distance (cm)');
ylabel('Response (counts)');
hold on
plot(InputArray(I,1),InputArray(I,2),'sk','MarkerSize',10);
hold off
legend('Input Data','Identified Outliers');
axis([0 InputArray(end,1) 0 max(ArrayToFit(:,2))*1.2]);
end
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% Cut away known dead channels (unnecessary if filtering with
hampel).
% ArrayToFit(130:134,:) = []; % Cut dead channels for better
fitting.
% Spline or Pchip fitting: pchip fitting provides 'flatter'/lower
maximum -> broader FWHM.
%
FitOfProfile =
fit(ArrayToFit(:,1),ArrayToFit(:,2),'smoothingspline','SmoothingParam'
, 0.999);
FitOfProfile = fit(ArrayToFit(:,1),ArrayToFit(:,2),'pchip');
% Determine resolution of provided profile.
SamplingResolution = InputArray(2,1) - InputArray(1,1);
% Find spatial coordinates across missing interval with identical
% sampling resolution and coordinates of removed dead channels.
IntervalX = [transpose(InputArray(128,1)+SamplingResolution :
SamplingResolution : InputArray(129,1)-SamplingResolution) ;
InputArray(I,1)];
% Determine magnitude of profile from fit at the 'X' spatial
coordinates.
IntervalY = feval(FitOfProfile,IntervalX);
% Concatenate vectors together.
CatArray = [ArrayToFit ; [IntervalX IntervalY]];
% Sort spatial vector into descending order,and then sort the
response vector based
% upon the corresponding swaps.
[CompleteArray,I] = sort(CatArray(:,1),1);
CompleteArray(:,2) = CatArray(I,2);
CentreArray = CompleteArray;
%% PLOT THE FIT, INPUT sDMG DATA AND INTERPOLATED DATA.
if showPlots == true
subplot(1,2,2);
scatter(InputArray(:,1),...
InputArray(:,2),...
40,...
'MarkerFaceColor',[0 0 .8]);
hold on
plot(FitOfProfile);
scatter(IntervalX(:,1),...
IntervalY(:,1),...
40,...
'MarkerFaceColor',[1 0 0]);
hold off
box on
xlabel('Distance (cm)');
ylabel('Response (counts)');
legend('Original Data','Fit','Interpolated Data');
axis([0 InputArray(end,1) 0 max(ArrayToFit(:,2))*1.2]);
end
elseif isSDMG == 2
%% FILTER ANY INPUT ARRAY FOR OUTLIERS ('DEAD' CHANNELS).
ArrayToFit = InputArray;
n = 9;
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sigma = 0.7;
[~,I] = hampel(ArrayToFit(:,2),n,sigma);
ArrayToFit(I,:) = [];
if showPlots == true
figure;
title('Determine Outliers in Data');
scatter(InputArray(:,1),...
InputArray(:,2),...
40,...
'MarkerFaceColor',[0 0 .8]);
box on
xlabel('Distance (cm)');
ylabel('Response (counts)');
hold on
plot(InputArray(I,1),InputArray(I,2),'sk','MarkerSize',10);
hold off
legend('Input Data','Identified Outliers');
axis([0 InputArray(end,1) 0 max(ArrayToFit(:,2))*1.2]);
end
%FitOfProfile =
fit(ArrayToFit(:,1),ArrayToFit(:,2),'smoothingspline','SmoothingParam'
, 0.999);
FitOfProfile = fit(ArrayToFit(:,1),ArrayToFit(:,2),'pchip');
IntervalX = InputArray(I,1);
IntervalY = feval(FitOfProfile,IntervalX);
CatArray = [ArrayToFit ; [IntervalX IntervalY]];
[CompleteArray,I] = sort(CatArray(:,1),1);
CompleteArray(:,2) = CatArray(I,2);
CentreArray = CompleteArray;
else
CentreArray = InputArray;
end
if useMaximumOfProfile == 0;
%% FINDING CENTRE OF ARRAY.
% Downsample data.
DownSampledInputArray = downsample(CentreArray,3);
% Filter out noise in downsampled data.
FilteredDSIA = medfilt1(DownSampledInputArray(:,2),5);
% Calculate the discrete forward derivative of the filtered data.
ForwardDerivative =
diff(FilteredDSIA)./diff(DownSampledInputArray(:,1));
% Determine the spatial coordinates of the max and min peaks.
LHS = DownSampledInputArray(ForwardDerivative ==
max(ForwardDerivative),1);
RHS = DownSampledInputArray(ForwardDerivative ==
min(ForwardDerivative),1);
% Calculate FWHM and estimate centre of profile.
FWHM = (RHS - LHS);
CentreEstimate = LHS + (FWHM/2);
% Find true centre of complete data from downsampled centre.
FindingCentre = (CentreArray(:,1) - CentreEstimate).^2;
% Determine Index of centre value and true centre value.
CentreIndex = find(FindingCentre == min(FindingCentre));
CentreValue = CentreArray(CentreIndex(1),1);
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%% DETERMINE MAXIMUM.
% Empirically determined formula to determine size of ROI to
average over
% for normalisation of profile and accurate percentage
calculation.
AreaOfProfile = (-0.0037602032*(FWHM^3)) + (0.0768540576*(FWHM^2))
+ (0.1020720234*(FWHM)) + (0.0532649909);
% Determine resolution of profile.
SamplingResolution = InputArray(2,1) - InputArray(1,1);
% Calculate number of elements to determine the 'average of',
about the centre.
NumberOfElements = AreaOfProfile/SamplingResolution;
% Round to nearest even integer.
NumberOfElements = 2*round(NumberOfElements/2);
Maximum = mean(CentreArray((CentreIndex(1) - NumberOfElements/2) :
(CentreIndex(1) + NumberOfElements/2) , 2));
%% FIT AND INTERPOLATE LOCATIONS.
FitModelOfInput = fit(CentreArray(:,1),CentreArray(:,2),'pchip');
if showPlots == true
figure;
scatter(InputArray(:,1),...
InputArray(:,2),...
40,...
'MarkerFaceColor',[0 0 .8]);
box on
axis tight;
hold on
plot(FitModelOfInput);
hold off
legend('Input Data','Fit');
xlabel('Distance (cm)');
ylabel('Response (counts)');
axis([0 InputArray(end,1) 0 max(CentreArray(:,2))*1.2]);
end
objective = @(i) FitModelOfInput(i) - (Yvalue*Maximum);
X(1,1) = fzero(objective,[CentreArray(1,1) CentreValue]);
%LHS
X(1,2) = fzero(objective,[CentreValue CentreArray(end,1)]);
%RHS
clearvars pitch y profile_temporary distance_temporary profile_max
profile_fit
%% PLOTTING.
if showPlots == true
figure;
subplot(1,2,1);
scatter(DownSampledInputArray(1:end-1,1),...
ForwardDerivative(:,1),...
40,...
'MarkerFaceColor',[0 0 .8]);
box on
xlabel('Distance (cm)');
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ylabel('First Derivative');
hold on
plot(DownSampledInputArray(ForwardDerivative ==
max(ForwardDerivative),1),ForwardDerivative(ForwardDerivative ==
max(ForwardDerivative),1),'sk','MarkerSize',10);
plot(DownSampledInputArray(ForwardDerivative ==
min(ForwardDerivative),1),ForwardDerivative(ForwardDerivative ==
min(ForwardDerivative),1),'sk','MarkerSize',10);
hold off
legend('Forward Derivative','Identified Max/Min');
subplot(1,2,2);
scatter(InputArray(:,1),...
InputArray(:,2),...
40,...
'MarkerFaceColor',[0 0 .8]);
box on
axis tight;
hold on
plot(FitModelOfInput);
line([InputArray(1,1),InputArray(end,1)],[Maximum,Maximum],'Color','g'
,'LineWidth',1,'LineStyle','--'); % Maximum
line([CentreArray((CentreIndex(1)NumberOfElements/2),1),CentreArray((CentreIndex(1)NumberOfElements/2),1)],[0,max(InputArray(:,2))*1.2],'Color','m','Line
Width',1,'LineStyle','--'); %LHS line of maximum area.
line([CentreArray((CentreIndex(1)+NumberOfElements/2),1),CentreArray((
CentreIndex(1)+NumberOfElements/2),1)],[0,max(InputArray(:,2))*1.2],'C
olor','m','LineWidth',1,'LineStyle','--'); %RHS line of maximum area.
line([X(1,1),X(1,1)],[0,max(InputArray(:,2))*1.2],'Color','k','LineWid
th',1,'LineStyle','--'); %LHS occurence of POI.
line([X(1,2),X(1,2)],[0,max(InputArray(:,2))*1.2],'Color','k','LineWid
th',1,'LineStyle','--'); %RHS occurence of POI.
hold off
legend('Input Data','Fit');
xlabel('Distance (cm)');
ylabel('Response (counts)');
axis([0 InputArray(end,1) 0 max(CentreArray(:,2))*1.2]);
end
else
%% USE THE MAXIMUM IN PROFILE.
FitModelOfInput = fit(InputArray(:,1),InputArray(:,2),'pchip');
MaximumOfInput = max(InputArray(:,2));
CentreOfProfile = InputArray(InputArray(:,2) == MaximumOfInput,1);
objective = @(i) FitModelOfInput(i) - (Yvalue*MaximumOfInput);
X(1,1) = fzero(objective,[InputArray(1,1) CentreOfProfile]);
%LHS
X(1,2) = fzero(objective,[CentreOfProfile InputArray(end,1)]);
%RHS
clearvars MaximumOfInput CentreOfProfile FitModelOfInput objective
end
end
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A.3.calculateEqualisation.m
function [ EqualisationFactors , EqualisationVector ] =
calculateEqualisation( Path , ...
Map )
%calculateEqualisation:
%
%% Select File:
fprintf('DETECTOR RESPONSE - EQUALISATION:\n');
fprintf('\tSelect the file/s to produce equalisation factors.\n');
[FileNames, FilePath] = uigetfile('*.txt', 'Select Decoded Files to
produce Equalisation Array:', Path);
if ischar(FilePath) == 0 && ischar(FileNames) == 0
% If cancel is pressed in pop-up window, function exits returning
0.
fprintf('\tCancel.\n');
EqualisationFactors = 0;
EqualisationVector = 0;
return
else
File = fullfile(FilePath, FileNames);
fprintf('\t\tFile selected: %s.\n',FileNames);
end
%% 0. HIDDEN PARAMETERS.
fprintf('\t2. Generating the equalisation factors...\n');
plotProfile = true;
plotTimeResponse = true;
ChannelNumber = 200;
baselineSubtractionOption = 0; % 0 = Manual, 1 = Automatic, 2 = off.
useForLoop = false;
LowerThreshold = 0.01;
UpperThreshold = 3;
LogicalStr = {'False', 'True'};
fprintf('\t\tPlot Time Response of channel %d: %s\n',ChannelNumber,
LogicalStr{plotTimeResponse + 1});
if baselineSubtractionOption == 0
fprintf('\t\tBaseline Subtraction: Manual\n');
elseif baselineSubtractionOption == 1
fprintf('\t\tBaseline Subtraction: Automatic\n');
elseif baselineSubtractionOption == 2
fprintf('\t\tBaseline Subtraction: Off\n');
end
fprintf('\t\tPlot the result: %s\n', LogicalStr{plotProfile + 1});
fprintf('\t\tRestrict Equalisation Factors below: %0.2f\n',
LowerThreshold);
fprintf('\t\tRestrict Equalisation Factors above: %0.2f\n',
UpperThreshold);
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%% 1. IMPORT DATA.
Data = importdata(File, '\t');
%% 2. SETUP TIME PARAMETERS.
samplingFrequency = 360;
frequency
period = 1/samplingFrequency;
numberOfSamples = size(Data,1);
time = (0:numberOfSamples-1)*period;
time = time';
vector

% Sampling
%
%
%
%

Sampling period
Length of signal
Time vector
Swap to column

%% 3. PLOT DETECTOR RESPONSE AS FUNCTION OF TIME.
if plotTimeResponse == true
figure;
plot(time,(Data(:,ChannelNumber))./65535*100,'LineWidth',1);
axis tight;
box on;
title('Channel Response');
ylabel('Response (%)');
xlabel('Time (s)');
end
%% 4. BASELINE SUBTRACTION OPTIONS.
baselineSubtractionTime = 1;
% Time (in seconds) from end of file
to consider noise over i.e. determines noise ROI.
if baselineSubtractionOption == 0
defaultAns = {num2str(period*(size(Data,1))baselineSubtractionTime),num2str(period*(size(Data,1)))};
answer = inputdlg({'Enter time 1 (s):','Enter time 2
(s):'},'Input',1,defaultAns);
RegionOfInterestLeft =
floor((str2double(answer{1}))*samplingFrequency);
RegionOfInterestRight =
floor((str2double(answer{2}))*samplingFrequency);
else
RegionOfInterestLeft = floor((period*(size(Data,1))baselineSubtractionTime)*samplingFrequency);
RegionOfInterestRight =
floor(period*(size(Data,1))*samplingFrequency);
end
% Calculate Noise.
MeanNoise = (mean(Data( RegionOfInterestLeft : RegionOfInterestRight ,
:))).*size(Data,1);
if baselineSubtractionOption == 2 % 2 - off.
IntegralData = sum(Data);
else
IntegralData = (sum(Data)) - MeanNoise;
end
%% 6. ZERO-OUT NEGATIVE VALUES.
if useForLoop == true
for i = 1 : size(IntegralData,2)
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if(IntegralData(1,i)<0)
IntegralData(1,i) = 0;
end
end
else
[~ , col] = find( IntegralData < 0);
IntegralData(col) = 0;
clearvars row col
end
%% 7.
IntegralMean = mean(IntegralData);
EqualisationVector = IntegralData./IntegralMean;
%% 8. THRESHOLD EQUALISATION FACTORS TO ELIMINATE HIGHS/LOWS.
if useForLoop == true
for i = 1 : size(EqualisationVector,2)
if(EqualisationVector(1,i)<LowerThreshold)
EqualisationVector(1,i) = 1;
end
if(EqualisationVector(1,i)>UpperThreshold)
EqualisationVector(1,i) = 1;
end
end
else
[~, col] = find( EqualisationVector < LowerThreshold);
EqualisationVector(col) = 1;
clearvars row col
[~, col] = find( EqualisationVector > UpperThreshold);
EqualisationVector(col) = 1;
end
%% 9.
EqualisationFactors = rearrange(EqualisationVector,Map);
[row, col] = find(isnan(EqualisationFactors));
for i=1:size(row,1)
EqualisationFactors(row(i),col(i)) = 0;
end
clearvars i
%% 10.
if plotProfile == true
plotProfileFromDetector( EqualisationFactors );
end
fprintf('\t3. Complete!\n\n');
end

A.4. integrateFile.m
function [ Output ] = integrateFile( Path , ...
Map , ...
EqualisationFactors, ...
Mask)
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%FileIntegrate:
%
% Check if equalisation factors are supplied or not, if not supplied
% calculate un-equalised profile.
if nargin == 2
EqualisationFactors = false;
Mask = false;
elseif nargin == 3
Mask = false;
end
%% Select File:
fprintf('\nDETECTOR RESPONSE - INTEGRATION:\n');
fprintf('\t1. Select the file/s to integrate.\n');
[FileNames, FilePath] = uigetfile('*.txt', 'Select Decoded Files for
Analysis:', Path);
if ischar(FilePath) == 0 && ischar(FileNames) == 0
% If cancel is pressed in pop-up window, function exits returning
0.
fprintf('\tCancel.\n');
Output = false;
return
else
File = fullfile(FilePath, FileNames);
fprintf('\t\tFile selected: %s.\n',FileNames);
end
if EqualisationFactors == false
fprintf('\t2. Generating the unequalised integral...\n');
else
fprintf('\t2. Generating the equalised integral...\n');
end
%% 0. HIDDEN PARAMETERS.
plotProfile = true;
plotTimeResponse = true;
ChannelNumber = 200;
baselineSubtractionOption = 2; % 0 = Manual, 1 = Automatic, 2 = off.
useForLoop = false;
filterData = true;
k = 50; % Number of adjacent samples on either side samples in data
over which to compute Hampel Identifier.
nsigma = 0.5; % Number of estimated standard deviations above which
will be filtered.
plotFilteredComparison = false;
plotType = 'charge';
chargeQuanta = 4.8; % (pC) - range 5
if strcmp(plotType,'raw') == true
modifier = 1;
labelY = 'Raw Response (counts)';
elseif strcmp(plotType,'response') == true
modifier = 65535/100;
labelY = 'Normalised Response (%)';
elseif strcmp(plotType,'charge') == true
modifier = 65535/chargeQuanta;
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labelY = 'Charge (pC)';
elseif strcmp(plotType,'dose') == true
%
modifier = 65535/(chargeQuanta*doseConversion);
%
labelY = 'Dose (cGy)';
end
%% DISPLAY OUTPUTS:
LogicalStr = {'False', 'True'};
fprintf('\t\tFilter data: %s\n', LogicalStr{filterData + 1});
if filterData == true
fprintf('\t\t\tHampel Filter, k: %d\n', k);
fprintf('\t\t\tHampel Filter, nsigma: %0.2f\n', nsigma);
end
fprintf('\t\tPlot Time Response of channel %d: %s\n',ChannelNumber,
LogicalStr{plotTimeResponse + 1});
if baselineSubtractionOption == 0
fprintf('\t\tBaseline Subtraction: Manual\n');
elseif baselineSubtractionOption == 1
fprintf('\t\tBaseline Subtraction: Automatic\n');
elseif baselineSubtractionOption == 2
fprintf('\t\tBaseline Subtraction: Off\n');
end
fprintf('\t\tPlot the result: %s\n', LogicalStr{plotProfile + 1});
clearvars LogicalStr
%% NESTED FUNCTIONS.
function [CorrectedIntegral , Integral] = baselineSubtract(file,
data, option, frequency, period, isUnFilteredData)
subtractionTime = 1;
% Time (in seconds) from end of file
to estimate average noise over.
if option == 0
defaultAns = {num2str(period*(size(data,1))subtractionTime),num2str(period*(size(data,1)))};
answer = inputdlg({'Enter time 1 (s):','Enter time 2
(s):'},'Input',1,defaultAns);
RegionOfInterestLeft =
floor((str2double(answer{1}))*frequency);
RegionOfInterestRight =
floor((str2double(answer{2}))*frequency);
else
RegionOfInterestLeft = floor((period*(size(data,1))subtractionTime)*frequency);
RegionOfInterestRight =
floor(period*(size(data,1))*frequency);
end
MeanNoise = (mean(data(RegionOfInterestLeft :
RegionOfInterestRight , :))).*size(data,1);
if option == 2
% If baseline subtraction is selected off.
[CorrectedIntegral , Integral] = sumData(file, data,
frequency, isUnFilteredData);
else
[CorrectedIntegral , Integral] = sumData(file, data,
frequency, isUnFilteredData);
if islogical(CorrectedIntegral) == false
CorrectedIntegral = CorrectedIntegral - MeanNoise;
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end
Integral = Integral - MeanNoise;
end
end
function [ CorrectedIntegral , Integral ] = sumData(file, data,
frequency, isUnFilteredData)
AngleFile = strcat(file(1:end-11),'angles.aux');
if exist(AngleFile,'file') == 2
AngleImport = importdata(AngleFile, '\t');
load('C:\Users\Matt\Google
Drive\MATLAB\Detector\DUO_angularCorrection');
pp =
pchip(DUO_angularCorrection(:,1),DUO_angularCorrection(:,2));
cf = zeros(size(AngleImport,1),1);
for j = 1:size(AngleImport,1)
cf(j,1) = ppval(pp,AngleImport(j,1));
end
correctedData = zeros(size(data,1),size(data,2));
for row = 1:size(data,1)
for col = 1:size(data,2)
correctedData(row,col) = data(row,col)/cf(row,1);
end
end
if isUnFilteredData == false
fprintf('\t\tAngular Correction Applied.\n');
figure;
subplot(1,2,1);
t =
linspace(1,size(AngleImport,1),size(AngleImport,1));
t = t*1/frequency;
scatter(t,AngleImport);
axis square; box on;
xlabel('Time (s)');ylabel('Angle (degrees)');
axis([0 t(end,end) -270 270]);
subplot(1,2,2);
scatter(t,cf);
axis square; box on;
xlabel('Time (s)');ylabel('Correction Factor');
axis([0 t(end,end) 0 2]);
end
CorrectedIntegral = (sum(correctedData));
Integral = (sum(data));
else
if isUnFilteredData == false
fprintf('\t\tNo Angular Correction.\n');
end
CorrectedIntegral = false;
Integral = (sum(data));
end
end
function [ I ] = zeroOut(inputIntegral, useLoop)
if useLoop == true
for j = 1 : size(inputIntegral,2)
if(inputIntegral(1,j)<0)
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inputIntegral(1,j) = 0;
end
end
else
[~ , c] = find( inputIntegral < 0);
inputIntegral(c) = 0;
end
I = inputIntegral;
end
function [UnequalisedIntegral, EqualisedIntegral] =
adjustIntegral(inputVector, inputMap, inputEQFactors)
Array = rearrange(inputVector,inputMap);
if inputEQFactors == false
UnequalisedIntegral = Array;
EqualisedIntegral = false;
else
UnequalisedIntegral = Array;
EqualisedIntegral = Array ./ inputEQFactors;
end
[r, c] = find(isnan(UnequalisedIntegral));
UnequalisedIntegral(r,c) = 0;
clearvars r c
[r, c] = find(isnan(EqualisedIntegral));
EqualisedIntegral(r,c) = 0;
end
%% 1. IMPORT DATA.
DataImport = importdata(File, '\t');
%% 2. SETUP TIME PARAMETERS.
samplingFrequency = 360;
frequency
period = 1/samplingFrequency;
numberOfSamples = size(DataImport,1);
time = (0:numberOfSamples-1)*period;
time = time';
vector

% Sampling
%
%
%
%

Sampling period
Length of signal
Time vector
Swap to column

%% 2.b) Filter Data
if filterData == true
Data = hampel(DataImport,k,nsigma);
else
Data = DataImport;
end
%% 3. PLOT DETECTOR RESPONSE AS FUNCTION OF TIME.
function resize1(source,event)
fig1Pos = fig1.Position;
ax1.Position = [0.1*fig1Pos(3) 0.15*fig1Pos(4) 0.8*fig1Pos(3)
0.75*fig1Pos(4)];
end
if plotTimeResponse == true
fig1 = figure;
fig1.SizeChangedFcn = @resize1;
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ax1 = axes(fig1);
ax1.Units = 'pixels';
ax1.Position = [0.1*fig1.Position(3) 0.15*fig1.Position(4)
0.8*fig1.Position(3) 0.8*fig1.Position(4)];
ax1.Box = 'on';
if filterData == true
plot(ax1,time,(DataImport(:,ChannelNumber))./modifier,'LineWidth',1);
hold(ax1,'on');
plot(ax1,time,(Data(:,ChannelNumber))./modifier,'LineWidth',1);
legend('Unfiltered Data','Hampel Filtered Data');
hold(ax1,'off');
else
plot(ax1,time,(Data(:,ChannelNumber))./modifier,'LineWidth',1);
end
ax1.Title.String ='Channel Response';
ax1.XLabel.String ='Distance (cm)';
ax1.YLabel.String = labelY;
end
clearvars numberOfSamples
%% 4. BASELINE SUBTRACTION OPTIONS.
[AngCorIntegral, Integral] = baselineSubtract(File, Data,
baselineSubtractionOption, samplingFrequency, period, false);
if filterData == true
[UnfiltAngCorIntegral, UnfiltIntegral] = baselineSubtract(File,
DataImport, baselineSubtractionOption, samplingFrequency, period,
true);
else
UnfiltAngCorIntegral = false;
UnfiltIntegral = false;
end
%% 5. ZERO-OUT NEGATIVE INTEGRAL VALUES.
Integral = zeroOut(Integral, useForLoop);
if islogical(AngCorIntegral) == false
AngCorIntegral = zeroOut(AngCorIntegral, useForLoop);
end
if filterData == true
UnfiltIntegral = zeroOut(UnfiltIntegral, useForLoop);
if islogical(UnfiltAngCorIntegral) == false
UnfiltAngCorIntegral = zeroOut(UnfiltAngCorIntegral,
useForLoop);
end
end
%% 6. MAP THE VECTOR INTO THE OUTPUT ARRAY.
[UnEqIntegral, EqIntegral] = adjustIntegral(Integral, Map,
EqualisationFactors);
if islogical(AngCorIntegral) == false
[UnEqAngCorIntegral, EqAngCorIntegral] =
adjustIntegral(AngCorIntegral, Map, EqualisationFactors);
else
UnEqAngCorIntegral = false;
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EqAngCorIntegral = false;
end
if filterData == true
[UnEqUnfiltIntegral, EqUnfiltIntegral] =
adjustIntegral(UnfiltIntegral, Map, EqualisationFactors);
if islogical(UnfiltAngCorIntegral) == false
[UnEqUnfiltAngCorIntegral, EqUnfiltAngCorIntegral] =
adjustIntegral(UnfiltAngCorIntegral, Map, EqualisationFactors);
else
UnEqUnfiltAngCorIntegral = false;
EqUnfiltAngCorIntegral = false;
end
end
%% 7. SELECT CORRECT INTEGRAL.
if islogical(EqualisationFactors) == false
if islogical(EqAngCorIntegral) == false
integral = EqAngCorIntegral;
else
integral = EqIntegral;
end
else
if islogical(UnEqAngCorIntegral) == false
integral = UnEqAngCorIntegral;
else
integral = UnEqIntegral;
end
end
if plotFilteredComparison == true
if islogical(EqualisationFactors) == false
if islogical(EqUnfiltAngCorIntegral) == false
unfiltintegral = EqUnfiltAngCorIntegral;
else
unfiltintegral = EqUnfiltIntegral;
end
else
if islogical(UnEqUnfiltAngCorIntegral) == false
unfiltintegral = UnEqUnfiltAngCorIntegral;
else
unfiltintegral = UnEqUnfiltIntegral;
end
end
end
%%
if size(Mask) > 1
channels = transpose(1:(size(integral,1)-1));
Horiz(:,1) = channels;
Vert(:,1) = channels;
Horiz(:,2) = integral(1:end-1,1);
Vert(:,2) = integral(1:end-1,2);
MaskH = Mask(:,1);
MaskV = Mask(:,2);
Horiz(MaskH,:) = [];
Vert(MaskV,:) = [];
FinalIntegral(:,1) =
interp1(Horiz(:,1),Horiz(:,2),channels,'pchip');
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FinalIntegral(:,2) =
interp1(Vert(:,1),Vert(:,2),channels,'pchip');
FinalIntegral(end+1,:) = 0;
integral = FinalIntegral;
EqIntegral = FinalIntegral;
end
%% 8. PLOT.
pitch = 0.02;
function resize2(source,event)
ax2.Position = [0.1*fig2.Position(3) 0.15*fig2.Position(4)
0.8*fig2.Position(3)/2 0.8*fig2.Position(4)];
ax3.Position = [0.55*fig2.Position(3) 0.15*fig2.Position(4)
0.8*fig2.Position(3)/2 0.8*fig2.Position(4)];
end
fig2 = figure;
orig2Position = fig2.Position;
fig2.Position = [orig2Position(1) orig2Position(2) 2*orig2Position(3)
orig2Position(4)];
fig2.SizeChangedFcn = @resize2;
ax2 = axes(fig2);
ax2.Units = 'pixels';
ax2.Position = [0.1*fig2.Position(3) 0.15*fig2.Position(4)
0.75*fig2.Position(3)/2 0.8*fig2.Position(4)];
ax3 = axes(fig2);
ax3.Units = 'pixels';
ax3.Position = [0.55*fig2.Position(3) 0.15*fig2.Position(4)
0.75*fig2.Position(3)/2 0.8*fig2.Position(4)];
% distance = transpose(((0:(size(Map,1)-1))*pitch));
distance = transpose(1:(size(Map,1)));
if plotProfile == true
if plotFilteredComparison == true
scatter(ax2,distance,integral(:,1),'filled');
hold(ax2,'on');
scatter(ax2,distance,unfiltintegral(:,1),'filled');
hold(ax2,'off');
scatter(ax3,distance,integral(:,2),'filled');
hold(ax3,'on');
scatter(ax3,distance,unfiltintegral(:,2),'filled');
hold(ax3,'off');
else
scatter(ax2,distance,integral(:,1),'filled');
scatter(ax3,distance,integral(:,2),'filled');
end
end
ax2.Box = 'on';
ax2.Title.String ='Horizontal';
ax2.XLabel.String ='Distance (cm)';
ax2.YLabel.String = labelY;
ax2.XLim = [0 max(distance)];
ax3.Box = 'on';
ax3.Title.String ='Vertical';
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ax3.XLabel.String ='Distance (cm)';
ax3.YLabel.String = labelY;
ax3.XLim = [0 max(distance)];
%% 9. ASSEMBLE OUTPUT.
Output.Equalised.Integral = EqIntegral;
Output.Equalised.AngularCorrectedIntegral = EqAngCorIntegral;
Output.Equalised.UnfilteredIntegral = EqUnfiltIntegral;
Output.Equalised.UnfilteredAngularCorrectedIntegral =
EqUnfiltAngCorIntegral;
Output.Unequalised.Integral = UnEqIntegral;
Output.Unequalised.AngularCorrectedIntegral = UnEqAngCorIntegral;
Output.Unequalised.UnfilteredIntegral = UnEqUnfiltIntegral;
Output.Unequalised.UnfilteredAngularCorrectedIntegral =
UnEqUnfiltAngCorIntegral;
Output.EqualisationFactors = EqualisationFactors;
Output.Map = Map;
Output.File = File;
%% Find Channels responsible for penumbra: 20, 50 & 80%
HorizontalOrVertical = 2; % 1 - Horizontal or 2 - Vertical.
function [out] = findChannels(inputdata, R, inputIntegral,
inputMap, HorV)
% Y
in(:,2) = inputIntegral(:,HorV);
% X
pitch = 0.02;
profileSize = size(in,1)-1;
distance = transpose((0:profileSize)*pitch);
in(:,1) = distance;
channel = findX(in,R,2,false);
channel = round(channel./pitch);
if size(Mask) > 1
while Mask(channel(1),HorV) == 1
channel(1) = channel(1)+1;
end
while Mask(channel(2),HorV) == 1
channel(2) = channel(2)+1;
end
end
channel = inputMap(channel,HorV);
out(:,1) = inputdata(:,channel(1));
out(:,2) = inputdata(:,channel(2));
end
Output.TimeResponse = findChannels(Data, 0.5, integral, Map,
HorizontalOrVertical);
figure;
subplot(1,2,1);
plot(time,(Output.TimeResponse(:,1))./modifier,'LineWidth',1);
axis tight;
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box on;
title('LHS Penumbra Channel');
ylabel(labelY);
xlabel('Time (s)');
subplot(1,2,2);
plot(time,(Output.TimeResponse(:,2))./modifier,'LineWidth',1);
axis tight;
box on;
title('RHS Penumbra Channel');
ylabel(labelY);
xlabel('Time (s)');
%%
fprintf('\t3. Complete!\n\n');
end
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Appendix B

B. Co-author works

The following pages detail the first page of manuscripts where I am co-author with a significant
contribution to the study, the experimental data of which relates directly to:



Chapter 6 – “Feasibility study of a novel multi-strip silicon detector for use in proton
therapy range verification quality assurance”, published in Radiation Measurements



Chapter 7 – “A silicon strip detector array for energy verification and quality assurance in
heavy ion therapy” (Debrot, 2018), published in Medical Physics
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